0001004878-14-000350.txt : 20140917
0001004878-14-000350.hdr.sgml : 20140917
20140917143524
ACCESSION NUMBER: 0001004878-14-000350
CONFORMED SUBMISSION TYPE: S-1
PUBLIC DOCUMENT COUNT: 10
FILED AS OF DATE: 20140917
DATE AS OF CHANGE: 20140917
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: 4th Grade Films Inc
CENTRAL INDEX KEY: 0001400683
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MANAGEMENT CONSULTING SERVICES [8742]
IRS NUMBER: 208980078
STATE OF INCORPORATION: UT
FISCAL YEAR END: 0131
FILING VALUES:
FORM TYPE: S-1
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-198797
FILM NUMBER: 141107514
BUSINESS ADDRESS:
STREET 1: 1350 INDEPENDENCE ST.
STREET 2: SUITE 300
CITY: LAKEWOOD
STATE: CO
ZIP: 80125
BUSINESS PHONE: 303-736-2442
MAIL ADDRESS:
STREET 1: 1350 INDEPENDENCE ST.
STREET 2: SUITE 300
CITY: LAKEWOOD
STATE: CO
ZIP: 80125
S-1
1
forms1sept-14.txt
FORM S-1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-1
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
STRAINWISE, INC
-------------------------------------
(Exact name of registrant as specified in its charter)
Utah
----------------------------------------------
(State or other jurisdiction of incorporation or organization)
1389
-----------------------------------------
(Primary Standard Industrial Classification Code Number)
20-8980078
--------------------------------
(I.R.S. Employer Identification Number)
1350 Independence St., Suite 300
Lakewood, CO 80215
(303) 736-2442
----------------------------------------
(Address, including zip code, and telephone number,
including area code, of registrant's principal executive offices)
Shawn Phillips
1350 Independence St., Suite 300
Lakewood, CO 80215
(303) 736-2442
------------------------------------
(Name, address, including zip code, and telephone
number,
including area code, of agent for service)
Copies to:
William T. Hart, Esq.
Hart & Hart, LLC
1624 Washington St.
Denver, CO 80203
(303) 839-0061
As soon as practicable after the effective date of this Registration
Statement (Approximate date of commencement of proposed sale to the
public)
If any of the securities being registered on this Form are to be offered on a
delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933 check the following box: [X]
If this Form is filed to register additional securities for an offering pursuant
to Rule 462(b) under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective
registration statement for the same offering. [ ]
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
1
If this Form is a post-effective amendment filed pursuant to Rule 462(d) under
the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [ ]
Indicate by check mark whether the registrant is a large accelerated filer, an
accelerated filer, a non-accelerated filer, or a smaller reporting company. See
the definitions of "large accelerated filer," "accelerated filer" and "smaller
reporting company" in Rule 12b2 of the Exchange Act.
Large accelerated filer [ ] Accelerated filer [ ]
Non-accelerated filer [ ] Smaller reporting company [X]
(Do not check if a smaller reporting company)
CALCULATION OF REGISTRATION FEE
Title of each Proposed Proposed
Class of Maximum Maximum
Securities Amount Offering Aggregate Amount of
to be to be Price Per Offering Registration
Registered Registered Share (1) Price Fee
---------- ---------- ----------- ------------- ------------
Common stock (2)
--------------------------------------------------------------------------------
Total 4,130,050 $2.50 $10,325,125 $1,330
------------------------------------------------------------------------------
(1) Offering price computed in accordance with Rule 457 (c).
(2) Shares of common stock offered by selling shareholders.
Pursuant to Rule 416, this Registration Statement includes such
indeterminate number of additional securities as may be required for issuance as
a result of any stock dividends, stock splits or similar transactions.
The registrant hereby amends this Registration Statement on such date or
dates as may be necessary to delay its effective date until the registrant shall
file a further amendment which specifically states that this Registration
Statement shall thereafter become effective in accordance with Section 8(a) of
the Securities Act of l933 or until the Registration Statement shall become
effective on such date as the Commission, acting pursuant to said Section 8(a),
may determine.
2
PROSPECTUS
STRAINWISE, INC.
Common Stock
By means of this prospectus a number of our shareholders are offering to
sell up to 2,517,700 shares of our common stock, as well as up to 1,612,350
shares of our common stock issuable upon the exercise of outstanding warrants.
Our common stock is traded on the OTC Bulletin Board under the symbol
"FHGR". On September 11, 2014, the closing price of our common stock was $2.00.
The shares owned by selling shareholders may be sold in the
over-the-counter market, or otherwise, at prices and terms then prevailing or at
prices related to the then current market price, or in negotiated transactions.
We will not receive any proceeds from the sale of the common stock by the
selling stockholders.
Neither the Securities and Exchange Commission nor any state securities
commission has approved or disapproved of these securities or passed upon the
accuracy or adequacy of this prospectus. Any representation to the contrary is a
criminal offense.
THESE SECURITIES ARE SPECULATIVE AND INVOLVE A HIGH DEGREE OF RISK. FOR A
DESCRIPTION OF CERTAIN IMPORTANT FACTORS THAT SHOULD BE CONSIDERED BY
PROSPECTIVE INVESTORS, SEE "RISK FACTORS" BEGINNING ON PAGE 5 OF THIS
PROSPECTUS.
The date of this prospectus is ___________, 2014.
3
PROSPECTUS SUMMARY
We provide the following services to the eight retail marijuana outlets and
one marijuana cultivation and growing facility owned by our Chief Executive
Officer:
o Branding, marketing, administrative and consulting;
o Accounting and financial;
o Compliance.
In addition to the foregoing, we plan to:
o provide nutrients and other cultivation supplies to licensed marijuana
growers;
o provide loans to individuals and business involved in the marijuana
industry; and
o lease equipment and facilities to licensed marijuana growers.
We plan to make these services available to retail stores and cultivation
and growing facilities in the regulated marijuana industry throughout the United
States.
We do not grow marijuana plants, produce marijuana infused products, sell
marijuana plants and/or sell marijuana infused products of any nature.
The Offering
By means of this prospectus a number of our shareholders are offering to
sell up to 2,517,700 shares of our common stock, as well as up to 1,612,350
shares of our common stock issuable upon the exercise of outstanding warrants.
See the section of this prospectus entitled "Selling Shareholders" for more
information.
The purchase of the securities offered by this prospectus involves a high
degree of risk. Risk factors include the lack of any relevant operating history,
losses since we were incorporated, the possible need for us to sell shares of
our common stock to raise capital and our auditors, in their report on our
financial statements for the year ended January 31, 2014 and the period ended
January 31, 2013 expressed substantial doubt as to our ability to continue in
business. See the "Risk Factors" section of this prospectus below for additional
Risk Factors.
As of the date of this prospectus, we had 26,948,884 outstanding shares of
common stock.
Forward-Looking Statements
This prospectus contains or incorporates by reference forward-looking
statements, concerning our financial condition, results of operations and
business. These statements include, among others:
4
o statements concerning the benefits that we expect will result from the
business activities that we contemplate; and
o statements of our expectations, beliefs, future plans and strategies,
anticipated developments and other matters that are not historical
facts.
You can find many of these statements by looking for words such as
"believes", "expects", "anticipates", "estimates" or similar expressions used in
this prospectus.
These forward-looking statements are subject to numerous assumptions, risks
and uncertainties that may cause our actual results to be materially different
from any future results expressed or implied in those statements. Because the
statements are subject to risks and uncertainties, actual results may differ
materially from those expressed or implied. We caution you not to put undue
reliance on these statements, which speak only as of the date of this
prospectus.
To the extent, the information contained in this prospectus, changes in any
material respect, we will amend this prospectus.
RISK FACTORS
This section discloses all material risks known to us. We do not make, nor
have we authorized any other person to make, any representation about the future
market value of our common stock. In addition to the other information contained
in this registration statement, the following factors should be considered
carefully in evaluating an investment in our securities. If any of the risks
discussed below materialize, our current and intended business could fail and
our common stock could decline in value or become worthless.
Risks about our Business
We have a limited operating history and may never be profitable. Since we
recently commenced operations under our new business plan, it is difficult for
potential investors to evaluate our business. We will need to raise additional
capital in order to fund our operations. There can be no assurance that we will
be profitable or that our shares will have any value.
There is substantial doubt about our ability to continue as a going
concern. Our financial statements have been prepared on a going concern basis,
which assumes that we will be able to realize our assets and discharge our
liabilities in the normal course of business for the foreseeable future. We
incurred a loss since inception $(119,100) resulting in an accumulated deficit
of $(119,000) as of April 30, 2014, and further losses are anticipated in the
development of our business.
Our ability to continue as a going concern is dependent upon our becoming
profitable in the future and/or obtaining the necessary financing to meet our
obligations and repay our liabilities arising from normal business operations
when they come due. There is no guarantee that we will be successful in
achieving these objectives.
5
All of our current agreements to provide our services are with affiliated
entities, and were not negotiated at arm's length. Since all of our agreements
to provide services are with affiliated entities and were not negotiated at
arm's length, there is no assurance that others engaged in the marijuana
industry will view the terms and conditions of these agreements and services as
reasonable or fair, which could substantially inhibit our ability to fulfill our
business model and grow. Further, disagreements that may arise among our
affiliated entities could result in the termination of our current agreements,
which could cause our business to fail.
We are dependent on entities controlled by affiliates for all of our
revenue. As of the date of this prospectus, all of our revenue was derived from
companies controlled by Shawn Phillips and Erin Phillips, two of our officers
and directors. Our business would suffer, and may fail, if Mr. and Mrs. Phillips
were unable to meet their financial commitments to us.
Our failure to obtain capital may significantly restrict our proposed
operations. We need capital to operate and fund our business plan. We do not
know what the terms of any future capital raising may be; however, any future
sale of our equity securities will dilute the ownership of existing stockholders
and could be at prices substantially below the price of our shares of common
stock in any pubic market that may exist for such shares. The failure of us to
obtain such capital as required may result in the slower implementation of our
business plan or our inability to continue our business.
Our business is dependent on laws pertaining to the marijuana industry.
Continued development of the marijuana industry is dependent upon continued
legislative authorization of marijuana at the state level. Any number of factors
could slow or halt progress in this area. Further, progress, while encouraging,
is not assured. While there may be ample public support for legislative action,
numerous factors impact the legislative process. Any one of these factors could
slow or halt the lawful public use of marijuana, which would negatively impact
our proposed business.
As of August 31, 2014, 21 states and the District of Columbia allow their
citizens to use Medical Marijuana. Additionally, voters in the states of
Colorado and Washington approved ballot measures last November to legalize
cannabis for adult use. The state laws are in conflict with the federal
Controlled Substances Act, which makes marijuana use and possession illegal on a
national level. The Obama administration has effectively stated that it is not
an efficient use of resources to direct law federal law enforcement agencies to
prosecute those lawfully abiding by state-designated laws allowing the use and
distribution of medical marijuana. However, there is no guarantee that the
administration will not change its stated policy regarding the low-priority
enforcement of such federal laws. Additionally, any new administration that
follows could change this policy and decide to enforce the federal laws
strongly. Any such change in the federal government's enforcement of current
federal laws or the enactment of new or more restrictive laws could cause
significant financial damage to us and our shareholders.
Further, and while we do not intend to harvest, distribute or sell
cannabis, by leasing facilities to growers of marijuana, we could be deemed to
be participating in marijuana cultivation, which remains illegal under federal
law, and may expose us to potential criminal liability, with the additional risk
6
that our properties could be subject to civil forfeiture proceedings.
The marijuana industry faces strong opposition. It is believed by many that
large well-funded businesses may have a strong economic opposition to the
marijuana industry. We believe that the pharmaceutical industry clearly does not
want to cede control of any product that could generate significant revenue. For
example, medical marijuana will likely adversely impact the existing market for
the current "marijuana pill" sold by mainstream pharmaceutical companies.
Further, the Medical Marijuana industry could face a material threat from the
pharmaceutical industry, should marijuana displace other drugs or encroach upon
the pharmaceutical industry's products. The pharmaceutical industry is well
funded with a strong and experienced lobby that eclipses the funding of the
Medical Marijuana movement. Any inroads the pharmaceutical industry could make
in halting or impeding the marijuana industry could have a detrimental impact on
our proposed business.
Marijuana remains illegal under Federal law. Marijuana is a Schedule-I
controlled substance and is illegal under federal law. Even in those states in
which the use of marijuana has been legalized, its use remains a violation of
federal law. Since federal law criminalizing the use of marijuana preempts state
laws that legalize its use, strict enforcement of federal law regarding
marijuana would likely result in our inability to proceed with our business plan
and could cause us to cease our business.
Laws and regulations affecting the marijuana industry are constantly
changing, which could detrimentally affect our proposed operations. Local, state
and federal marijuana laws and regulations are broad in scope and subject to
evolving interpretations, which could require us to incur substantial costs
associated with compliance or alter our business plan. In addition, violations
of these laws, or allegations of such violations, could disrupt our business and
result in a material adverse effect on our operations. In addition, it is
possible that regulations may be enacted in the future that will be directly
applicable to our proposed business. We cannot predict the nature of any future
laws, regulations, interpretations or applications, nor can we determine what
effect additional governmental regulations or administrative policies and
procedures, when and if promulgated, could have on our business.
Potential competitors could duplicate our business model. There are limited
aspects of our business which are protected by patents, copyrights, trademarks
or trade names. As a result, potential competitors could duplicate our business
model with little effort.
We are dependent on our management and the loss of any of our officers
could harm our business. Our future success depends largely upon the experience,
skill, and contacts of our officers. The loss of the services of these officers
may have a material adverse effect upon our business.
Risks about our Common Stock
Disclosure requirements pertaining to penny stocks may reduce the level of
trading activity in the market for our common stock and investors may find it
difficult to sell their shares. Trading of our common stock will be subject to
7
Rule 15g-9 of the Securities and Exchange Commission, which rule imposes certain
requirements on broker/dealers who sell securities subject to the rule to
persons other than established customers and "accredited investors." For
transactions covered by the rule, brokers/dealers must make a special
suitability determination for purchasers of the securities and receive the
purchaser's written agreement to the transaction prior to sale. The Securities
and Exchange Commission also has rules that regulate broker/dealer practices in
connection with transactions in "penny stocks". Penny stocks generally are
equity securities with a price of less than $5.00 (other than securities
registered on certain national securities exchanges or quoted on the NASDAQ
system, provided that current price and volume information with respect to
transactions in that security is provided by the exchange or system). The penny
stock rules require a broker/dealer, prior to a transaction in a penny stock not
otherwise exempt from the rules, to deliver a standardized risk disclosure
document prepared by the Securities and Exchange Commission that provides
information about penny stocks and the nature and level of risks in the penny
stock market. The broker/dealer also must provide the customer with current bid
and offer quotations for the penny stock, the compensation of the broker/dealer
and its salesperson in the transaction and monthly account statements showing
the market value of each penny stock held in the customer's account. The bid and
offer quotations, and the broker/dealer and salesperson compensation
information, must be given to the customer orally or in writing prior to
effecting the transaction and must be given to the customer in writing before or
with the customer's confirmation.
There is no established public market for our common stock, and any market
that may develop could be volatile. There is currently no established public
market for our common stock, and no assurance can be given that any established
public market for our shares will commence, or if one does commence, that it
will continue, in any respect. Interest in our common stock may not lead to a
liquid trading market, and the market price of our common stock may be volatile.
The following may result in short-term or long-term negative pressure on the
trading price of our shares, among other factors:
o Conditions and publicity regarding the life settlement market and
related regulations generally;
o Price and volume fluctuations in the stock market at large, which do
not relate to our operating performance; and
o Comments by securities analysts or government officials, including
those with regard to the viability or profitability of the life
settlement industry generally or with regard to our ability to meet
market expectations.
The stock market has from time to time experienced extreme price and volume
fluctuations that are unrelated to the operating performance of particular
companies.
We are an "emerging growth company," subject to less stringent reporting
and regulatory requirements of other publicly-held companies, and this status
may have an adverse effect on our ability to attract interest in our common
stock. We are an "emerging growth company" as defined in the Jumpstart Our
Business Startups Act of 2012, or "JOBS Act." As long as we remain an "emerging
growth company," we may take advantage of certain exemptions from various
reporting and regulatory requirements that are applicable to other public
8
companies that are not an "emerging growth company." We cannot predict if
investors will find our common stock less attractive if we choose to rely on
these exemptions. If some investors find our common stock less attractive as a
result of any choices to reduce future disclosure, there may be a less active
trading market for our common stock and our stock price may be more volatile.
Our management, who are husband and wife, own approximately 94.7% of our
outstanding common stock and could elect all of our directors who in turn elect
all of our officers. This percentage of stock ownership is significant in that
it could carry any vote on any matter requiring stockholder approval, including
the subsequent election of directors, who in turn elect all officers. As a
result, these persons effectively control the Company, regardless of the vote of
other stockholders. As a result, other stockholders may not have an effective
voice in our affairs. See the section of this prospectus captioned "Principal
Shareholders". This percentage does not include shares underlying outstanding
options or warrants that can be exercised within 60 days.
Future sales of our common stock could adversely affect our stock price and
our ability to raise capital in the future, resulting in our inability to raise
required funding for our operations. Future sales of substantial amounts of our
common stock could harm any market that develops in our common stock. This also
could harm our ability to raise capital in the future. Of the 1,307,000 shares
of our common stock that are freely tradable, approximately 284,000 of such
shares are subject to Lock-Up/Leak-Out Agreements, and no public resale of any
of these securities can be made until November 19, 2014 report (the "Lock-Up
Period"); thereafter, each of holder of these shares of common stock can
publicly sell 1/6th of his, her or its respective holdings during each of the
next six consecutive months, in "broker's transactions" and in compliance with
the "manner of sale" requirements of Securities and Exchange Commission Rule
144, all on a non-cumulative basis, meaning that if no common stock was sold
during any such monthly period while common stock was qualified to be sold, such
shares of common stock cannot be sold in the next successive monthly period (the
"Leak-Out Period"). Notwithstanding the foregoing, the Company can waive these
requirements, pro rata, if it determines in good faith that these agreements may
have an adverse effect on any public market for our common stock that exists at
the time of any such determination. Any sales of substantial amounts of our
common stock in the public market, or the perception that those sales might
occur, could harm the market price, if any, of our common stock. See the section
of this prospectus captioned "Market Price of Common Stock" and "Principal
Shareholders". Further, certain stockholders have registration rights under
which we will be required to register their shares for resale with the
Securities and Exchange Commission; these shares or any registered securities we
may register can also have an adverse effect on any market for our common stock.
We will not solicit the approval of our stockholders for the issuance of
authorized but unissued shares of our common stock unless this approval is
deemed advisable by our Board of Directors or is required by applicable law,
regulation or any applicable stock exchange listing requirements. The issuance
of any additional shares of our common stock could dilute the value of our
outstanding shares of common stock.
9
MARKET FOR OUR COMMON STOCK
Our common stock is quoted on the OTC Bulletin Board under the trading
symbol "FHGR". There has been very limited trading of our common stock since
trading began on August 29, 2014.
With the exception of the 25,641,884 shares issued in connection with the
acquisition of Strainwise Colorado, all outstanding shares of our common stock
have satisfied the resale requirements of Securities and Exchange Commission
Rule 144.
The resale of the shares that we are registering for resale could have a
substantial adverse effect on any market for our common stock. See the "Selling
Shareholders" section of this prospectus for more information.
Holders of our common stock are entitled to receive dividends as may be
declared by the Board of Directors. Our Board of Directors is not restricted
from paying any dividends but is not obligated to declare a dividend. No cash
dividends have ever been declared and it is not anticipated that cash dividends
will ever be paid. We currently intends to retain any future earnings to finance
future growth. Any future determination to pay dividends will be at the
discretion of our directors and will depend on our financial condition, results
of operations, capital requirements and other factors the board of directors
considers relevant.
Our Articles of Incorporation authorize the Board of Directors to issue up
to 5,000,000 shares of preferred stock. The provisions in the Articles of
Incorporation relating to the preferred stock allow directors to issue preferred
stock with multiple votes per share and dividend rights, which would have
priority over any dividends paid with respect to the holders of common stock.
The issuance of preferred stock with these rights may make the removal of
management difficult even if the removal would be considered beneficial to
shareholders generally, and will have the effect of limiting shareholder
participation in certain transactions such as mergers or tender offers if these
transactions are not favored by management.
As of September 12, 2014, and giving effect to the acquisition of
Strainwise Colorado, we had approximately 138 shareholders of record and
26,948,884 outstanding shares of common stock.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATION
The following discussion should be read in conjunction with the financial
statements of Strainwise included as part of this registration statement.
On August 19, 2014 the Company acquired approximately 90% of the
outstanding shares of Strainwise, Inc., a Colorado corporation in exchange for
23,124,184 shares of the Company's common stock. On September 12, 2014 the
Company acquired the remaining outstanding shares of Strainwise Colorado in
exchange for 2,517,700 shares of the Company's common stock.
10
Although, from a legal standpoint, the Company acquired Strainwise on
August 19, 2014, for financial reporting purposes the acquisition of Strainwise
constituted a recapitalization, and the acquisition will be accounted for
similar to a reverse merger, whereby Strainwise was deemed to have acquired the
Company.
Strainwise was incorporated in Colorado as a limited liability company on
June 8, 2012, and converted to a Colorado corporation on January 16, 2014.
However, Strainwise did not begin operations until January 1, 2014, when it
began providing branding and fulfillment services to five grow facilities and
eight retail stores (seven of which sell recreational and medical marijuana to
the public and one of which only sells medical marijuana to the public)
(collectively the "Affiliated Entities") owned by Shawn Phillips, an officer and
director of the Company. As a result, comparison of Strainwise's operating
results for the year ended January 31, 2014, and the three months ended May 31,
2014, would not be meaningful.
Since January 1, 2014, Strainwise has been providing branding and
fulfillments services to the marijuana retail stores and grow facilities owned
by Mr. Phillips. As of August 31, 2014 Strainwise was not providing services to
any other entities.
Strainwise's operating expenses, as a % of revenue, for the year ended
January 31, 2014, were 89%. Strainwise's operating expenses, as a percentage of
revenue, for the three months ended April 30, 2014, were 107%. The increase in
expenses vs. revenue during the three months ended April 30, 2014 was the result
of increased compensation expenses, increased occupancy costs for new grow
facilities, and interest expense.
The Company's estimated capital requirements for the twelve months ending
July 31, 2015 are as follows: (i) approximately $750,000 for lease payments and
operational costs to develop a 65,000 square foot grow facility located in the
metro Denver area, (ii) approximately $300,000 to $500,000 for additional
equipment such as grow lights, electrical upgrades, generators and air
conditioning and (iii) approximately $2,181,500 for payments on our four
operating leases.
When the grow facility is completed, the Company will lease the facility to
affiliated dispensaries.
As of August 31, 2014, 2014, the Company's operating expenses, excluding
payments required for its operating leases, were approximately $153,000 per
month.
Between March 15, 2014 and August 19, 2014, Strainwise Colorado sold
2,224,700 units, at a price of $1.00 per unit, to a group of private investors.
Each unit consisted of one share of Strainwise's common stock and one warrant.
Every two warrants entitle the holder to purchase one share of Strainwise's
common stock at a price of $5.00 per share at any time prior to January 31,
2019. When the Company acquires the remaining shares of Strainwise pursuant to
the short form merger, the Company will exchange its warrants for the
outstanding Strainwise warrants. The warrants to be issued by the Company will
have the same terms as the Strainwise warrants.
11
On March 20, 2014 the Company borrowed $850,000 from an unrelated third
party. The loan bears interest at 25% per year, payable monthly, and matures on
September 21, 2014. On July 16, 2014, the terms of the loan were amended such
that $200,000 of the loan was converted into 293,000 shares of the Company's
common stock and the Company agreed to pay the remaining balance of the loan
($325,000), plus accrued interest and a prepayment penalty of $11,250, prior to
July 29, 2014. The $850,000 loan was used (i) to secure approximately $217,800
of deposits for the future rental and/or purchase of grow facilities to lease to
growers in the industry, (ii) to acquire approximately $175,000 of cultivation
equipment (iii) to make approximately $63,500 of tenant improvements to grow
facilities under lease, (iv) to pay approximately $373,000 of principal and
interest to the note holder, and (v) to pay other miscellaneous expenses
As of August 31, 2014, the Company had borrowed $499,500 from Shawn
Phillips. The loan from Mr. Phillips does not bear interest, is not secured, and
is due on demand. The amount borrowed from Mr. Phillips was used primarily for
the following: (i) approximately $241,000 for payroll, (ii) approximately
$99,500 for nutrient purchases, (iii) approximately $82,000 for occupancy costs
and (iv) approximately $34,300 for general and administrative expenses.
Contractual Obligations
The future minimum payments under the terms of the Company's material
contractual obligations are shown below.
Year Ending January 31,
-----------------------------------------------
Description 2015 2016 2017 2018 2019 Thereafter
----------- ---- ---- ---- ---- ---- ----------
Corporate office
lease $ 59,900 $ 67,400 $ 52,700 $ -- $ -- $ --
Operating Leases 2,121,600 7,208,600 7,265,000 7,476,700 7,585,400 8,123,400
----------- ----------- ----------- ----------- ----------- ---------
Total: $2,181,500 $7,276,000 $7,317,700 $7,476,700 $7,585,400 $8,123,400
The Company will need to raise enough capital to fund its operations until
it is able to earn a profit. The Company does not know what the terms of any
future capital raising may be but any future sales of the Company's equity
securities will dilute the ownership of existing stockholders and could be at
prices below the market price of the Company's common stock. The inability of
the Company to obtain the capital which it requires may result in the failure of
the Company. The Company does not have any commitments from any person to
provide the Company with capital.
Trends
The factors that will most significantly affect the Company's future
operating results, liquidity and capital resources will be:
o Government regulation of the marijuana industry;
12
o Revision of Federal banking regulations for the marijuana industry;
and
o Legalization of recreational marijuana in states other than Colorado
and Washington.
Other than the foregoing, the Company does not know of any trends, events
or uncertainties that have had, or are reasonably expected to have, a material
impact on:
o revenues or expenses;
o any material increase or decrease in liquidity; or
o expected sources and uses of cash.
Critical Accounting Policies and New Accounting Pronouncements
See Notes 1 and 8 to the financial statements included as part of this
registration statement, for a description of the Company's critical accounting
policies and the potential impact of the adoption of any new accounting
pronouncements.
BUSINESS
On August 19, 2014, pursuant to an Agreement to Exchange Securities (the
"Agreement"), we acquired approximately 90% of the outstanding common stock of
Strainwise, Inc., a Colorado corporation ("Strainwise Colorado"), in exchange
for 23,124,184 shares of our common stock.
In connection with the acquisition:
o we caused 1,038,000 shares of our outstanding common stock to be
cancelled;
o Shawn Phillips was appointed a director and the Chief Executive
Officer of the Company;
o Erin Phillips was appointed a director and the President, and
Principal Financial and Accounting Officer of the Company;
o David Modica was appointed a director and Manager of Quality Control
and a director of the Company;
o Shane Thueson, Nicholl Doolin and John Winchester, resigned as
officers and directors of the Company; and
o the Company sold its motion picture film business and related assets
to Shane Thueson.
On September 5, 2014 we changed our name to Strainwise, Inc.
On September 12, 2014 we acquired the remaining outstanding shares of
Strainwise Colorado in exchange for the issuance of 2,517,000 shares of our
common stock. In connection with this transaction:
13
o we issued 1,112,350 Series A warrants to former Strainwise Colorado
shareholders in exchange for a like number of warrants held by the
former Strainwise Colorado shareholders. The Series A warrants we
issued have the same terms as the warrants exchanged by the former
Strainwise Colorado shareholders (exercise price: $5.00 per
share/expiration date: January 31, 2019).
o we issued 500,000 warrants to one non-affiliated person in exchange
for a like number of warrants held by the former Strainwise Colorado
warrant holder. The warrants we issued have the same terms as the
warrants exchanged by the former Strainwise Colorado warrant holder
(exercise price: $0.10 per share/expiration date: January 31, 2019).
Unless otherwise indicated, all references to us include the operations of
Strainwise Colorado.
As a result of the acquisition of Strainwise Colorado, we now provide
services to the regulated marijuana industry.
Presently, cannabis production and sales are largely the domain of
"mom-and-pop" operations that are not as large as they could be since marijuana
remains illegal under federal law and banks and credit card companies are
prohibited from processing marijuana business transactions according to
applicable federal rules and regulations. However, working within state
guidelines, entrepreneurs are moving forward with ambitious cannabis business
strategies. Management believes the current group of retail and cannabis
production companies see potential for increased sales and profits, especially
if they can transition these mom-and-pop operations to mid-sized businesses, and
subsequently transition the mid-sized businesses to larger, national brands.
Shawn Phillips, the founder of Strainwise, owns seven recreational
marijuana retail stores, one medical marijuana store, and three sophisticated
and efficient product cultivation ("grow") facilities, which collectively
contain approximately 80,000 square feet of growing space (the "Affiliated
Entities"). The eight retail stores have been in operation as medical marijuana,
and subsequently, retail marijuana outlets, for between one and three years.
As a result of the ownership and operation of their own retail marijuana
stores and growing facilities, Shawn Phillips, and his wife Erin, are aware that
the operators of many of the potential client stores need the services the
Company plans to provide. Such services are presently beyond the reach (both
financially and operationally) for a large majority of retail owners. The
mom-and-pop owners do not have sufficient economies of scale, nor the level of
management sophistication and background to enable them to fully leverage their
business opportunity within the marijuana industry.
Our branding and fulfillment services are provided under Master Service
Agreements:
o Branding, Marketing and Administrative Consulting Services: Customers
may contract with us to use the Strainwise name, logo and affinity
images in their retail store locations. A monthly fee permits our
14
branding customer to use the Strainwise brand at one specific
location. In addition, we will assist operators in marketing and
managing their businesses, setting up new retail locations and general
business planning and execution at an hourly rate. This includes
services to establish an efficient, predictable production process, as
well as, nutrient recipes for consistent and appealing marijuana
strains.
o Accounting and Financial Services: For a monthly fee, we provide our
customers with a fully implemented general ledger system, with an
industry centric chart of accounts, which enables management to
readily monitor and manage all facets of a marijuana medical
dispensary, retail store and grow facility. We provide bookkeeping,
accounts payable processing, cash management, general ledger
processing, financial statement preparation, state and municipal sales
tax filings, and state and federal income tax compilation and filings
on behalf of the Company and the Captive Stores on an ongoing basis.
o Compliance Services: The rules, regulations and state laws governing
the production, distribution and retail sale of marijuana can be
complex, many times obtuse, and may prove cumbersome with which to
comply. Thus, customers may contract with us to implement a compliance
process, based upon the number and type of licenses and permits for
their specific business. We provide this service on both an hourly
rate and stipulated monthly fee.
o Nutrient Supplier: The Company presently is one of the larger, single
purchasers of nutrients and other cultivation supplies for the sole
purpose of growing marijuana. As a result, we are able to make bulk
purchases with price breaks, based upon volume. We serve as a sole
source nutrient purchasing agent and distributor with pricing based
upon our bulk purchasing power.
o Lending: We will provide loans to individuals and businesses in the
cannabis industry. However, Colorado State law does not allow entities
operating under a cannabis license to pledge the assets or the license
of the cannabis operation for any type of general borrowing activity.
Thus, our lending will be on an unsecured basis, with reliance on a
personal guarantee of the borrower.
o Lease of Grow Facilities and Equipment: We lease grow equipment and
facilities on a turn-key basis to customers in the cannabis industry.
We will also enter into sale lease backs of grow lights, tenant
improvements and other grow equipment.
The Company presently provides these branding and fulfillment services to
the eight retail marijuana outlets and one grow facility owned by Shawn
Phillips. The Company plans to make these services available to independent
retail stores and grow facilities in the regulated marijuana industry throughout
the United States.
15
The Company does not grow marijuana plants, produce marijuana infused
products, sell marijuana plants and/or sell marijuana infused products of any
nature.
Operating Leases
On March 7, 2014, we leased a grow facility containing approximately 26,700
square feet ("Custer Lease") for a term of five years commencing on April 1,
2014. Under the terms of the lease, we paid a security deposit of $29,200. The
lessor will provide all of the tenant improvements that will enable the
continuous cultivation of marijuana plants under 459 grow lights.
On April 1, 2014, we leased a grow facility containing approximately 65,000
square feet ("51st Ave Lease") for a term of five years and nine months,
commencing on August 17, 2014. Under the terms of the lease, we are obligated to
pay a security deposit of $150,000, one-third of which was paid upon the
execution of the lease, the second third of which is due and payable after the
first harvest or by October 1, 2014, and the final third of which is due and
payable after the second harvest or by December 1, 2014. The lessor will provide
all of the tenant improvements that will enable the continuous cultivation of
marijuana plants under 1,680 grow lights.
On April 22, 2014, we leased a grow facility containing approximately
38,000 square feet ("Nome Lease") for a term of seven years, commencing on April
22, 2014. Under the terms of the lease, we paid a security deposit of $133,679.
The lessor will provide all of the tenant improvements that will enable the
continuous cultivation of marijuana plants under 800 grow lights.
On June 10, 2014, we leased a grow facility containing approximately
113,000 square feet ("32nd Ave Lease") for a term of five years and nine months,
commencing on July 1, 2014. Under the terms of the lease, we paid a security
deposit of $250,000, $150,000 of which was paid upon the execution of the lease,
and $100,000 of which will be paid when a certificate of occupancy is issued
(expected in early 2015). The lessor will provide all of the tenant
improvements that will enable the continuous cultivation of marijuana plants
under 1,936 grow lights.
We have the option to renew the leases described above at the end of their
terms at mutually agreed upon rates. There are no options to purchase the
properties underlying these leases.
The future minimum payments under the terms of the Operating Leases are
shown below.
Lease Payments Due During
Year Ending January 31,
----------------------------------------------------------------------
Lease 2015 2016 2017 2018 2019 Thereafter
---- ---- ---- ---- ---- ----------
Custer 59,800 652,900 626,000 481,700 214,700 2,400
51st Ave. 1,058,700 2,616,600 2,662,000 2,772,900 2,893,900 3,206,500
Nome 445,600 549,100 568,100 587,200 625,400 1,289,100
32nd Ave. 557,500 3,390,000 3,408,900 3,634,900 3,851,400 3,625,400
-------- ---------- ---------- ---------- ------------ ---------
Total $2,121,600 $7,208,600 $7,265,000 $7,476,700 $7,585,400 $8,123,400
========== ========== ========== ========== =========== ==========
16
We will sublease the grow facilities described above to the Affiliated
Entities for their grow operations. We expect to charge the Affiliated Entities
approximately 140% of the amount we pay the leasors of these properties.
Master Service Agreements
We provide branding and fulfillment services to eight retail marijuana
stores and one cultivation and growing facility owned by Mr. Phillips.
Pursuant to the terms of these agreements, the marijuana stores and grow
facility collectively pay us $81,500 each month for branding, marketing,
administration, accounting and compliance services. We also supply nutrients to
the one grow facility at a 90% mark-up to our cost for the nutrients.
Our agreements with the marijuana outlets and grow facility expire on
December 31, 2023.
Market Conditions
In Colorado (with 5.1 million residents), the 2013 medical marijuana
market, with approximately 500 licensed dispensaries and 110,000 legal medical
users, is believed to be approximately $200,000,000.
In January 2014, the market was expanded in Colorado to allow adult use,
including adult visitors from other states, of marijuana for recreational
purposes. Voters in Washington State recently approved a ballot measure to
legalize cannabis for adult use. Many experts predict that other states will
follow Colorado and Washington in enacting legislation or approving ballot
measures that expand the permitted use of cannabis.
While projections vary widely, many believe that, as a result of the
legalization of recreational marijuana in 2014, the Colorado medical and
recreational market combined will reach $600,000,000 (according to Colorado
State University).
One study of the marijuana industry predicts that by 2018, it will be a $10
billion industry, according to the January 8, 2014, article in the Huffington
Post. These numbers may be conservative when one considers that the alcohol and
tobacco industries are both $300 billion plus industries.
Government Regulation
Marijuana is a Schedule-I controlled substance and is illegal under federal
law. Even in those states in which the use of marijuana has been legalized, its
use remains a violation of federal law.
A Schedule I controlled substance is defined as a substance that has no
currently accepted medical use in the United States, a lack of safety for use
under medical supervision and a high potential for abuse. The Department of
Justice defines Schedule 1 controlled substances as "the most dangerous drugs of
all the drug schedules with potentially severe psychological or physical
dependence." If the federal government decides to enforce the Controlled
Substances Act in Colorado with respect to marijuana, persons that are charged
with distributing, possessing with intent to distribute, or growing marijuana
could be subject to fines and terms of imprisonment, the maximum being life
imprisonment and a $50 million fine.
17
As of August 31, 2014, 21 states and the District of Columbia allow their
citizens to use Medical Marijuana. Additionally, voters in the states of
Colorado and Washington approved ballot measures last November to legalize
cannabis for adult use. The state laws are in conflict with the federal
Controlled Substances Act, which makes marijuana use and possession illegal on a
national level. The Obama administration has effectively stated that it is not
an efficient use of resources to direct federal law enforcement agencies to
prosecute those lawfully abiding by state-designated laws allowing the use and
distribution of medical marijuana. However, there is no guarantee that the
administration will not change its stated policy regarding the low-priority
enforcement of such federal laws. Additionally, any new administration that
follows could change this policy and decide to enforce the federal laws
strongly. Any such change in the federal government's enforcement of such
current federal laws could cause significant financial damage to the Company and
its shareholders. While the Company does not intend to harvest, distribute or
sell cannabis, the Company may be irreparably harmed by a change in enforcement
by the federal or state governments or the enactment of new and more restrictive
laws.
General
The Company's offices are located at 1350 Independence Street, Suite 300,
Lakewood, CO 80215. The Company leases its offices from an entity controlled by
Erin Phillips, the President and a director of the Company. The lease is for a
31 month period, commencing in January 2014 for 6,176 square feet at a annual
rate of $64,848 for the first 12 months, $67,936 for the subsequent 12 months
and $41,431 for the subsequent seven months, payable monthly, through October
31, 2016. As of August 31, 2014, the Company had 10 full time employees and one
part time employee.
MANAGEMENT
Name Age Position
---- --- --------
Shawn Phillips 42 Chief Executive Officer and a Director
Erin Phillips 37 President, Chief Financial and Accounting
Officer and a Director
David Modica 37 Manager of Quality Control and a Director
Shawn and Erin Phillips are husband and wife.
The following is a brief summary of the background of each officer and
director including their principal occupation during the five preceding years.
All directors will serve until their successors are elected and qualified or
until they are removed.
Shawn Phillips is one of the early pioneers in the marijuana industry in
Colorado and is one of the founders of Strainwise. Currently, Shawn owns and
holds all of the licenses issued by the State of Colorado for the eight
marijuana stores (the "Captive Stores"). In concert with his spouse, Erin
Phillips, he has been instrumental in the management of the operations of these
18
stores since the date they were either purchased as an existing retail store or
initially opened for medical marijuana sales beginning in 2010. In addition,
Shawn oversees the growing facilities which supply the various strains of
product to the Captive Stores and other retail operations in Colorado. Prior to
2010 Mr. Phillips was the owner/operator of RLO Realty, a residential and
commercial real estate firm (2008-2010), an account executive with Stewart Title
Company (2007-2008) and the owner/operator of Legacy Funding, a residential
mortgage company (2001-2007). Mr. Phillips holds a B.S in Accounting from
Colorado State University, and using his accounting education and experience,
his established reliable point-of-sale accounting procedures and financial
controls for these stores and the multiple production facilities. Mr. Phillips
filed a personal bankruptcy petition in September 2009 and received a discharge
in January 2010.
Erin Phillips has over 17 years of operational and management experience.
Erin is one of the early pioneers in the marijuana industry in Colorado and is
one of the founders of Strainwise. In concert with her spouse, Shawn Phillips,
she has been instrumental in the management of the operations of the eight
Captive Stores since the date they were either purchased as an existing retail
store, or initially opened for medical marijuana sales beginning in 2010. Erin
is responsible for managing the marketing, advertising and promotions at the
Captive Stores, and is responsible for establishing and expanding the brand
recognition of the Strainwise name and logo throughout the Company's target
markets. Prior to establishing Strainwise, Erin spent 13 years in the mortgage
industry as a business owner, audit and funding supervisor, title company
closer, mortgage loan processer, and loan originator.
David Modica has been the Quality Control Manager and a director of
Strainwise since 2013. In this capacity, he works with the managers of the
cultivation and grow facilities owned by Shawn Phillips to maintain the quality
of the proprietary strains and marijuana products grown in these facilities.
Upon initially joining Strainwise, he was tasked with converting the
point-of-sale systems used by the Captive Stores to a more advanced system which
can better track all categories of inventory. Prior to joining Strainwise, he
was the owner and operator of a residential rental company (2005 to 2013), a web
developer for Design Factory International (2003 to 2005), and a web
developer/designer for Eastridge Technology (2001 to 2003). Mr. Modica obtained
his B.A. from the University of North Carolina at Chapel Hill in 2000, with a
degree in Journalism and Mass Communications.
Shawn Phillips, Erin Phillips and David Modica are not independent as that
term is defined in Section 803 of the NYSE MKT Company Guide.
We do not have a financial expert as that term is defined by the Securities
and Exchange Commission.
Our Board of Directors does not have standing audit, nominating or
compensation committees, committees performing similar functions, or charters
for such committees. Instead, the functions that might be delegated to such
committees are carried out by our Board of Directors, to the extent required.
Our Board of Directors believes that the cost of associated with such
committees, has not been justified under our current circumstances.
19
Given our lack of operations to date, our Board of Directors believes that
its current members have sufficient knowledge and experience to fulfill the
duties and obligations of an audit committee. None of the current Board members
is an "audit committee financial expert" within the meaning of the rules and
regulations of the Securities and Exchange Commission. The Board has determined
that each of its members is able to read and understand fundamental financial
statements and has substantial business experience that results in that member's
financial sophistication.
Our Board of Directors does not currently have a policy for the
qualification, identification, evaluation, or consideration of board candidates
and does not think that such a policy is necessary at this time, because it
believes that, given the limited scope of our operations, a specific
nominatingpolicy would be premature and of little assistance until our
operations are at a more advanced level. Currently the entire Board decides on
nominees.
Our Board of Directors does not have any defined policy or procedural
requirements for shareholders to submit recommendations or nominations for
directors. We do not have any restrictions on shareholder nominations under its
articles of incorporation or bylaws. The only restrictions are those applicable
generally under Utah law and the federal proxy rules. The Board will consider
suggestions from individual shareholders, subject to an evaluation of the
person's merits. Shareholders may communicate nominee suggestions directly to
the Board, accompanied by biographical details and a statement of support for
the nominees. The suggested nominee must also provide a statement of consent to
being considered for nomination. There are no formal criteria for nominees.
Our Board of Directors does not have a "leadership structure" since each
board member is free to introduce any resolution at any meeting of our directors
and is entitled to one vote at any meeting.
Holders of our common stock may send written communications to our entire
board of directors, or to one or more board members, by addressing the
communication to "the Board of Directors" or to one or more directors,
specifying the director or directors by name, and sending the communication to
our offices in Lakewood, Colorado. Communications addressed to the Board of
Directors as whole will be delivered to each board member. Communications
addressed to a specific director (or directors) will be delivered to the
director (or directors) specified.
Security holder communications not sent to the Board of Directors as a
whole or to specified board members will be relayed to board members.
During the three years ended June 30, 2014 we did not compensate any person
for serving as an officer or director.
The following shows the amounts the Company expects to pay to its officers
during the twelve months ending August 31, 2015 and the amount of time these
persons expect to devote to the Company.
20
Projected % of time to be devoted
Name Compensation to the Company's business
---- ------------ -------------------------
Shawn Phillips $160,000 85%
Erin Phillips $180,000 90%
David Modica $ 72,000 95%
During the period from inception (June 8, 2012) through April 30, 2014
Strainwise paid the following compensation to its officers:
Name Salary Bonus Options Total
---- ------ ----- ------- -----
Shawn Phillips $ -- $ -- $ -- $ --
Erin Phillips $ 22,500 $ -- $ -- $ 22,500
David Modica $ 9,000 $ -- $ -- $ 9,000
The Company's directors serve until the next annual meeting of the
Company's shareholders and until their successors have been duly elected and
qualified. The Company's officers serve at the discretion of the Company's
directors. The Company does not compensate any person for acting as a director.
The Company's current officers and directors were elected to their positions in
August 2014.
We do not have any securities authorized for issuance under any equity
compensation plans.
Non-Compete Agreements
Both Shawn and Erin Phillips have entered into non-compete agreements
wherein they agreed that during their employment and for a period of five (5)
years after termination of their relationship with Strainwise, without the
express written consent of Strainwise, they shall not, directly or indirectly
(i) employ, solicit for employment, or recommend for employment any person
employed by the Company; (ii) contact or solicit any person or business which
was a client of the Company at any time within twelve (12) months before the
termination of the employment with Strainwise in connection with any matters
similar in nature or related to any business conducted between or contemplated
by the Company and such client at any time during their employment with
Strainwise; (iii) engage in any present or contemplated business activity that
is or may be competitive with the Company (or any part thereof) in the State of
Colorado or any other state of the United States of America where the Company
(or any part thereof) conducts its business. For purposes of their non-compete
agreements, Shawn and Erin Phillips agreed that to engage in a business in
competition with the business of the Company, or a "competitive business" shall
mean: (i) to be employed by, (ii) own an interest in, (iii) be a consultant to,
(iv) be a partner in (v) or otherwise participate in any business or venture
which offers or sells to businesses or persons, cannabis related products or
services which are the same as or similar to those which are, at the then
applicable time, being offered and sold by the Company (or any part thereof).
21
Non-Disclosure Agreements
Both Shawn and Erin Phillips have entered into non-disclosure agreements
wherein they agreed not, directly or indirectly, to use, make available, sell,
disclose or otherwise communicate to any third party, other than in their
assigned duties and for the benefit of the Company, any of the confidential
information of Strainwise, either during or after their relationship with
Strainwise. They agreed not to publish, disclose or otherwise disseminate
suchinformation without prior written approval of an executive officer (other
than themselves) of Strainwise. They acknowledged that they are aware that the
unauthorized disclosure of Confidential Information of Strainwise may be highly
prejudicial to its interests, an invasion of privacy, and an improper disclosure
of trade secrets.
Proprietary and confidential information shall include, but not be limited
to:
1) methods, processes and/or technologies for the growing, cultivation
and production of cannabis and marijuana plants and products;
2) cannabis business processes, procedures and strategies;
3) retail and medical cannabis store operations;
4) cannabis branding and fulfillment services;
5) forecasts, unpublished financial information, budgets, projections,
customer lists, and client identities, characteristics and agreements;
6) software, processes, trade secrets, computer programs, electronic
codes, inventions, innovations, discoveries, improvements, data,
know-how, and formats;
7) business, marketing, and strategic plans;
8) information about costs, profits, markets, sales, contracts and lists
of clients and referral sources;
9) employee personnel files and compensation information;
10) customer lists and names of customer contact personnel; and
11) customer terms, information, payments and data.
Exchange Option and Mandatory Exchange
Shawn and Erin Phillips have granted an option to the Company that entitles
the Company to acquire the eight marijuana stores (the "Captive Stores") now
owned and that may become owned by Mr. or Mrs. Phillips in the future ("Exchange
Option"). The Exchange Option may be exercised by the Company anytime within a
six month period from the date that laws or regulations permit the Company to
own all or a part of the Captive Stores.
Upon the exercise of the Exchange Option, the Phillips will be obligated to
exchange the Captive Stores (or such percentage interest in the Captive Store
that the Company can legally acquire) for shares of the Company's common stock
(the "Exchange Shares").
The number of the Exchange Shares to be issued to the Phillips will be
determined by the following formula:
5 x A x B
---------
C
22
Where:
A = the combined EBITDA of the Captive Stores for the immediately
preceding twelve (12) month period from the date the Exchange Option
is exercised.
B = The percentage in the Captive Stores that can be acquired by the
Company.
C = the average closing price on the Pink Sheets, OTC Bulletin Board,
NASDAQ, or NYSE/MKT for the ninety (90) days preceding the date the
Exchange Option is exercised;
Combined EBITDA will be determined using generally accepted accounting
principles, consistently applied.
Notwithstanding the above, the number of Exchange Shares will be reduced,
if necessary, such that, following the issuance of the Exchange Shares, the
total number of shares of the Company's common stock owned by the Phillips,
together with any shares issuable upon the exercise of any option or warrants
held by the Phillips, or any shares issuable upon the conversion of any
securities owned by the Phillips, will not exceed 85% of the Company's
outstanding shares of common stock.
Any advances to the Phillips and/or accounts receivable from the Phillips,
or any distributions to them in excess of the capital account of any Captive
Store at the time of the completion of the exchange, will (i) be personally
guaranteed by both Shawn and Erin Phillips, (ii) will be payable 36 months from
the date of the completion of the exchange, and (iii) will bear interest, to be
adjusted monthly, at the LIBOR rate plus 3%.
If the Exchange Option is exercised, the following is an example of the
number of Exchange Shares to be issued to the Phillips, assuming the Company can
legally acquire a 50% interest in the Captive Stores:
o Combined EBITDA for the immediately preceding twelve (12) month period
- $80,000,000; o Fifty percent of the combined EBITDA - $80,000,000 X
50% = $40,000,000;
o Combined EBITDA multiplied by 5 times - 40,000,000 X 5 = 200,000,000;
o Average market price for the preceding ninety (90) day period - $20;
and
o Number of Exchange Shares to be issues to Phillips - 10,000,000
In the event the Captive Stores are not owned equally by Erin and Shawn
Phillips:
o the Exchange Shares to be issued to Erin Phillips will be based upon
the percentage of the combined EBITDA of the Captive Stores owed by
Erin Phillips; and
23
o the Exchange Shares to be issued to Shawn Phillips will be based upon
the percentage of the combined EBITDA of the Captive Stores owed by
Shawn Phillips
The Exchange Shares will be "restricted shares", as that term is defined in
Rule 144 of the Securities Exchange Commission. At the option of the holder of
the Exchange Shares, the Exchange Shares will be included in the first
registration statement filed by the Company with the Securities and Exchange
Commission following the exercise of the Exchange Option, excluding any
registration statement on Form S-4, S-8, or any other inapplicable form (the
"piggy-back" registration rights). Notwithstanding the above, the underwriter of
any public offering conducted by the Company may limit the Exchange Shares which
may be sold due to market conditions.
No shareholder of the Company will be granted piggyback registration rights
superior to those of the Exchange Shares. The Company will pay all registration
expenses (exclusive of underwriting discounts and commissions and special
counsel to the Phillips). The registration rights may be transferred provided
that the Company (i) is given prior written notice; (ii) the transfer is in
connection with a transfer of not less than 1,000,000 shares of the Company's
common stock; and (iii) the transfer is to no more than three persons.
PRINCIPAL SHAREHOLDERS
The following table shows the ownership, as of the date of this prospectus,
of those persons owning beneficially 5% or more of the Company's common stock
and the number and percentage of outstanding shares owned by each of the
Company's directors and officers and by all officers and directors as a group.
Unless otherwise indicated, each owner has sole voting and investment power over
their shares of common stock.
Name Shares Owned % of Outstanding Shares
---- ------------ -----------------------
Shawn Phillips -- --
Erin Phillips 23,124,184 94.7%
David Modica 11,500 Nil
All officers and directors
as a group (three persons) 23,135,684 94.7%
The address of each person listed above is 1350 Independence St., Suite 300
Lakewood, CO 80125.
24
SELLING SHAREHOLDERS
By means of this prospectus
o a number of our shareholders are offering to sell up to 2,517,700
shares of our common stock, as well as up to 1,112,350 shares of our
common stock issuable upon the exercise of our Series A warrants, and
o a person holding an option to purchase 500,000 shares of our common
stock is offering to sell the shares issuable upon the exercise of the
option.
The following selling shareholders acquired their shares in connection
with our acquisition of Strainwise Colorado.
Shares
Issuable upon
exercise of Shares to be
Shares Series A Sold in this Ownership
Name of Selling Shareholder Owned Warrants Offering After Offering
--------------------------- ------ -------- ----------- --------------
Jeffrey Beatie 2,000 1,000 3,000 --
Brian and Donna Beck 30,000 15,000 45,000 --
Cathy Boring 5,000 2,500 7,500 --
Donald Boring 200,000 100,000 300,000 --
Jeff and Audry Carapella 10,000 5,000 15,000 --
Matt Cinquanta 25,000 12,500 37,500 --
David Clark 10,000 5,000 15,000 --
Rick Clayton 25,000 12,500 37,500 --
Francis Conry 1,000 500 1,500 --
Thomas Cook 20,000 10,000 30,000 --
Paula and Patrick Delaney 4,200 2,100 6,300 --
Matthew Ehrhard 10,000 5,000 15,000 --
Steven Haggerty 50,000 25,000 75,000 --
Henrietta Hubenka 10,000 5,000 15,000 --
Gale James 50,000 25,000 75,000 --
Ronald Kadziel 50,000 25,000 75,000 --
Vivienne Khong 200,000 100,000 300,000 --
Stan Kotzker 75,000 37,500 112,500 --
Vikki and George
Kourkouliotis 10,000 5,000 15,000 --
Sean and Shannon Leonard 20,000 10,000 30,000 --
Naratorn Menzie 25,000 12,500 37,500 --
Michael Novick 20,000 10,000 30,000 --
James and Kelly Oleis 30,000 15,000 45,000 --
David Phillips 55,000 27,500 82,500 --
Mark Shanely 25,000 12,500 37,500 --
Mary Jane Shanely 1,000 500 1,500 --
Alan Simon 50,000 25,000 75,000 --
25
Shares
Issuable upon
exercise of Shares to be
Shares Series A Sold in this Ownership
Name of Selling Shareholder Owned Warrants Offering After Offering
--------------------------- ------ -------- ----------- --------------
Timothy Sisto 15,000 7,500 22,500 --
Colleen Snead 1,000 500 1,500 --
Jeff and Judith Stettler 2,000 1,000 3,000 --
Mark Strait 6,000 3,000 9,000 --
Ken Turner, III 10,000 5,000 15,000 --
Violetta Wells 10,000 5,000 15,000 --
Tim Wingard 25,000 12,500 37,500 --
Jason D. Amos 10,000 5,000 15,000 --
Erik Aude 1,000 500 1,500 --
Josh Boren 3,000 2,500 5,500 --
Eric Busch 10,000 5,000 15,000 --
Tadd Busch 22,500 11,250 33,750 --
Judy Camarena 10,000 5,000 15,000 --
Tom Campbell 10,000 5,000 15,000 --
Linda Carhart 7,500 3,750 11,250 --
Dane Casterson 130,000 65,000 195,000 --
Daril Cinquanta 1,000 500 1,500 --
Cosmo Investments 50,000 25,000 75,000 --
Ronald Curtis 5,000 2,500 7,500 --
Brian and Tonya Destarac 1,000 500 1,500 --
Tonya Destarac/Gooch 1,000 500 1,500 --
Cory and Patricia Fisher 5,000 2,500 7,500 --
Don and Betty Fisher 25,000 12,500 37,500 --
Jeffrey Fullerton 25,000 12,500 37,500 --
Brad Goldwater 2,000 1,000 3,000 --
Charles Guyette 275,000 137,500 412,500 --
James and Elzabeth Hannon 50,000 25,000 75,000 --
Margaret Heath 10,000 5,000 15,000 --
Gary and Wanda Hermanson 50,000 25,000 75,000 --
Dave Huggins 50,000 25,000 75,000 --
Kirk Huston 5,000 2,500 7,500 --
Steven James 50,000 25,000 75,000 --
Jennifer Kealy 4,000 2,000 6,000 --
Daniel Liccardi 20,000 10,000 30,000 --
Michael McVay 25,000 12,500 37,500 --
Naratorn Menzie 10,000 5,000 15,000 --
Dominic Mincks 6,000 3,000 9,000 --
David Modica 25,000 12,500 37,500 --
Tricia Morin 40,000 20,000 60,000 --
Nathan Myers 3,000 1,500 4,500 --
26
Shares
Issuable upon
exercise of Shares to be
Shares Series A Sold in this Ownership
Name of Selling Shareholder Owned Warrants Offering After Offering
--------------------------- ------ -------- ----------- --------------
Melissa Myrick 5,000 2,500 7,500 --
November First Co. 25,000 12,500 37,500 --
Victoria Palmen 2,000 1,000 3,000 --
Shawnda Peck 10,000 5,000 15,000 --
Albert Silvestri 20,000 10,000 30,000 --
Beverly Smith 12,500 6,250 18,750 --
Sean Stephens 5,000 2,500 7,500 --
Michael Tompeter Trust 50,000 25,000 75,000 --
Ken Turner 10,000 5,000 15,000 --
Malcolm Weiss 1,000 500 1,500 --
Brian Weston 10,000 5,000 15,000 --
Grant Whitus 25,000 12,500 37,500 --
Roderick Wilson 10,000 5,000 15,000 --
----------- ---------- --------- --------
2,224,700 1,112,350 3,337,050 --
Randall Taylor 293,000 -- 293,000 _________
----------- ---------- ---------- -----------
2,517,700 1,112,350 3,630,050 --
========== ========= ========== ===========
In January, 2014 Strainwise Colorado issued warrants to an unaffiliated
person for services rendered. The warrants allowed the holder to purchase up to
500,000 shares of Strainwise Colorado's common stock at a price of $0.10 per
share at any time prior to January 31, 2019. When we acquired the remaining
shares of Strainwise on September 12, 2014, we exchanged warrants for the
previously issued Strainwise warrants. The warrants we issued have the same
terms as the Strainwise warrants. The person named below is the holder of these
warrants.
Shares
Issuable upon Shares to be
Shares exercise of Sold in this Ownership
Name of Selling Shareholder Owned Warrants Offering After Offering
--------------------------- ------ -------- ----------- --------------
John Walsh 55,408 500,000 500,000 55,408 (1)
(1) Represents less than 1% of our outstanding shares. The controlling persons
of the non-individual selling shareholders named
above are:
Name of Shareholder Controlling Person
------------------- ------------------
Cosmo Investments Trenton Staley
November First Co. Larry Hansen
Michael Trompeter Trust Michael Trumpeter
27
No selling shareholder has, or had, any material relationship with us, or
our officers or directors. No selling shareholder is, to our knowledge,
affiliated with a securities broker.
The shares of common stock owned by the selling shareholders may be offered
and sold by means of this prospectus from time to time as market conditions
permit, in the over-the-counter market, or otherwise, at prices and terms then
prevailing or at prices related to the then-current market price, or in
negotiated transactions.
The shares of common stock may be sold by one or more of the following
methods, without limitation:
o a block trade in which a broker or dealer so engaged will attempt to
sell the securities as agent but may position and resell a portion of
the block as principal to facilitate the transaction;
o purchases by a broker or dealer as principal and resale by such broker
or dealer for its account pursuant to this prospectus;
o ordinary brokerage transactions and transactions in which the broker
solicits purchasers; and
o face-to-face transactions between sellers and purchasers without a
broker/dealer.
In competing sales, brokers or dealers engaged by the selling shareholders
may arrange for other brokers or dealers to participate. Brokers or dealers may
receive commissions or discounts from selling shareholders in amounts to be
negotiated. As to any particular broker-dealer, this compensation might be in
excess of customary commissions. Neither we nor the selling stockholders can
presently estimate the amount of such compensation. Notwithstanding the above,
no FINRA member will charge commissions that exceed 8% of the total proceeds
from the sale.
The selling shareholders and any broker/dealers who act in connection with
the sale of their securities may be deemed to be "underwriters" within the
meaning of ss.2(11) of the Securities Acts of 1933, and any commissions received
by them and any profit on any resale of the securities as principal might be
deemed to be underwriting discounts and commissions under the Securities Act.
If any selling shareholder enters into an agreement to sell his or her
securities to a broker-dealer as principal, and the broker-dealer is acting as
an underwriter, we will file a post-effective amendment to the registration
statement, of which this prospectus is a part, identifying the broker-dealer,
providing required information concerning the plan of distribution, and
otherwise revising the disclosures in this prospectus as needed. We will also
file the agreement between the selling shareholder and the broker-dealer as an
exhibit to the post-effective amendment to the registration statement.
The selling stockholders may also sell their shares pursuant to Rule 144
under the Securities Act of 1933.
28
We have advised the selling shareholders that they, and any securities
broker/dealers or others who sell the common stock or warrants on behalf of the
selling shareholders, may be deemed to be statutory underwriters and will be
subject to the prospectus delivery requirements under the Securities Act of
1933. We have also advised each selling shareholder that in the event of a
"distribution" of the securities owned by the selling shareholder, the selling
shareholder, any "affiliated purchasers", and any broker/dealer or other person
who participates in the distribution may be subject to Rule 102 of Regulation M
under the Securities Exchange Act of 1934 ("1934 Act") until their participation
in that distribution is completed. Rule 102 makes it unlawful for any person who
is participating in a distribution to bid for or purchase securities of the same
class as is the subject of the distribution. A "distribution" is defined in Rule
102 as an offering of securities "that is distinguished from ordinary trading
transactions by the magnitude of the offering and the presence of special
selling efforts and selling methods". We have also advised the selling
shareholders that Rule 101 of Regulation M under the 1934 Act prohibits any
"stabilizing bid" or "stabilizing purchase" for the purpose of pegging, fixing
or stabilizing the price of the common stock in connection with this offering.
DESCRIPTION OF SECURITIES
Common Stock
We are authorized to issue 50,000,000 shares of common stock. Holders of
common stock are each entitled to cast one vote for each share held of record on
all matters presented to shareholders. Cumulative voting is not allowed; hence,
the holders of a majority of our outstanding shares of common stock can elect
all directors.
Holders of common stock are entitled to receive such dividends as may be
declared by the Board out of funds legally available and, in the event of
liquidation, to share pro rata in any distribution of our assets after payment
of liabilities. Our directors are not obligated to declare a dividend. It is not
anticipated that dividends will be paid in the foreseeable future.
Holders of common stock do not have preemptive rights to subscribe to any
additional shares which may be issued in the future. There are no conversion,
redemption, sinking fund or similar provisions regarding the common stock. All
outstanding shares of common stock are fully paid and nonassessable.
Preferred Stock
We are authorized to issue 5,000,000 shares of preferred stock. Shares of
preferred stock may be issued from time to time in one or more series as may be
determined by the Board of Directors. The voting powers and preferences, the
relative rights of each such series and the qualifications, limitations and
restrictions of each series will be established by the Board of Directors. Our
directors may issue preferred stock with multiple votes per share and dividend
rights which would have priority over any dividends paid with respect to the
holders of our common stock. The issuance of preferred stock with these rights
may make the removal of management difficult even if the removal would be
considered beneficial to shareholders generally, and will have the effect of
limiting shareholder participation in transactions such as mergers or tender
29
offers if these transactions are not favored by management. As of the date of
this prospectus we had not issued any shares of preferred stock.
Warrants
On September 12, 2014, we acquired the remaining outstanding shares of
Strainwise Colorado in exchange for the issuance of 2,517,000 shares of our
common stock. In connection with this transaction:
o we issued 1,112,350 Series A warrants to former Strainwise Colorado
shareholders in exchange for a like number of warrants held by the
former Strainwise Colorado shareholders. Each Series A warrant allows
the holder to purchase one share of our common stock. The Series A
warrants we issued have the same terms as the warrants exchanged by
the former Strainwise Colorado shareholders (exercise price: $5.00 per
share/expiration date: January 31, 2019);
o we issued 500,000 warrants to one non-affiliated person in exchange
for a like number of warrants held by the former Strainwise Colorado
warrant holder. Each warrant allows the holder to purchase one share
of our common stock. The warrants we issued have the same terms as the
warrants exchanged by the former Strainwise Colorado warrant holder
(exercise price: $0.10 per share/expiration date: January 31, 2019).
Transfer Agent and Registrar
Our transfer agent is:
Standard Registrar & Transfer Co., Inc.
12528 South 1840 East
Draper, UT 84020
LEGAL PROCEEDINGS
We are not involved in any legal proceedings and we do not know of any
legal proceedings which are threatened or contemplated.
INDEMNIFICATION
Our Bylaws authorize indemnification of a director, officer, employee or
agent against expenses incurred by him in connection with any action, suit, or
proceeding to which he is named a party by reason of his having acted or served
in such capacity, except for liabilities arising from his own misconduct or
negligence in performance of his duty. In addition, even a director, officer,
employee, or agent found liable for misconduct or negligence in the performance
of his duty may obtain such indemnification if, in view of all the circumstances
in the case, a court of competent jurisdiction determines such person is fairly
and reasonably entitled to indemnification. Insofar as indemnification for
liabilities arising under the Securities Act of 1933 may be permitted to our
30
directors, officers, or controlling persons pursuant to these provisions, we
have been informed that, in the opinion of the Securities and Exchange
Commission, such indemnification is against public policy as expressed in the
Act and is therefore unenforceable.
AVAILABLE INFORMATION
We have filed with the Securities and Exchange Commission a Registration
Statement on Form S-1 (together with all amendments and exhibits) under the
Securities Act of 1933, as amended, with respect to the Securities offered by
this prospectus. This prospectus does not contain all of the information set
forth in the Registration Statement, certain parts of which are omitted in
accordance with the rules and regulations of the Securities and Exchange
Commission. For further information, reference is made to the Registration
Statement which may be read and copied at the Commission's Public Reference
Room.
We are subject to the requirements of the Securities and Exchange Act of
1934 and are required to file reports and other information with the Securities
and Exchange Commission. Copies of any such reports and other information filed
by us can also be read and copied at the Commission's Public Reference Room.
The Public Reference Room is located at 100 F Street, N.E., Washington,
D.C. 20549. The public may obtain information on the operation of the Public
Reference Room by calling the Commission at 1-800-SEC-0330. The SEC maintains an
internet site that contains reports, proxy and information statements, and other
information regarding public companies. The address of the site is
http://www.sec.gov.
31
TABLE OF CONTENTS
Page
----
PROSPECTUS SUMMARY ...................................................
RISK FACTORS .........................................................
MARKET FOR OUR COMMON STOCK ..........................................
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITIONS AND RESULTS OF OPERATIONS...............................
BUSINESS..............................................................
MANAGEMENT ...........................................................
PRINCIPAL SHAREHOLDERS................................................
SELLING SHAREHOLDERS..................................................
DESCRIPTION OF SECURITIES.............................................
LEGAL PROCEEDINGS.....................................................
INDEMNIFICATION ......................................................
AVAILABLE INFORMATION.................................................
FINANCIAL STATEMENTS..................................................
No dealer, salesperson or other person has been authorized to give any
information or to make any representation not contained in this prospectus, and
if given or made, such information or representations must not be relied upon as
having been authorized by the Company. This prospectus does not constitute an
offer to sell, or a solicitation of an offer to buy, any of the securities
offered in any jurisdiction to any person to whom it is unlawful to make an
offer by means of this prospectus.
32
FINANCIAL STATEMENTS
FOR THE YEAR ENDED JANUARY 31, 2014 AND
THE PERIOD ENDED JANUARY 31, 2013
(Audited)
33
THIS PAGE INTENTIONALLY LEFT BLANK
34
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
To the Board of Directors and Stockholders of Strainwise, Inc.:
We have audited the accompanying balance sheets of Strainwise, Inc. ("the
Company") as of January 31, 2014 and 2013 and the related statement of
operations, changes in members' equity (deficit) and cash flows for the years
then ended. These financial statements are the responsibility of the Company's
management. Our responsibility is to express an opinion on these financial
statements based on our audit.
We conducted our audit in accordance with standards of the Public Company
Accounting Oversight Board (United States). Those standards require that we plan
and perform the audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in the financial
statements, assessing the accounting principles used and significant estimates
made by management, as well as evaluating the overall financial statement
presentation. We believe that our audit provides a reasonable basis for our
opinion.
In our opinion, the financial statement referred to above present fairly, in all
material respects, the financial position of Strainwise, Inc., as of January 31,
2014 and 2013 and the results of its operations and its cash flows for the years
then ended, in conformity with generally accepted accounting principles in the
United States of America.
The company is not required to have, nor were we engaged to perform, an audit of
its internal control over financial reporting. Our audit included consideration
of internal control over financial reporting as a basis for designing audit
procedures that are appropriate in the circumstances, but not for the purpose of
expressing an opinion on the Company's internal control over financial
reporting. Accordingly, we express no such opinion.
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. As discussed in Note 2 to the
financial statements, the Company's significant operating losses raise
substantial doubt about its ability to continue as a going concern. The
financial statements do not include any adjustments that might result from the
outcome of this uncertainty.
/s/ B F Borgers CPA PC
B F Borgers CPA PC
Denver, CO
August 14, 2014
35
STRAINWISE, INC.
CONDENSED BALANCE SHEETS
(AUDITED)
January 31, January 31,
2014 2013
-------------- ------------
ASSETS
Current assets:
Cash $ 100 $ 100
Prepaid expense 10,000 -
-------------- ------------
Total current assets 10,100 100
Office equipment and furnishings 10,500 -
Trademark, net amortization of $61 and $0 at
January 31,
2014 and 2013, respectively 10,949 -
-------------- ------------
Total assets $31,549 $ 100
============== ============
LIABILITIES
Current liabilities:
Due to affiliated entities and related
parties $ 50,203 $ -
-------------- ------------
Total current liabilities 50,203
-
Deferred rent 3,273 -
-------------- ------------
53,476 ,
STOCKHOLDERS' (DEFICIT) EQUITY
Common stock, no par value, 100,000,000
shares authorized, 20,430,000 issued
and outstanding - -
Additional Paid in Capital 48,292 100
(Deficit) Retained Earnings (70,219) -
-------------- ------------
Total stockholder's equity 100
(21,927)
-------------- ------------
Total liabilities and stockholders' deficit $ 31,549 $ 100
============== ============
See accompanying notes.
36
STRAINWISE, INC.
CONDENSED STATEMENTS OF OPERATIONS
(AUDITED)
Period
(Inception
of June 8,
Year Ended 2012) ended
January 31, January 31,
2014 2013
------------- -------------
Revenues from affiliated entities and
related parties $ 104,378 -
Operating costs and expenses
Nutrient purchases 18,094 -
Compensation 60,560 -
Rent and other occupancy 5,404 -
General and administrative 9,753 -
------------- -------------
Total operating costs and expenses
93,811 -
------------- -------------
Income from operations
10,567 -
Other costs and expenses
Financing costs 20,000 -
General and Administrative Costs 60,725 -
Amortization 61 -
------------- -------------
Loss before taxes on income -
(70,219)
Provision for taxes on income - -
------------- -------------
Net loss $ (70,219) -
============= =============
Basic loss per common share $ (0.082) -
============= =============
Fully diluted loss per common share $ (0.052) -
============= =============
Basic weighted average number of shares
outstanding 851,250 -
============= =============
Fully diluted weighted average number of
shares outstanding 1,351,250
============= =============
See accompanying notes.
37
STRAINWISE, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(AUDITED)
Period
(Inception
Year of June 8,
Ended 2012)
January ended
31, January
2014 31, 2013
----------- ------------
Cash flows from operating activities:
Net (loss) $ (70,219) $ -
Changes in current assets and liabilities:
Increase in amounts due to affiliates
50,203 -
Deferred rent 3,273
Stock-based compensation 48,192
Increase in prepaid expenses
(10,000) -
----------- ------------
Net cash used in operating activities 21,499 -
Cash flows from investing activities:
Purchases of office equipment and furnishings
(10,500) -
Establishment of trade mark
(10,949) -
----------- ------------
Net cash flows from investing activities
(21,449) -
Cash flows from financing activities:
Contribution of capital for common stock
- 100
----------- ------------
Net cash flows from financing activities
- 100
----------- ------------
Net cash flows - 100
Cash and Cash equivalents, beginning of period 100 -
----------- ------------
Cash and Cash equivalents, end of period $ 100 $ 100
=========== ============
Supplemental cash flow disclosures:
Cash paid for interest $ - $ -
=========== ============
Cash paid for income taxes $ - $ -
=========== ============
See accompanying notes.
38
STRAINWISE, INC.
STATEMENT OF CHANGES IN CONDENSED STOCKHOLDERS' DEFICIENCY For
the Period from June 8, 2012 (date of inception) to January 31, 2014
(Audited)
Common Stock
------------------
Additional
Capital In Deficit
Excess of Par Accumulated in
Shares Amount Value Development Stage Total
---------------------------------------------------------------
Balance, June 8,
2012, Inception
Membership interest
issued for cash - $ - $ 100 $ - $ 100
Net loss - - - - -
---------------------------------------------------------------
Balance, January
31, 2013 - - 100 - 100
Conversion of
common shares for
membership
interest 20,430,000 - - - -
Stock-based
compensation - - 48,192 - 48,192
Net loss - - - (70,219) (70,219)
---------------------------------------------------------------
Balance, January
31, 2014 20,430,000 - $ 48,292 $(70,219) $(21,927)
===============================================================
See accompanying notes.
39
STRAINWISE, INC.
NOTES TO THE AUDITED FINANCIAL STATEMENTS
Note 1 - Organization and summary of significant accounting policies:
Following is a summary of our organization and significant accounting policies:
Organization and nature of business - STRAINWISE, INC. (identified in these
footnotes as "we" "us" or the "Company") provides branding and fulfillment
services to entities in the cannabis retail and production industry. The Company
was incorporated in the state of Colorado as a limited liability company on June
8, 2012, and subsequently converted to a Colorado corporation on January 16,
2014.
The Company provides sophisticated fulfillment and branding services and
solutions to (i) one grow facility and eight retail stores (seven of which sell
recreational and medical marijuana to the public and one of which only sells
medical marijuana to the public) owned by an officer and director of the Company
("Affiliated Entities"), and (ii) makes such services available to independent
retail stores and grow facilities in the regulated cannabis industry throughout
the United States.
The branding and fulfillment services that we currently provide are summarized,
as follows:
o Branding, Marketing and Administrative Consulting Services: Customers
may contract with us to use the Strainwise name, logo and affinity
images in their retail store locations. A monthly fee permits our
branding customer to use the Strainwise brand at one specific
location. In addition, we will assist operators in marketing and
managing their businesses, setting up new retail locations and general
business planning and execution at an hourly rate. This includes
services to establish an efficient, predictable production process, as
well as, nutrient recipes for consistent and appealing marijuana
strains.
o Accounting and Financial Services: For a monthly fee, we provide our
customers with a fully implemented general ledger system, with an
industry centric chart of accounts, which enables management to
readily monitor and manage all facets of a marijuana medical
dispensary, retail store and grow facility. We provide bookkeeping,
accounts payable processing, cash management, general ledger
processing, financial statement preparation, state and municipal sales
tax filings, and state and federal income tax compilation and filings
on behalf of the Company and the Captive Stores on an ongoing basis.
o Compliance Services: The rules, regulations and state laws governing
the production, distribution and retail sale of marijuana can be
complex, and may prove cumbersome with which to comply. Thus,
customers may contract with us to implement a compliance process,
based upon the number and type of licenses and permits for their
specific business. We provide this service on both an hourly rate and
stipulated monthly fee.
o Nutrient Supplier: The Company presently is a bulk purchaser of
nutrients and other cultivation supplies for the sole purpose of
growing marijuana. As a result, we are able to make bulk purchases
with price breaks, based upon volume. We serve as a sole source
nutrient purchasing agent and distributor with pricing based upon our
bulk purchasing power.
o Lending: We will provide loans to individuals and businesses in the
cannabis industry. However, Colorado State law does not allow entities
operating under a cannabis license to pledge the assets or the license
of the cannabis operation for any type of general borrowing activity.
Thus, our lending will be on an unsecured basis, with reliance on a
personal guarantee of the borrower.
o Lease of Grow Facilities and Equipment: We lease grow equipment and
facilities on a turn-key basis to customers in the cannabis industry.
We will also enter into sale lease backs of grow lights, tenant
improvements and other grow equipment. o
40
We do not directly grow marijuana plants, produce marijuana infused products,
sell marijuana plants and or sell marijuana infused products of any nature.
Share exchange - As more fully described in Note 9 herein, on August 19, 2014,
we entered into an Agreement to Exchange Securities ("Share Agreement") with 4th
Grade Films, Inc. ("FHGR"), pursuant to which FHGR acquired approximately 90 %
of the outstanding shares of Strainwise in exchange for 23,124,184 shares of
FHGR's common stock. FHGR is a publicly-traded company, incorporated in Utah,
with its common stock currently quoted on the OTC Bulletin Board. It is
contemplated that the Exchange will qualify as a tax-free reorganization under
the U.S. Internal Revenue Code.
As part of the Share Exchange, we paid $134,700 of FHGR's liabilities and
purchased 1,038,000 shares of FHGR's common stock for $120,300 from two
shareholders of FHGR. The 1,038,000 shares were returned to treasury and
cancelled. FHGR also agreed to sell its rights to a motion picture, together
with all related domestic and international distribution agreements, and all
pre-production and other rights to the film, to a former officer and director of
FHGR in consideration for the assumption by a shareholder of FHGR of all
liabilities of FHGR (net of the $134,700 we paid) which were outstanding
immediately prior to the closing of the transaction.
The business combination will be accounted for as a reverse acquisition and
recapitalization, using accounting principles applicable to reverse acquisitions
whereby the financial statements subsequent to the date of the transaction will
be presented as a continuation of the Company. Under reverse acquisition
accounting, the Company (subsidiary) is treated as the accounting parent
(acquirer) and FHGR (parent) is treated as the accounting Subsidiary (acquiree).
Following the Share Exchange, FHGR has 24,431,184 outstanding shares of common
stock, with the current shareholders of FHGR owning 1,307,000 of the
post-closing shares.
Basis of presentation - The accounting and reporting policies of the Company
conform to U.S. generally accepted accounting principles.
Use of estimates - The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amount of revenues and expenses during the reporting
period. Actual results could differ from those estimates.
Cash and cash equivalents - For purposes of the statement of cash flows, we
consider all cash in banks, money market funds, and certificates of deposit with
a maturity of less than three months to be cash equivalents.
Prepaid expenses - The amount of prepaid expenses as of January 31, 2014 and
January 31, 2013 is $10,000 and $0, respectively. Prepaid expenses at January
31, 2014 is comprised of a retainer paid to our legal counsel.
Fair value of financial instruments and derivative financial instruments - The
carrying amounts of cash and current liabilities approximate fair value because
of the short maturity of these items. These fair value estimates are subjective
in nature and involve uncertainties and matters of significant judgment, and,
therefore, cannot be determined with precision. Changes in assumptions could
significantly affect these estimates. We do not hold or issue financial
instruments for trading purposes, nor do we utilize derivative instruments in
the management of our foreign exchange, commodity price or interest rate market
risks.
The FASB Codification clarifies that fair value is an exit price, representing
the amount that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants. It also
requires disclosure about how fair value is determined for assets and
liabilities and establishes a hierarchy for which these assets and liabilities
must be grouped, based on significant levels of inputs as follows:
Level 1: Quoted prices in active markets for identical assets or liabilities.
Level 2: Quoted prices in active markets for similar assets and liabilities
and inputs that are observable for the asset or liability.
Level 3: Unobservable inputs in which there is little or no market data,
which require the reporting entity to develop its own assumptions.
41
The determination of where assets and liabilities fall within this hierarchy is
based upon the lowest level of input that is significant to the fair value
measurement.
Office equipment - Office equipment is recorded at cost and is depreciated under
straight line methods over each item's estimated useful life. We review our
office equipment for impairment whenever events or changes in circumstances
indicate that the carrying value of such assets may not be recoverable.
Maintenance and repairs of property and equipment are charged to operations.
Major improvements are capitalized. Upon retirement, sale or other disposition
of office equipment, the cost and accumulated depreciation are eliminated from
the accounts and any gain or loss is included in operations.
Office equipment, net of accumulated amortization and depreciation are comprised
of the following:
January 31, January
31,
2014 2013
------------ -----------
Office equipment:
Office furniture and fixtures $10,500 $ -
Accumulated amortization and depreciation - -
------------ -----------
$ 10,500 $ -
There was no depreciation charged to operations for the year ended January 2014
and 2013 in that the office equipment was not placed into service until the last
few days of January 2014.
Income taxes - The Company accounts for income taxes pursuant to ASC 740. Under
ASC 740 deferred taxes are provided on a liability method whereby deferred tax
assets are recognized for deductible temporary differences and operating loss
carryforwards and deferred tax liabilities are recognized for taxable temporary
differences. Temporary differences are the differences between the reported
amounts of assets and liabilities and their tax bases. Deferred tax assets are
reduced by a valuation allowance when, in the opinion of management, it is more
likely than not that some portion or all of the deferred tax assets will not be
realized. Deferred tax assets and liabilities are adjusted for the effects of
changes in tax laws and rates on the date of enactment.
Long-Lived Assets - In accordance with ASC 350, the Company regularly reviews
the carrying value of intangible and other long-lived assets for the existence
of facts or circumstances, both internally and externally, that suggest
impairment. If impairment testing indicates a lack of recoverability, an
impairment loss is recognized by the Company if the carrying amount of a
long-lived asset exceeds its fair value.
Trademarks - Trademarks are stated at cost and are amortized using the
straight-line method over fifteen years. Accumulated amortization was $100 and
$0 at January 31, 2014 and 2013, respectively.
Intangible assets subject to amortization consist of the following at January
31, 2014:
Gross
Carrying Accumulated
Amount Amortization Net
----------- ------------- ---------------
Trademarks $ 11,010 $ 61 $ 10,949
======== ==== ========
Deferred Rent - The Company recognizes rent expense from operating leases on the
straight-line basis. Differences between the expense recognized and actual
payments are recorded as deferred rent.
Revenue recognition - Revenue is recognized on an accrual basis as earned under
contract terms. Specifically, revenue from product sales is recognized
subsequent to a customer ordering a service or product at an agreed upon fee or
price, delivery has occurred, and collectability is reasonably assured.
Comprehensive Income (Loss) - Comprehensive income is defined as all changes in
stockholders' equity (deficit), exclusive of transactions with owners, such as
capital investments. Comprehensive income includes net income or loss, changes
in certain assets and liabilities that are reported directly in equity such as
translation adjustments on investments in foreign subsidiaries and unrealized
42
gains (losses) on available-for-sale securities. From our Inception there have
been no differences between our comprehensive loss and net loss.
Net income per share of common stock - We have adopted applicable FASB
Codification regarding Earnings per Share, which require presentation of basic
and diluted EPS on the face of the income statement for all entities with
complex capital structures and requires a reconciliation of the numerator and
denominator of the basic EPS computation to the numerator and denominator of the
diluted EPS computation. In the accompanying financial statements, basic
earnings per share of common stock is computed by dividing net income by the
weighted average number of shares of common stock outstanding during the period.
Note 2 - Going concern:
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. For the period ended January 31, 2014,
the Company has had limited operations. As of January 31, 2014, the Company has
not become profitable. In view of these matters, the Company's ability to
continue as a going concern is dependent upon the Company's ability to begin
operations and to achieve a level of profitability. The Company intends to
continue financing its future development activities and its working capital
needs largely from the sale of public equity securities with some additional
funding from other traditional financing sources, including term notes until
such time that funds provided by operations are sufficient to fund working
capital requirements. The financial statements of the Company do not include any
adjustments relating to the recoverability and classification of recorded
assets, or the amounts and classifications of liabilities that might be
necessary should the Company be unable to continue as a going concern.
Note 3 - Related Party Transactions:
Substantially all of our revenues to date have been derived from Master Service
Agreements with eight retail marijuana stores and one cultivation and growing
facility that are majority owned by our Chief Executive Officer, who is also the
husband or our majority shareholder and our President. Pursuant to the terms of
these Master Service Agreements, the marijuana stores and grow facility pay us
monthly fees for branding, marketing, administration, accounting and compliance
services. We also supply nutrients to the one grow facility at a 90% mark-up to
our cost for the nutrients.
Related party revenue was $104,378 and $0.00, respectively, for the years ended
January 31, 2014 and 2013. As of January 31, 2014 and 2013, we had accounts
receivable from affiliated entities of $70,000 and $0, respectively. As of
January 31, 2013 and 2014, we had accounts payable to affiliated entities of
$120,203 and $0, respectively.
Although our agreements with the marijuana outlets and grow facility expire on
December 31, 2023, all terms and contracts related to this revenue are
determined by related parties and these terms can change at any time.
Note 4 - Operating Leases:
The Company rents office space for its corporate needs from an affiliated
Company. The affiliate entered into a 31 month lease agreement in January 1,
2014 to lease 6,176 square feet for an annual rate of $64,848 for the first
twelve months, and $67,936 for the subsequent 12 months, and $41,431 for the
subsequent 7 months paid monthly, through October 31, 2016. See Note 9 for a
full explanation of operating leases that went into effect after the balance
sheet date, but before issuance.
Note 5 - Issuance of shares:
The Company was originally organized as a limited liability company on June 8,
2012 with $100 of membership equity. On January 16, 2014, the Company converted
to a corporation and issued a total of 20,430,000 shares in exchange for the one
hundred percent of the membership interests owned by the majority shareholder
and President of the Company. As of January 31, 2014 there were a total of
20,430,000 shares of common stock issued and outstanding.
43
Note 6 - Income Taxes:
The Company uses the liability method of accounting for income taxes under which
deferred tax assets and liabilities are recognized for the future tax
consequences of temporary differences between the accounting bases and the tax
bases of the Company's assets and liabilities. The deferred tax assets and
liabilities are computed using enacted tax rates in effect for the year in which
the temporary differences are expected to reverse.
The Company adopted the provisions of ASC 740, "Income Taxes" on April 1, 2007.
FASB ASC 740 provides detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in the
financial statements. Tax positions must meet a "more-likely-than-not"
recognition threshold at the effective date to be recognized upon the adoption
of FASB ASC 740 and in subsequent periods.
The components of the income tax provision are as follows:
Year Ended January 31,
---------------------------
2014 2013
----------- -----------
-----------
Income tax expense (benefit):
Current:
Federal $ (11,742) $ -
State (3,251) -
----------- -----------
Deferred income tax expense (benefit): -
(14,993)
Valuation allowance 14,993 -
----------- -----------
Provision $ - $ -
=========== ===========
Note 7 - New accounting pronouncements:
The Financial Accounting Standards Board ("FASB") periodically issues new
accounting standards in a continuing effort to improve standards of financial
accounting and reporting. The Company has reviewed the recently issued
pronouncements. During this review the Company decided to early adopt ASU
2014-10 which eliminates the definition of a development stage entity,
eliminates the development stage presentation and disclosure requirements under
ASC 915, and amends provisions of existing variable interest entity guidance
under ASC 810.
Note 8 - Equity:
Approved Warrants - In January 2014, the Company issued stock-based compensation
to a consultant in the form of warrants to purchase 500,000 shares of the
Company's common stock, at a price of $0.10 per share, at any time prior to
January 31, 2019. The Board of Directors determined the exercise price and terms
of the warrant.
The Black-Scholes option-pricing model was used to estimate the warrant fair
values. This option-pricing model requires a number of assumptions, of which the
most significant are, expected stock price volatility, the expected pre-vesting
forfeiture rate and the expected warrant term (the amount of time from the grant
date until the warrants are exercised or expire). Expected volatility was
estimated utilizing a weighted average of comparable published volatilities
based on industry comparables. Expected pre-vesting forfeitures were based upon
management's best estimates. The expected warrant term was based on the term of
the warrant. The fair value of the warrants granted during the year ended
January 31, 2014 was estimated, as of the grant date, using the Black-Scholes
option pricing model, with the following assumptions:
Expected volatility 187%
Risk-free interest .25%
rate
Expected dividends -
Expected terms (in 5
years)
Share price at date $0.10
of issuance
44
The warrants outstanding and activity as of and for the year ended January 31,
2014:
Remaining
Weighted Contractual
Average Term
Exercise (in
Shares Price years)
---------- -------- ---------
---------- -------- ---------
Outstanding at January 31, $ - -
2013
Granted 500,000 $ 0.10 5
Exercised - $ - -
Forfeited - $ - -
Outstanding at January 31,
2014 500,000 $ 0.10 5
--------- -------- ---------
Exercisable at January 31, 500,000 $ 0.10 5
2014 --------- -------- ---------
The weighted average fair value of warrants granted at January 31, 2014 was
$0.10. The exercise price of the warrants granted at January 31, 2014 equaled
the estimated fair market value of the stock at the time of grant which was
$0.10. No warrants were exercised during the current fiscal year. Accordingly,
the Company did not realize any tax deductions related to the intrinsic value of
exercised warrants.
In accordance with EITF 96-18 ' Accounting for Equity Instruments That Are
Issued to Other Than Employees for Acquiring, or in Conjunction with Selling,
Goods or Services', the total amount of share-based compensation expense
recorded at January 31, 2014 of $48,192 will be fully recorded in the current
year since no future services are required for the consultant to exercise the
warrants.
Note 9 - Subsequent events:
Share Exchange - On August 19, 2014, we entered into an Agreement to Exchange
Securities ("Share Exchange") with 4th Grade Films, Inc. ("FHGR"), pursuant to
which FHGR will acquire approximately 90 % of the outstanding shares of
Strainwise in exchange for 23,124,184 shares of FHGR's common stock. FHGR is a
publicly-traded company, incorporated in Utah, with its common stock currently
quoted on the OTC Bulletin Board. It is contemplated that the Exchange will
qualify as a tax-free reorganization under the U.S. Internal Revenue Code.
As part of the Share Exchange, we paid $134,700 of FHGR's liabilities and
purchased 1,038,000 shares of FHGR's common stock for $120,300 from two
shareholders of FHGR. The 1,038,000 shares were returned to treasury and
cancelled. FHGR also agreed to sell its rights to a motion picture, together
with all related domestic and international distribution agreements, and all
pre-production and other rights to the film, to a former officer and director of
FHGR in consideration for the assumption by a shareholder of FHGR of all
liabilities of FHGR (net of the $134,700 we paid) which were outstanding
immediately prior to the closing of the transaction.
The business combination will be accounted for as a reverse acquisition and
recapitalization, using accounting principles applicable to reverse acquisitions
whereby the financial statements subsequent to the date of the transaction will
be presented as a continuation of the Company. Under reverse acquisition
accounting, the Company (subsidiary) is treated as the accounting parent
(acquirer) and FGHR (parent) is treated as the accounting subsidiary (acquiree).
As a result of the Share Exchange, FGHR has 24,431,184 outstanding shares of
common stock, with the current shareholders of FGHR owning 1,307,000 of the
post-closing shares.
Operating Leases - We entered into a lease agreement on March 7, 2014 to lease a
grow facility of approximately 26,700 square feet ("Custer Lease") for a term of
five years commencing on April 1, 2014. Lease payments are scheduled to be
$29,200 per month for the first twelve months of the lease, and then are
scheduled to be $27,500 per month for the subsequent 12 months, $28,325 per
month for the subsequent 12 months, $29,170 per month for the subsequent 12
months and $30,035 per month for the final 12 months of the lease. Under the
terms of the Custer Lease, we are obligated to pay a security deposit of $29,200
which was due and paid upon the execution of the Custer Lease. We have the
option to renew the Custer Lease at the end of the term of the lease at a
mutually agreed upon rate per square foot; there is no option to purchase the
property underlying the Custer Lease. The Lessor will provide all of the tenant
45
improvements that will enable the continuous cultivation of marijuana plants
under approximately 460 grow lights. We will lease this grow facility to the
affiliated entities on a long term basis.
We entered into a lease agreement on April 1, 2014 to lease a grow facility of
approximately 65,000 square feet ("51st Ave Lease") for a term of five years and
nine months. The terms of the 51st Ave Lease stipulates the payment of $15,000
per month, prorated if necessary, until such time that the Lessor is able to
deliver a Certificate of Occupancy, which is scheduled to occur on August 1,
2014. Thereafter, lease payments are scheduled to be $176,456 per month for the
first six months of the lease, and then are scheduled to be $221,833 per month
for the subsequent 24 months, $231,917 per month for the subsequent 12 months,
$242,000 per month for the subsequent 12 months and $247,041 per month for the
final 12 months of the lease. Under the terms of the 51st Ave Lease, we are
obligated to pay a security deposit of $150,000 one third of which was due and
paid upon the execution of the 51st Ave Lease, the second third is due and
payable after the first harvest or by October 1, 2014, and the final third is
due and payable after the second harvest or by December 1, 2014.We have the
option to renew the 51st Ave Lease at the end of the term of the lease at a
mutually agreed upon rate per square foot; there is no option to purchase the
property underlying the 51st Avenue Lease. The Lessor will provide all of the
tenant improvements that will enable the continuous cultivation of marijuana
plants under approximately 1,940 grow lights. We will lease this grow facility
to the affiliated entities on a long term basis.
We entered into a lease agreement on April 22, 2014 to lease a grow facility of
approximately 38,000 square feet ("Nome Lease") for a term of seven years. The
lease payments are scheduled to be $44,570 per month for the first twelve months
of the lease, and then are scheduled to be $46,151 per month for the subsequent
12 months, $47,743 per month for the subsequent 12 months, $49,334 per month for
the subsequent 12 months and $50,925 per month for the subsequent 12 months,
$52,517 per month for the subsequent 12 months, and $54,108 for the final 12
months of the lease. Under the terms of the Nome Lease, we are obligated to pay
a security deposit of $133,679 one half of which was due and paid upon the
execution of the Nome Lease, the final half was due and payable 30 days after
the commencement date. We have the option to renew the Nome Lease at the end of
the term of the lease at a mutually agreed upon rate per square foot; there is
no option to purchase the property underlying the Nome Lease. The Lessor will
provide all of the tenant improvements that will enable the continuous
cultivation of marijuana plants under approximately 920 grow lights. We will
lease this grow facility to the affiliated entities on a long term basis.
We entered into a lease agreement on June 10, 2014 to lease a grow facility of
approximately 113,000 square feet ("32nd Ave Lease") for a term of five years
and nine months which will not become effective until the proper Licenses are
awarded, expected to be September 1, 2014. The terms of the 32nd Ave Lease
stipulates the payment of $25,000 per month, prorated if necessary, until such
time that the Lessor is able to deliver a Certificate of Occupancy, which is
scheduled to occur in early 2015. Thereafter, lease payments are scheduled to be
$282,500 per month for the first Sixteen months of the lease, and then are
scheduled to be $301,333 per month for the subsequent 12 months, $320,167 per
month for the subsequent 12 months, and $329,583 per month for the final 12
months of the lease. Under the terms of the 32nd Ave Lease, we are obligated to
pay a security deposit of $250,000, $150,000 of which was due and paid upon the
execution of the 32nd Ave Lease, and $100,000 due upon obtaining the Certificate
of Occupancy. We have the option to renew the 32nd Ave Lease at the end of the
term of the lease at a mutually agreed upon rate per square foot; there is no
option to purchase the property underlying the 32nd Ave Lease. The Lessor will
provide all of the tenant improvements that will enable the continuous
cultivation of marijuana plants under approximately 3,000 grow lights. We will
lease this grow facility to the affiliated entities on a long term basis.
Future minimum payments for these leases are:
For the Year
Ended January 31, Amount
---------------- ------
2015 $2,181,500
2016 $7,276,000
2017 $7,317,700
2018 $7,476,700
2019 $8,123,000
Convertible Note Payable - The Company issued $850,000 in a convertible note on
March 20, 2014 (the "Note"). The Note has an interest rate of 25%, payable
monthly, and matures on September 21, 2014. The outstanding principal balance of
the Note, plus any accrued but unpaid interest on the Note, is convertible at
46
any time on or before the maturity date at $1 per common share. The convertible
note is personally guaranteed by our majority shareholder and by an officer and
director of the Company.
On July 16, 2014, the terms of the Note were amended ("Amendment") wherein the
holder of the Note elected to convert $200,000 of the principal of the Note into
293,000 of our common shares of stock at a price of $.6825 per share. As a
component of the Amendment, we in turn elected to prepay the remaining principal
balance of the Note, after the scheduled payment of the principal and accrued
interest due the holder on July 24, 2014 and to pay a prepayment penalty of
$11,250. The difference in the premium of the per share price of $0.6825 per the
Amendment and the $1 per share per the Note, plus the amount of the prepayment
penalty will be charged to interest expense ratably over the term of the
Amendment.
Private Offering - Through a private offering of our common stock at $1 per
share, we have collected $2,140,700 as of the date of the issuance of the
financial statements, July 31, 2014. Coupled with the 293,000 common shares
issued in connection with the conversion of the convertible note described
above, 22,863,700 shares of common stock would be outstanding upon the
completion of our stock offering. As part of the private offering, we sold
warrants which entitle the holders to purchase up to 1,070,350 shares of our
common stock. The warrants can be exercised at any time prior to January 31,
2019 at a price of $5.00 per share.
47
STRAINWISE, INC.
INTERIM FINANCIAL STATEMENTS
For the three month period ended April 30, 2014
(UNAUDITED)
48
STRAINWISE, INC.
CONDENSED BALANCE SHEETS
(Unaudited)
April 30, January 31,
2014 2014
-------------- ------------
ASSETS
Current assets:
Cash in trust account $ 317,579 $ 100
Prepaid expenses and other assets 84,200 10,000
-------------- ------------
Total current assets 401,779 10,100
Tenant improvements and office equipment, net
of
accumulated amortization and depreciation
of $22,667
and $0 at April 30 and January 31, 2014,
respectively 246,079 10,500
Prepaid expenses and other assets 296,187 -
Trademark, net of accumulated amortization of
$244
and $61, at April 30 and January 31,
2014, respectively 10,766 10,949
-------------- ------------
Total assets $ 954,811 $ 31,549
============== ============
LIABILITIES AND STOCKHOLERS' (DEFICIT)
LIABILITIES
Current liabilities:
Due to affiliated entities $ 171,320 $ 50,203
Accrued interest payable 8,051 -
-------------- ------------
Total current liabilities 179,371 50,203
Convertible note payable, net of unamortized
discount of $29,634 790,366 -
Deferred rent 13,133 3,273
-------------- ------------
Total liabilities 982,870 53,476
STOCKHOLDERS' (DEFICIT) EQUITY
Common stock, no par value, 100,000,000 shares
authorized, 20,430,000 issued and outstanding - -
Additional Paid in Capital 48,292 48,292
Share subscriptions receivable 941,200 -
Subscriptions to common stock (941,200)
(Deficit) Retained Earnings (76,351) (70,219)
-------------- ------------
Total stockholder's equity (28,059) (21,927)
-------------- ------------
Total liabilities and stockholder's deficit $ 954,811 $31,549
============== ============
See accompanying notes.
49
STRAINWISE, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
Three Three
Months Months
Ended Ended
April 30, April 30,
2014 2013
------------- ------------
Revenues from affiliated entities $ 536,209 $ -
Operating costs and expenses:
Nutrient purchases 99,496 -
Compensation 241,711 -
Rent and other occupancy 78,046 -
General and administrative 34,187 -
------------- ------------
Total operating costs and expenses 453,440 -
------------- ------------
Income from operations 82,769
-
Other costs and expenses
Interest expense 39,718 -
Professional, legal and consulting
fees 26,323 -
Depreciation and amortization
expense 22,860 -
------------- ------------
Loss before taxes on income
(6,132) -
Provision for taxes on income - -
------------- ------------
Net loss $ (6,132) $ -
============= ============
Basic loss per common share $ (0.00030) $ -
============= ============
Fully diluted loss per common share $ (0.00029) -
============= ============
Weighted average number of shares
outstanding 20,430,000 -
============= ============
Fully diluted weighted average number
of shares outstanding 20,930,000 -
============= ============
See accompanying notes.
50
STRAINWISE, INC.
CONDENSED STATEMENT OF CASH FLOWS
(UNAUDITED)
Three
months
Three months ended
ended April 30,
April 30, 2014 2013
--------------- ----------
Cash flows from operating activities:
Net (loss) $ (6,132) $ -
Adjustments to reconcile net loss to net
cash used in operating activities:
Depreciation and amortization 22,860 -
Unamortized discount on debt (29,635) -
Changes in current assets and liabilities:
Increase in amounts due affiliates 121,118 -
Increase in prepaid expenses and other
assets (393,248) -
Decrease in trademark 183 -
Increase in accrued expenses and deferred 17,912 -
rent
--------------- ------------
Net cash used in operating activities (266,942) -
Cash flows from investing activities:
Investment in tenant improvements and
office equipment (235,579) -
--------------- ------------
Net cash flow from investing (235,579) -
activities
Cash flows from financing activities:
Proceeds from common stock subscriptions - 100
Proceeds from convertible note payable,
inclusive of discount of $45,000 895,000 -
Payments on convertible notes payable (75,000) -
--------------- ------------
Net cash flows from financing activities 820,000 100
--------------- ------------
Net cash flows 317,479 100
Cash and equivalent, beginning of period 100 -
--------------- ------------
Cash and equivalent, end of period $ 317,579 $ 100
=============== ============
Supplemental cash flow disclosures:
Cash paid for interest $ 26,587 $ -
=============== ============
Cash paid for income taxes $ - $ -
=============== ============
See accompanying notes.
51
STRAINWISE, INC.
STATEMENT OF CHANGES IN CONDENSED STOCKHOLDERS' DEFICIENCY For
the Period from June 8, 2012 (date of inception) to April 30, 2014
(UNAUDITED)
Common Stock
Additional Deficit
Capital In Accumulated
Excess in
of Par Development
Shares Amount Value Stage Total
------------------------------------------------------
Balance, June 8, 2012, - $ - $ - $ - $ -
inception
Membership interest issued
for cash - - 100 - 100
Net loss - - - - -
------------------------------------------------------
Balance, January 31, 2013 - - 100 - 100
Conversion of common
shares
for membership interest 20,430,000 - - - -
Stock-based compensation - - 48,192 - 48,192
Net loss for the period - - - (70,219) (70,219)
-----------------------------------------------------
Balance, January 31, 2014 20,430,000 - 48,292 (70,219) $(21,927)
Subscriptions to common
stock 941,200 - 941,200 - 941,200
Share subscriptions
receivable - - (941,200) - (941,200)
Net loss - - - (6,132) (6,132)
-----------------------------------------------------
Balance, April 30, 2014 21,371,200 $ - $ 48,292 $(76,351) $(28,059)
=====================================================
See accompanying notes.
52
STRAINWISE, INC.
Notes to the Unaudited Financial Statements
April 30, 2014
Note 1 - Organization and summary of significant accounting policies:
Following is a summary of our organization and significant accounting policies:
Organization and nature of business - STRAINWISE, INC. (identified in these
footnotes as "we" "us" or the "Company") provides branding and fulfillment
services to entities in the cannabis retail and production industry. The Company
was incorporated in the state of Colorado as a limited liability company on June
8, 2012, and subsequently converted to a Colorado corporation on January 16,
2014.
The Company provides sophisticated fulfillment and branding services and
solutions to (i) one grow facility and eight retail stores (seven of which sell
recreational and medical marijuana to the public and one of which only sells
medical marijuana to the public) owned by an officer and director of the Company
("Affiliated Entities") and (ii) makes such services available to independent
retail stores and grow facilities in the regulated cannabis industry throughout
the United States.
The branding and fulfillment services that we currently provide are summarized,
as follows:
o Branding, Marketing and Administrative Consulting Services: Customers
may contract with us to use the Strainwise name, logo and affinity
images in their retail store locations. A monthly fee permits our
branding customer to use the Strainwise brand at one specific
location. In addition, we will assist operators in marketing and
managing their businesses, setting up new retail locations and general
business planning and execution at an hourly rate. This includes
services to establish an efficient, predictable production process, as
well as, nutrient recipes for consistent and appealing marijuana
strains.
o Accounting and Financial Services: For a monthly fee, we provide our
customers with a fully implemented general ledger system, with an
industry centric chart of accounts, which enables management to
readily monitor and manage all facets of a marijuana medical
dispensary, retail store and grow facility. We provide bookkeeping,
accounts payable processing, cash management, general ledger
processing, financial statement preparation, state and municipal sales
tax filings, and state and federal income tax compilation and filings
on behalf of the Company and the Captive Stores on an ongoing basis.
o Compliance Services: The rules, regulations and state laws governing
the production, distribution and retail sale of marijuana can be
complex, and may prove cumbersome with which to comply. Thus,
customers may contract with us to implement a compliance process,
based upon the number and type of licenses and permits for their
specific business. We provide this service on both an hourly rate and
stipulated monthly fee.
o Nutrient Supplier: The Company presently is a bulk purchaser of
nutrients and other cultivation supplies for the sole purpose of
growing marijuana. As a result, we are able to make bulk purchases
with price breaks, based upon volume. We serve as a sole source
nutrient purchasing agent and distributor with pricing based upon our
bulk purchasing power.
o Lending: We will provide loans to individuals and businesses in the
cannabis industry. However, Colorado State law does not allow entities
operating under a cannabis license to pledge the assets or the license
of the cannabis operation for any type of general borrowing activity.
Thus, our lending will be on an unsecured basis, with reliance on a
personal guarantee of the borrower.
53
o Lease of Grow Facilities and Equipment: We lease grow equipment and
facilities on a turn-key basis to customers in the cannabis industry.
We will also enter into sale lease backs of grow lights, tenant
improvements and other grow equipment.
We do not directly grow marijuana plants, produce marijuana infused products,
sell marijuana plants and or sell marijuana infused products of any nature.
Share exchange - On August 19, 2014, we entered into an Agreement to Exchange
Securities ("Share Exchange") with 4th Grade Films, Inc. ("FHGR"), pursuant to
which FHGR will acquire approximately 90 % of the outstanding shares of
Strainwise in exchange for 23,124,184 shares of FHGR's common stock. FHGR is a
publicly-traded company, incorporated in Utah, with its common stock currently
quoted on the OTC Bulletin Board. It is contemplated that the Exchange will
qualify as a tax-free reorganization under the U.S. Internal Revenue Code.
As part of the Share Exchange, we paid $134,700 of FHGR's liabilities and
purchased 1,038,000 shares of FHGR's common stock for $120,300 from two
shareholders of FHGR. The 1,038,000 shares were returned to treasury and
cancelled. FHGR also agreed to sell its rights to a motion picture, together
with all related domestic and international distribution agreements, and all
pre-production and other rights to the film, to a former officer and director of
FHGR in consideration for the assumption by a shareholder of FHGR of all
liabilities of FHGR (net of the $134,700 we paid) which were outstanding
immediately prior to the closing of the transaction.
The business combination will be accounted for as a reverse acquisition and
recapitalization, using accounting principles applicable to reverse acquisitions
whereby the financial statements subsequent to the date of the transaction will
be presented as a continuation of the Company. Under reverse acquisition
accounting, the Company (subsidiary) is treated as the accounting parent
(acquirer) and FGHR (parent) is treated as the accounting Subsidiary (acquiree).
If the Share Exchange is completed, FGHR will have 24,431,184 outstanding shares
of common stock, with the current shareholders of FGHR owning 1,307,000 of the
post-closing shares.
Basis of presentation - The accounting and reporting policies of the Company
conform to U.S. generally accepted accounting principles.
Use of estimates - The preparation of financial statements in conformity with
generally accepted accounting principles requires management to make estimates
and assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the financial
statements and the reported amount of revenues and expenses during the reporting
period. Actual results could differ from those estimates.
Cash and cash equivalents - For purposes of the statement of cash flows, we
consider all cash in banks, money market funds, and certificates of deposit with
a maturity of less than three months to be cash equivalents. During 2014, the
Company entered into an agreement with our Chief Executive Officer to hold all
of our cash funds in his personal bank account in trust for the Company. Because
of current banking regulations, marijuana centric entities are not afforded
normal banking privileges, and thus, we were not able to obtain a corporate bank
account at a federally charted bank until well into the end of the second
quarter of operations in 2014. Under the terms of our trust agreement with our
Chief Executive Officer, he agreed to hold our cash in his personal bank account
and to make payments of our funds only for our business purposes and to allow
daily access to the bank account for ongoing oversight of his fiduciary
responsibility to the Company. Additionally, the trust agreement required that
the Chief Executive Officer make copies available of all transactions applicable
to our operations to our accounting staff on a weekly, or as requested basis. At
April 30, 2014 and January 31, 2014 there were cash deposits in the personal
bank account of the Chief Executive Officer held in trust for us in the amount
of $317,579 and $0, respectively.
Prepaid expenses and other assets - The Company pays rent in advance of the
rental period. The Company records the carrying amount as of the balance sheet
date of rental payments made in advance of the rental period; such amounts are
charged against earnings within one year. The Company also capitalizes any
prepaid expenses related to the reverse merger.
The amount of prepaid expenses and other assets as of April 30, 2014 and January
31, 2014 is $380,387 and $10,000, respectively.
Current prepaid expenses and other assets are comprised of the following:
January
April 30, 31,
2014 2014
------------ ----------
Prepaid reverse merger fees $ 35,000 $ -
Prepaid rent 29,200 -
Rent deposits 20,000 10,000
------------ ----------
$ 84,200 $ 10,000
============ ==========
54
Noncurrent prepaid expenses and other assets are comprised of the following:
April 30, April 30,
2014 2013
------------ ----------
Prepaid rent $ 54,108 $ -
Security deposits 242,079 -
------------ ----------
$ 296,187 $ -
============ ==========
Fair value of financial instruments and derivative financial instruments - The
carrying amounts of cash and current liabilities approximate fair value because
of the short maturity of these items. These fair value estimates are subjective
in nature and involve uncertainties and matters of significant judgment, and,
therefore, cannot be determined with precision. Changes in assumptions could
significantly affect these estimates. We do not hold or issue financial
instruments for trading purposes, nor do we utilize derivative instruments in
the management of our foreign exchange, commodity price or interest rate market
risks.
The FASB Codification clarifies that fair value is an exit price, representing
the amount that would be received to sell an asset or paid to transfer a
liability in an orderly transaction between market participants. It also
requires disclosure about how fair value is determined for assets and
liabilities and establishes a hierarchy for which these assets and liabilities
must be grouped, based on significant levels of inputs as follows:
Level 1: Quoted prices in active markets for identical assets or liabilities.
Level 2: Quoted prices in active markets for similar assets and liabilities and
inputs that are observable for the asset or liability.
Level 3: Unobservable inputs in which there is little or no market data,
which require the reporting entity to develop its own assumptions.
The determination of where assets and liabilities fall within this hierarchy is
based upon the lowest level of input that is significant to the fair value
measurement.
Tenant improvements and office equipment - Tenant improvements are recorded at
cost and are amortized over the term of the applicable lease period. Office
equipment is recorded at cost and is depreciated under straight line methods
over each item's estimated useful life. We review our tenant improvements and
office equipment for impairment whenever events or changes in circumstances
indicate that the carrying value of such assets may not be recoverable.
Maintenance and repairs of property and equipment are charged to operations.
55
Major improvements are capitalized. Upon retirement, sale or other disposition
of property and equipment, the cost and accumulated depreciation are eliminated
from the accounts and any gain or loss is included in operations.
Tenant improvements and office equipment, net of accumulated amortization and
depreciation are comprised of the following:
April 30, January
2014 31, 2014
-------------- -----------
Tenant improvements:
Upgrades of HVAC systems $ 181,000 $ -
Upgrades of electrical generators and power
equipment 42,590 -
Office equipment:
Computer equipment 3,777 -
Office furniture and fixtures 16,389 10,500
Machinery 25,000 -
-------------- -----------
268,756 10,500
Accumulated amortization and depreciation (22,667) -
-------------- -----------
$ 246,079 $ 10,500
============== ===========
Tenant improvements are amortized over the term of the lease, and office
equipment is depreciated over its useful lives, which has been deemed by
management to be three years. Amortization and depreciation expense for the
three months ended April 30, 3014 and April 30, 2013 was $22,700 and $0,
respectively.
Income taxes - The Company accounts for income taxes pursuant to ASC 740. Under
ASC 740 deferred taxes are provided on a liability method whereby deferred tax
assets are recognized for deductible temporary differences and operating loss
carryforwards and deferred tax liabilities are recognized for taxable temporary
differences. Temporary differences are the differences between the reported
amounts of assets and liabilities and their tax bases. Deferred tax assets are
reduced by a valuation allowance when, in the opinion of management, it is more
likely than not that some portion or all of the deferred tax assets will not be
realized. Deferred tax assets and liabilities are adjusted for the effects of
changes in tax laws and rates on the date of enactment.
Long-Lived Assets - In accordance with ASC 350, the Company regularly reviews
the carrying value of intangible and other long-lived assets for the existence
of facts or circumstances, both internally and externally, that suggest
impairment. If impairment testing indicates a lack of recoverability, an
impairment loss is recognized by the Company if the carrying amount of a
long-lived asset exceeds its fair value.
Trademarks - Trademarks and other intangible assets are stated at cost and
are amortized using the straight-line method over fifteen years.
Accumulated amortization was $244 and $0 at April 30, 2014 and 2013,
respectively and consisted of the following at April 30, 2014:
Gross
Carrying Accumulated
Amount Amortization Net
------------- ------------ --------------
Trademarks $11,010 $244 $ 10,766
============= ============ ==============
Deferred Rent - The Company recognizes rent expense from operating leases on the
straight-line basis. Differences between the expense recognized and actual
payments are recorded as deferred rent.
Revenue recognition - Revenue is recognized on an accrual basis as earned under
contract terms. Specifically, revenue from product sales is recognized
subsequent to a customer ordering a service or product at an agreed upon fee or
price, delivery has occurred, and collectability is reasonably assured.
Comprehensive Income (Loss) - Comprehensive income is defined as all changes in
stockholders' equity (deficit), exclusive of transactions with owners, such as
capital investments. Comprehensive income includes net income or loss, changes
in certain assets and liabilities that are reported directly in equity such as
translation adjustments on investments in foreign subsidiaries and unrealized
gains (losses) on available-for-sale securities. From our Inception there have
been no differences between our comprehensive loss and net loss.
56
Net income per share of common stock - We have adopted applicable FASB
Codification regarding Earnings per Share, which require presentation of basic
and diluted EPS on the face of the income statement for all entities with
complex capital structures and requires a reconciliation of the numerator and
denominator of the basic EPS computation to the numerator and denominator of the
diluted EPS computation. In the accompanying financial statements, basic
earnings per share of common stock is computed by dividing net income by the
weighted average number of shares of common stock outstanding during the period.
Note 2 - Going concern:
The accompanying financial statements have been prepared assuming that the
Company will continue as a going concern. For the period ended April 30, 2014,
the Company has had limited operations. As of April 30, 2014, the Company has
not become profitable. In view of these matters, the Company's ability to
continue as a going concern is dependent upon the Company's ability to begin
operations and to achieve a level of profitability. The Company intends to
continue financing its future development activities and its working capital
needs largely from the sale of public equity securities with some additional
funding from other traditional financing sources, including term notes until
such time that funds provided by operations are sufficient to fund working
capital requirements. The financial statements of the Company do not include any
adjustments relating to the recoverability and classification of recorded
assets, or the amounts and classifications of liabilities that might be
necessary should the Company be unable to continue as a going concern.
Note 3 - Related Party Transactions:
Substantially all of our revenues to date have been derived from Master Service
Agreements with eight retail marijuana stores and one cultivation and growing
facility that are majority owned by our Chief Executive Officer, who is also the
husband or our majority shareholder and our President. Pursuant to the terms of
these Master Service Agreements, the marijuana stores and grow facility pay us
monthly fees for branding, marketing, administration, accounting and compliance
services. We also supply nutrients to the one grow facility at a 90% mark-up to
our cost for the nutrients.
Related party revenue was $104,378 and $0.00, respectively, for the years ended
January 31, 2014 and 2013. As of January 31, 2014 and 2013, we had accounts
receivable from affiliated entities of $70,000 and $0, respectively. As of
January 31, 2013 and 2014, we had accounts payable to affiliated entities of
$120,203 and $0, respectively.
Although our agreements with the marijuana outlets and grow facility expire on
December 31, 2023, all terms and contracts related to this revenue are
determined by related parties and these terms can change at any time.
Note 4 - Operating Leases:
The Company entered into a lease agreement with an affiliate for our corporate
office needs. The lease is for a 31 month period, commenced in January 2014 for
6,176 square feet at an annual rate of $64,848 for the first twelve months,
$67,936 for the subsequent 12 months, and $41,431 for the subsequent 7 months
paid monthly, through October 31, 2016.
We entered into a lease agreement on March 7, 2014 to lease a grow facility of
approximately 26,700 square feet ("Custer Lease") for a term of five years
commencing on April 1, 2014. Lease payments are scheduled to be $29,200 per
month for the first twelve months of the lease, and then are scheduled to be
$27,500 per month for the subsequent 12 months, $28,325 per month for the
subsequent 12 months, $29,170 per month for the subsequent 12 months and $30,035
per month for the final 12 months of the lease. Under the terms of the Custer
57
Lease, we are obligated to pay a security deposit of $29,200 which was due and
paid upon the execution of the Custer Lease. We have the option to renew the
Custer Lease at the end of the term of the lease at a mutually agreed upon rate
per square foot; there is no option to purchase the property underlying the
Custer Lease. The Lessor will provide all of the tenant improvements that will
enable the continuous cultivation of marijuana plants under approximately 460
grow lights. We will lease this grow facility to the affiliated entities on a
long term basis.
We entered into a lease agreement on April 1, 2014 to lease a grow facility of
approximately 65,000 square feet ("51st Ave Lease") for a term of five years and
nine months. The terms of the 51st Ave Lease stipulates the payment of $15,000
per month, prorated if necessary, until such time that the Lessor is able to
deliver a Certificate of Occupancy, which is scheduled to occur on August 1,
2014. Thereafter, lease payments are scheduled to be $176,456 per month for the
first six months of the lease, and then are scheduled to be $221,833 per month
for the subsequent 24 months, $231,917 per month for the subsequent 12 months,
$242,000 per month for the subsequent 12 months and $247,041 per month for the
final 12 months of the lease. Under the terms of the 51st Ave Lease, we are
obligated to pay a security deposit of $150,000 one third of which was due and
paid upon the execution of the 51st Ave Lease, the second third is due and
payable after the first harvest or by October 1, 2014, and the final third is
due and payable after the second harvest or by December 1, 2014. We have the
option to renew the 51st Ave Lease at the end of the term of the lease at a
mutually agreed upon rate per square foot; there is no option to purchase the
property underlying the 51st Avenue Lease. The Lessor will provide all of the
tenant improvements that will enable the continuous cultivation of marijuana
plants under approximately 1,940 grow lights. We will lease this grow facility
to the affiliated entities on a long term basis.
We entered into a lease agreement on April 22, 2014 to lease a grow facility of
approximately 38,000 square feet ("Nome Lease") for a term of seven years. The
lease payments are scheduled to be $44,570 per month for the first twelve months
of the lease, and then are scheduled to be $46,151 per month for the subsequent
12 months, $47,743 per month for the subsequent 12 months, $49,334 per month for
the subsequent 12 months and $50,925 per month for the subsequent 12 months,
$52,517 per month for the subsequent 12 months, and $54,108 for the final 12
months of the lease. Under the terms of the Nome Lease, we are obligated to pay
a security deposit of $133,679 one half of which was due and paid upon the
execution of the Nome Lease, the final half was due and payable 30 days after
the commencement date. We have the option to renew the Nome Lease at the end of
the term of the lease at a mutually agreed upon rate per square foot; there is
no option to purchase the property underlying the Nome Lease. The Lessor will
provide all of the tenant improvements that will enable the continuous
cultivation of marijuana plants under approximately 920 grow lights. We will
lease this grow facility to the affiliated entities on a long term basis.
Future minimum payments for these leases are:
For the Period
Ending April 30, Amount
---------------- ------
2015 $2,550,987
2016 $3,608,905
2017 $3,637,249
2018 $3,746,079
2019 $3,855,572
Note 5 - Issuance of Shares:
The Company was originally organized as a limited liability company on June 8,
2012 with $100 of membership equity. On January 16, 2014, the Company converted
to a corporation and issued a total of 20,340,000 shares in exchange for the one
hundred percent of the membership interests owned by the majority shareholder
and President of the Company. As of April 30, 2014, there were a total of
20,340,000 shares of common stock issued and outstanding. Through a private
offering of our common stock at $1 per share, we have collected $941,200 from
subscribers as for April 30, 2014 for 941,200 shares. The total shares of common
stock that would be issued and outstanding upon the completion of our stock
offering and the issuance of shares to the current subscribers, the total amount
of our common shares issued and outstanding would be 21,281,200 shares.
Note 6 - Income Taxes:
The Company uses the liability method of accounting for income taxes under which
deferred tax assets and liabilities are recognized for the future tax
consequences of temporary differences between the accounting bases and the tax
bases of the Company's assets and liabilities. The deferred tax assets and
liabilities are computed using enacted tax rates in effect for the year in which
the temporary differences are expected to reverse.
The Company adopted the provisions of ASC 740, "Income Taxes" on April 1, 2007.
FASB ASC 740 provides detailed guidance for the financial statement recognition,
measurement and disclosure of uncertain tax positions recognized in the
financial statements. Tax positions must meet a "more-likely-than-not"
recognition threshold at the effective date to be recognized upon the adoption
of FASB ASC 740 and in subsequent periods. The components of the income tax
provision are as follows:
58
Three Months Ended April
30,
---------------------------
2014 2013
----------- -----------
Income tax expense (benefit):
Current:
Federal $ 13,205 $ -
State (3,536) -
----------- -----------
Deferred income tax expense (benefit): -
9,670
Valuation allowance (9,670) -
----------- -----------
Provision $ - $ -
=========== ===========
We have a net operating loss carryforward for financial statement reporting
purposes of $76,351 from the year ended January 31, 2014
Note 7 - Convertible Note Payable:
Notes payable consist of the following:
April 30, 2014 January 31, 2014
-------------- ----------------
Convertible notes payable, with interest due monthly
at 25% per annum, maturing September 21, 2014: $850,000 --
Discount 45,000 --
----------
$895,000 --
Less Payment (75,000) --
Less Unamortized Discount (29,635) --
----------- --------
Balance: $790,365 --
========== ========
The unamortized discount on the convertible note at April 30, 2014 was
calculated as follows:
Discount $45,000
Less Amortization through 4/17/14,
using an imputed rate of 22.9% (10,286)
Less Amortization from 4/18 to 4/30,
using an imputed rate of 26.1% (5,080)
---------
Unamortized Premium: $29,634
========
The Company issued a note for $850,000 in a convertible note on March 20, 2014
(the "Note"). The Note has an interest rate of 25%, payable monthly, and matures
on September 21, 2014. The outstanding principal balance of the Note, plus any
accrued but unpaid interest on the Note, is convertible at any time on or before
the maturity date at $1 per common share. The convertible note is personally
guaranteed by our majority shareholder and by an officer and director of the
Company.
On July 16, 2014, the terms of the Note were amended ("Amendment") wherein the
holder of the Note elected to convert $200,000 of the principal of the Note into
293,000 of our common shares of stock at a price of $.6825 per share. As a
component of the Amendment, we in turn elected to prepay the remaining principal
balance of the Note, after the scheduled payment of the principal and accrued
interest due the holder on July 24, 2014 and to pay a prepayment penalty of
$11,250. The difference in the premium of the per share price of $0.6825 per
share per the Amendment and the $1 per share per the Note, plus the amount of
the prepayment penalty will be charged to interest expense in the month the
transaction occurred.
Note 8 - New accounting Pronouncements:
The Financial Accounting Standards Board ("FASB") periodically issues new
accounting standards in a continuing effort to improve standards of financial
accounting and reporting.
59
The Company elected to adopt ASU 2014-10, Development Stage Entities:
Elimination of Certain Financial Reporting Requirements, Including an Amendment
to Variable Interest Entities Guidance in Topic 810, Consolidation. The adoption
of this ASU allows the company to remove the inception to date information and
all references to development stage. We do not expect the adoption of recently
issued accounting pronouncements to have a significant impact on our results of
operations, financial position or cash flow.
Note 9 - Subsequent Events:
Share Exchange - On August 19, 2014, we entered into an Agreement to Exchange
Securities ("Share Exchange") with 4th Grade Films, Inc. ("FHGR"), pursuant to
which FHGR will acquire approximately 90 % of the outstanding shares of
Strainwise in exchange for 23,124,184 shares of FHGR's common stock. FHGR is a
publicly-traded company, incorporated in Utah, with its common stock currently
quoted on the OTC Bulletin Board. It is contemplated that the Exchange will
qualify as a tax-free reorganization under the U.S. Internal Revenue Code.
As part of the Share Exchange, we paid $134,700 of FHGR's liabilities and
purchased 1,038,000 shares of FHGR's common stock for $120,300 from two
shareholders of FHGR. The 1,038,000 shares were returned to treasury and
cancelled. FHGR also agreed to sell its rights to a motion picture, together
with all related domestic and international distribution agreements, and all
pre-production and other rights to the film, to a former officer and director of
FHGR in consideration for the assumption by a shareholder of FHGR of all
liabilities of FHGR (net of the $134,700 we paid) which were outstanding
immediately prior to the closing of the transaction.
The business combination will be accounted for as a reverse acquisition and
recapitalization, using accounting principles applicable to reverse acquisitions
whereby the financial statements subsequent to the date of the transaction will
be presented as a continuation of the Company. Under reverse acquisition
accounting, the Company (subsidiary) is treated as the accounting parent
(acquirer) and FGHR (parent) is treated as the accounting Subsidiary (acquiree).
If the Share Exchange is completed, FGHR will have 24,431,184 outstanding shares
of common stock, with the current shareholders of FGHR owning 1,307,000 of the
post-closing shares.
Operating Lease - We entered into a lease agreement on June 10, 2014 to lease a
grow facility of approximately 113,000 square feet ("32nd Ave Lease") for a term
of five years and nine months which will not become effective until the proper
Licenses are awarded, expected to be September 1, 2014. The terms of the 32nd
Ave Lease stipulates the payment of $25,000 per month, prorated if necessary,
until such time that the Lessor is able to deliver a Certificate of Occupancy,
which is scheduled to occur in early 2015. Thereafter, lease payments are
scheduled to be $282,500 per month for the first Sixteen months of the lease,
and then are scheduled to be $301,333 per month for the subsequent 12 months,
$320,167 per month for the subsequent 12 months, and $329,583 per month for the
final 12 months of the lease. Under the terms of the 32nd Ave Lease, we are
obligated to pay a security deposit of $250,000, $150,000 of which was due and
paid upon the execution of the 32nd Ave Lease, and $100,000 due upon obtaining
the Certificate of Occupancy. We have the option to renew the 32nd Ave Lease at
the end of the term of the lease at a mutually agreed upon rate per square foot;
there is no option to purchase the property underlying the 32nd Ave Lease. The
Lessor will provide all of the tenant improvements that will enable the
continuous cultivation of marijuana plants under approximately 3,000 grow
lights. We will lease this grow facility to the affiliated entities on a long
term basis.
Private Stock Offering - Through a private offering of our common stock at $1
per share, we have collected $941,200 from subscribers as for April 30, 2014 for
941,200 shares, and we have collected an additional $1,199,500 from May 1, 2014
through, July 31, 2014. Thus, total subscriptions to common stock through the
private offering is 2,140,700 shares. Coupled with the 293,000 common shares
issued in connection with the conversion of the convertible note described
above, upon the completion of our stock offering and the issuance of shares to
the current subscribers we would have 22,863,700 outstanding shares of common
stock. As part of the private offering, we sold warrants which entitle the
holders to purchase up to 1,070,350 shares of our common stock. The warrants can
be exercised at any time prior to January 31, 2019 at a price of $5.00 per
share.
60
STRAINWISE, INC.
PRO FORMA FINANCIAL STATEMENTS
(UNAUDITED)
61
STRAINWISE, INC.
Condensed Pro Forma Balance Sheets
(Unaudited)
Pro Forma Combined InformationThe following unaudited pro forma condensed
combined balance sheet as of April 30, 2014 is based on (i) the historical
balance sheet of Strainwise, Inc. as of April 30, 2014 and (ii) the historical
balance sheet of 4th Grade Films, Inc as of March 31, 2014.
Strainwise
Inc.
Strainwise, 4th Grade Pro
Inc. Films, Inc. Notes Adjustments Forma
---------- ---------- ------ ----------- ---------
ASSETS
Current assets:
Cash in trust account $317,579 $32 (3) (32) $317,579
Prepaid expenses and
other assets 84,200 - 84,200
---------- ---------- ---------
Total current assets 401,779 32 401,779
Tenant improvements and
office equipment, net of
accumulated amortization
and depreciation of
$22,667 246,079 - 246,079
Prepaid expenses and
other assets 296,187 296,187
Trademark, net of
accumulated amortization
of $244 10,766 - 10,766
---------- ---------- ---------
Total $954,811 $32 $954,811
========== ========== =========
LIABILITIES AND STOCKHOLDERS' DEFICIT
LIABILITIES
Due to affiliated entities $171,320 $ - $171,320
Payable to Shareholder - 26,961 (3) (26,961) -
Accrued interest payable 8,051 1,500 (3) (1,500) 8,051
---------- ---------- ---------
Total current liabilities 179,371 28,461 179,371
Convertible note payable,
net of unamortized
discount of $29,634 790,366 -
790,366
Note payable to - 106,072 (3) (106,072) -
shareholder
Deferred rent 13,133 - 13,133
---------- ---------- ---------
Total lliabilities 982,870 134,533 982,870
STOCKHOLDERS' (DEFICIT)
EQUITY
Common stock, no par
value, 100,000,000 shares
authorized, 23,124,184
issued and outstanding - 23,450 (1) (23,450) -
Additional Paid in Capital 48,292 123,762 (1) (123,762) 48,292
Share subscriptions
receivable 941,200 - 941,200
Subscriptions to common
stock (941,200) - (941,200)
(Deficit) Retained
Earnings (76,351) (281,713) (2) 281,713 (76,351)
---------- ---------- ---------
Total stockholder's equity (28,059) (134,501) (28,059)
---------- ---------- ---------
Total $954,811 $32 $954,811
========== ========== =========
See accompanying notes.
62
STRAINWISE, INC.
Condensed Pro Forma Statements of Operations
(Unaudited)
The following unaudited pro forma condensed combined statement of operations and
comprehensive loss for the three months ended April 30, 2014 is based on (i) the
historical results of operations of Strainwise, Inc. for the three months ended
April 30, 2014, and (ii) the historical results of operations of 4th Grade
Films, Inc. for the three months ended March 31, 2014
Strainwise
Inc.
Strainwise, 4th Grade Pro
Inc. Films, Inc. Notes Adjustments Forma
---------- ---------- ------ ----------- ---------
Revenues from affiliated
entities $ 536,209 $ - $ 536,209
Operating costs and
expenses
Nutrient purchases 99,496 - 99,496
-
Compensation 241,711 241,711
Rent and other occupancy 78,046 225 (2) 225 78,046
General and -
administrative 34,187 34,187
------------ --------- -----------
Total operating costs 453,440 225 453,440
------------ --------- -----------
Income from operations 82,769 225 82,769
Other Costs and Expenses
Interest Expense 39,718 (2,545) (2) 2,545 (39,718)
Professional, legal and
consulting fees 26,323 (2,400) (2) 2.400 (26,323)
Amortization and
depreciation 22,860 - (22,860)
------------ --------- -----------
Loss before taxes on income (6,132) (5,170) (6,132)
Provision for taxes on
income - - -
------------ --------- -----------
Net loss $ (6,132) (5,170) $(6,132)
============ ========= ===========
See accompanying notes.
63
STRAINWISE, INC.
Pro Forma Summary and Adjustments to the Balance Sheet and Statements
of Operations
(Unaudited)
Summary
The unaudited pro forma condensed consolidated balance sheet and statement of
operations reflects amounts as if the transaction had occurred on March 31,
2014. As a result of this business combination, 4th Grade Films, Inc.
("Strainwise") became a wholly owned subsidiary of the Company.
The information presented in the unaudited pro forma combined financial
statements does not purport to represent what the financial position or results
of operations would have been had the acquisition occurred as of April 30, 2014,
nor is it indicative of future financial position or results of operations. You
should not rely on this information as being indicative of the historical
results that would have been achieved had the companies always been combined, or
the future result that the combined company will experience after the Exchange
Transaction is consummated.
The pro forma adjustments are based upon available information and certain
assumptions that the Company believes is reasonable under the circumstances. The
unaudited pro forma financial statements should be read in conjunction with the
accompanying notes and assumptions and the historical financial statements of
the Company and Strainwise.
The accompanying pro forma financial statements include the balance sheet as of
April 30, 2014 and the statement operations for the three months then ended.
These financial statements reflect the acquisition by 4th Grade Films, Inc
("FHGR") of Strainwise, Inc. ("Strainwise").
In August 19, 2014, Strainwise entered into an agreement to exchange securities
with FHGR, whereby a shareholder of Strainwise received 23,124,874 shares of the
common stock of FHGR in exchange for approximately 90% of the outstanding shares
of Strainwise. As part of this agreement, Strainwise paid $134,700 of FHGR's
liabilities and purchased 1,038,000 shares of FHGR's common stock for $120,300
from two shareholders of FHGR. The 1,038,000 shares were returned to treasury
and cancelled. FHGR also agreed to sell its rights to a motion picture, together
with all related distribution agreements, and all pre-production and other
rights to the film, to a former officer and director of FHGR in consideration
for the assumption by a shareholder of FHGR of all liabilities of FHGR (net of
the $134,700 paid by Strainwise) which were outstanding immediately prior to the
closing of the transaction.
The transaction was accounted for as a reverse acquisition whereby Strainwise
was consider to be the accounting acquirer.
Pro forma adjustments:
1. To reflect the issuance of 23,124,184 shares of no par value common
stock of Strainwise in exchange for approximately 94.7% of FHGR and
the cancellation of 1,038,000 shares of FHGR.
2. To reclassify the current period loss and to reclassify the
accumulated deficit of FHGR.
3. To reflect the payment of FHGR's liabilities in the amount of
$134,700.
64
PART II
Information Not Required in Prospectus
Item 13. Other Expenses of Issuance and Distribution.
The following table sets forth the costs and expenses payable by us in
connection with the issuance and distribution of the securities being
registered.
SEC Filing Fee $1,330
Blue Sky Fees and Expenses 2,000
Legal Fees and Expenses 30,000
Accounting Fees and Expenses 5,000
Miscellaneous 1,6701
TOTAL $40,000
=======
All expenses other than the SEC filing fee are estimated.
Item 14. Indemnification of Officers and Directors
The Utah Revised Business Corporation Act and our bylaws provide that we
may indemnify any and all of our officers, directors, employees or agents or
former officers, directors, employees or agents, against expenses actually and
necessarily incurred by them, in connection with the defense of any legal
proceeding or threatened legal proceeding, except as to matters in which such
persons shall be determined to not have acted in good faith and in our best
interest.
Item 15. Recent Sales of Unregistered Securities.
The following lists all sales of our securities during the past three
years:
On August 29, 2014, we acquired approximately 90% of the outstanding common
stock of Strainwise, Inc., a Colorado corporation ("Strainwise Colorado"), in
exchange for 23,214,184 shares of our common stock.
On September 12, 2014 we acquired the remaining outstanding shares of
Strainwise Colorado in exchange for the issuance of 2,517,000 shares of our
common stock. In connection with this transaction:
o we issued 1,112,350 Series A warrants to former Strainwise Colorado
shareholders in exchange for a like number of warrants held by the
former Strainwise Colorado shareholders. The Series A warrants we
issued have the same terms as the warrants exchanged by the former
Strainwise Colorado shareholders (exercise price: $5.00 per
share/expiration date: January 31, 2019).
o we issued 500,000 warrants to one non-affiliated person in exchange
for a like number of warrants held by the former Strainwise Colorado
warrant holder. The warrants we issued have the same terms as the
warrants exchanged by the former Strainwise Colorado warrant holder
1
(exercise price: $0.10 per share/expiration date: January 31, 2019).
In connection with the issuance of these shares, we relied upon the
exemption provided by Section 4(a)(2) of the Securities Act of 1933, as amended
(the "Securities Act"). The persons who acquired these shares and warrants were
sophisticated investors and were provided full information regarding our
business and operations. There was no general solicitation in connection with
the offer or sale of these securities. The persons who acquired these securities
acquired them for their own accounts. The certificates representing these
securities will bear a restricted legend providing that they cannot be sold
except pursuant to an effective registration statement or an exemption from
registration under the Securities Act. No commission was paid to any person in
connection with the offer or sale of these securities.
The following lists all sales of Strainwise, Inc.'s ("Strainwise Colorado")
securities during the past three years.
On January 16, 2014 Strainwise Colorado issued 20,430,000 shares of its
common stock to Erin Phillips in consideration for the assignment to Strainwise
Colorado of all of the outstanding membership interests in Strainwise, LLC.
In January, 2014 Strainwise Colorado issued warrants to an unaffiliated
person for services rendered. The warrants allow the holder to purchase up to
500,000 shares of Strainwise Colorado's common stock at a price of $0.10 per
share at any time prior to January 31, 2019.
In July, 2014 Strainwise Colorado issued 293,000 shares of its common stock
to one person as a result of the conversion of a note in the principal amount of
$200,000.
Between March 15, 2014 and August 19, 2014 Strainwise Colorado sold
2,224,700 units, at a price of $1.00 per unit, to 81 private investors of whom
50 were accredited investors. Each unit consisted of one share of Strainwise
Colorado's common stock and one warrant. Every two warrants entitle the holder
to purchase one share of Strainwise Colorado's common stock at a price of $5.00
per share at any time prior to January 31, 2019.
Strainwise Colorado relied upon the exemption provided by Section 4(a)(2)
of the Securities Act of 1933, as amended (the "Securities Act") in connection
with sale and issuance of these securities. The persons who acquired these
securities were "sophisticated investors" and were provided full information
regarding the business and operations of Strainwise Colorado. There was no
general solicitation in connection with the offer or sale of these securities.
The persons who acquired these securities acquired them for their own accounts.
The certificates representing the shares of common stock and warrants will bear
a restricted legend providing that they cannot be sold except pursuant to an
effective registration statement or an exemption from registration under the
Securities Act. No commission was paid to any person in connection with the sale
or issuance of these securities.
2
Item 16. Exhibits
The following exhibits are filed with this Registration Statement:
Exhibit
Number Description of Exhibit
------- ----------------------
2.1 Agreement to Exchange Securities with Strainwise, Inc. (2)
2.2 Plan of Merger
3.1(a) Articles of Incorporation (1)
3.1(b) Articles of Amendment dated July 21, 2004 (1)
3.1(c) Amendment to Articles of Incorporation dated September 5,
2014
3.3 Bylaws (1)
10.1 Exchange Option
10.2 Custer Lease (2)
10.3 51st Ave. Lease (2)
10.4 Nome Lease (2)
10.5 32nd Ave. Lease (2)
10.6 Form of Master Service Agreement, together with schedule
required by Instruction 2 to Item 601(a) of Regulation
S-K.(2)
10.7 Lock-Up/Leak-Out Agreements, together with schedule required
by Instruction 2 to Item 601(a) of Regulation S-K.
10.8 Non-Disclosure/Non-Compete Agreements
21 Subsidaries
23.1 Consent of Attorneys
23.2 Consent of Accountants
(1) Incorporated by reference to the same exhibit filed with the Company's
amended registration statement on Form 10-SB filed on October 29, 2007.
(2) Incorporated by reference to the same exhibit filed with the Company's 8-K
report filed on August 21, 2014.
Item 17. Undertakings
The undersigned registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a
post-effective amendment to this registration statement:
3
(i) To include any prospectus required by Section l0 (a)(3) of the
Securities Act:
(ii)To reflect in the prospectus any facts or events which, individually
or together, represent a fundamental change in the information in the
registration statement. Notwithstanding the foregoing, any increase or decrease
in volume of securities offered (if the total dollar value of securities offered
would not exceed that which was registered) and any deviation from the low or
high end of the estimated maximum offering range may be reflected in the form of
prospectus filed with the Commission pursuant to Rule 424(b) if, in the
aggregate, the changes in volume and price represent no more than a 20% change
in the maximum aggregate offering price set forth in the "Calculation of
Registration Fee" table in the effective registration statement; and
(iii) To include any material information with respect to the plan of
distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement.
(2) That, for the purpose of determining any liability under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such securities at that time shall be deemed to be the initial bona
fide offering thereof.
(1) To remove from registration by means of a post-effective amendment any of
the securities that remain unsold at the termination of the offering.
Insofar as indemnification for liabilities arising under the Securities Act
of l933 (the "Act") may be permitted to directors, officers and controlling
persons of the Registrant pursuant to the foregoing provisions or otherwise, the
Registrant has been advised that in the opinion of the Securities and Exchange
Commission such indemnification is against public policy as expressed in the Act
and is, therefore, unenforceable. In the event that a claim for indemnification
against such liabilities (other than the payment by the Registrant of expenses
incurred or paid by a director, officer or controlling person of the Registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter
has been settled by controlling precedent, submit to a court of appropriate
jurisdiction the question of whether such indemnification by it is against
public policy as expressed in the Act and will be governed by the final
adjudication of such issue.
(4) That, for the purpose of determining liability under the Securities
Act of 1933 to any purchaser:
(i) If the registrant is relying on Rule 430B:
(A)Each prospectus filed by the registrant pursuant to Rule 424(b)(3)
shall be deemed to be part of the registration statement as of the date
the filed prospectus was deemed part of and included in the registration
statement; and
4
(B)Each prospectus required to be filed pursuant to Rule 424(b)(2),
(b)(5), or (b)(7) as part of a registration statement in reliance on Rule
430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or
(x) for the purpose of providing the information required by section 10(a)
of the Securities Act of 1933 shall be deemed to be part of and included
in the registration statement as of the earlier of the date such form of
prospectus is first used after effectiveness or the date of the first
contract of sale of securities in the offering described in the
prospectus. As provided in Rule 430B, for liability purposes of the issuer
and any person that is at that date an underwriter, such date shall be
deemed to be a new effective date of the registration statement relating
to the securities in the registration statement to which that prospectus
relates, and the offering of such securities at that time shall be deemed
to be the initial bona fide offering thereof. Provided, however, that no
statement made in a registration statement or prospectus that is part of
the registration statement or made in a document incorporated or deemed
incorporated by reference into the registration statement or prospectus
that is part of the registration statement will, as to a purchaser with a
time of contract of sale prior to such effective date, supersede or modify
any statement that was made in the registration statement or prospectus
that was part of the registration statement or made in any such document
immediately prior to such effective date; or
(ii)If the registrant is subject to Rule 430C, each prospectus filed
pursuant to Rule 424(b) as part of a registration statement relating to an
offering, other than registration statements relying on Rule 430B or other than
prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and
included in the registration statement as of the date it is first used after
effectiveness. Provided, however, that no statement made in a registration
statement or prospectus that is part of the registration statement or made in a
document incorporated or deemed incorporated by reference into the registration
statement or prospectus that is part of the registration statement will, as to a
purchaser with a time of contract of sale prior to such first use, supersede or
modify any statement that was made in the registration statement or prospectus
that was part of the registration statement or made in any such document
immediately prior to such date of first use.
(5) That, for the purpose of determining liability of the registrant under
the Securities Act of 1933 to any purchaser in the initial distribution of the
securities:
The undersigned registrant undertakes that in a primary offering of
securities of the undersigned registrant pursuant to this registration
statement, regardless of the underwriting method used to sell the securities to
the purchaser, if the securities are offered or sold to such purchaser by means
of any of the following communications, the undersigned registrant will be a
seller to the purchaser and will be considered to offer or sell such securities
to such purchaser:
(i) Any preliminary prospectus or prospectus of the undersigned
registrant relating to the offering required to be filed pursuant to Rule 424;
(ii)Any free writing prospectus relating to the offering prepared by or
on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;
5
(iii) The portion of any other free writing prospectus relating to the
offering containing material information about the undersigned registrant or its
securities provided by or on behalf of the undersigned registrant; and
(iv)Any other communication that is an offer in the offering made by the
undersigned registrant to the purchaser.
6
SIGNATURES
Pursuant to the requirements of the Securities Act of l933, the registrant
has duly caused this registration statement to be signed on its behalf by the
undersigned, thereunto duly authorized, in the Denver, Colorado on the 15th day
of September 2014.
STRAINWISE, INC.
By: /s/ Shawn Phillips
------------------------------------
Shawn Phillips, Chief Executive Officer
In accordance with the requirements of the Securities Act of l933, this
registration statement has been signed by the following persons in the
capacities and on the dates indicated:
Signature Title Date
/s/ Shawn Phillips Chief Executive Officer September 15, 2014
---------------------- and a Director
Shawn Phillips
/s/ Erin Phillips Chief Financial and September 15, 2014
---------------------- Accounting Officer
Erin Phillips and a Director
/s/ David Modica Director September 15, 2014
----------------------
David Modica
STRAINWISE, INC.
FORM S-1
EXHIBITS
EX-2
2
s1exh22sept-14.txt
EXH. 2.2 - PLAN OF MERGER
EXHIBIT 2.2
PLAN OF MERGER
(a)CONSTITUENT CORPORATIONS: Strainwise, Inc.
("SW") (A Colorado corporation)
SWM Corp. ("SWMC")
(A Colorado corporation)
SWM is a wholly owned subsidiary of SW
(b)SURVIVING CORPORATION: Strainwise, Inc. (A Colorado corporation)
(c) Pursuant to C.R.S. 7-111-104 and effective as of the date of the merger
(i) all shares of SWMC shall be cancelled;
(ii) all assets of SWMC shall become assets of SW;
(iii) all liabilities of SWMC shall be assumed by SW;
(iv) SWMC shall cease to exist;
(v) each shareholder of SW, with the exception of 4th Grade Films, Inc.
("4G"), will receive one share of 4G's common stock for each common
share which such shareholder owns in SW;
(vi) all issued and outstanding shares of SW, with the exception of the
shares held by 4G, shall be cancelled;
(vii) all outstanding Series A warrants of SW will be cancelled;
(viii) each person holding a Series A warrant of SW will receive a
Series A warrant from 4G entitling such person to purchase that
number of shares of 4G equal to the number of shares which such
person could have purchased in SW pursuant to the SW warrant, and
upon the same terms as provided in the SW warrant,
(ix) a warrant for the purchase of 500,000 shares of SW's common stock at
a price of $0.10 per share, expiring on January 31, 2019 will be
cancelled, and
(x) the holder of the warrant described in (ix) above will receive a
warrant from 4G entitling such person to purchase that number of
shares of 4G equal to the number of shares which such person could
have purchased in SW pursuant to the SW warrant, and upon the same
terms as provided in the SW warrant.
EX-3
3
s1exh31csept-14.txt
EXH. 3.1(C) - UTAH AMENDED ART. OF INC.
EXHIBIT 3.1(c)
Date: 09/08/2014
Receipt Number: 9708676
Amount Paid: $117.00
State of Utah
DEPARTMENT OF COMMERCE
Division of Corporations & Commercial Code
Articles of Amendment to Articles of Incorporation (Profit)
Entity Number: 6585117-0142
----------------------
Non-Refundable Processing fee: $37.00
Pursuant to UCA ss.16-10a part 10, the individual name bellowed causes this
Amendment to the Articles of Incorporation to be delivered to the Utah Division
of Corporations for filing, and states as follows:
1. The name of the corporation is: 4th GRADE FILMS, INC.
2. The date the following amendment(s) was adopted: 09/05/2014
3. If changing the corporation name, the new name of the corporation is:
STRAINWISE, INC.
4. The text of each amendment adopted (include attachment if additional space
neede):
Article I
Name
The name of this Corporation is "Strainwise, Inc."
5. If providing for an exchange, reclassification or cancellation of issued
shares, provisions for implementing the amendment if not contained in the
amendment itself:
6. Indicate the manner in which the amendment(s) was adopted (mark only one):
[X] Adopted by Incorporators or Board of Directors - Shareholder action not
required
[ ] Adopted by shareholders - Number of votes cast for amendment was
sufficient for approval.
7. Delayed effective date (if not to be effective upon filing) _______________
(not to exceed 90 days)
Under penalty or perjury, I declare that this Amendment of Articles of
Incorporation has been examined by me and is, to the best of my knowledge and
belief, true, correct and complete
By: /s/ Shawn Phillips
Title: Chief Executive Officer
Date: 9/5/2014
State of Utah
Department of Commerce
Division of Corporations and Commercial Code
I hereby certify that the foregoing has been filed
and approved on this 5th day of September, 2014
In this office of this Division and hereby issued
This certificate hereof
Examiner tr Date 9/9/14
/s/ Kathy Berg
Kathy Berg, Division Director
EX-5
4
s1exh5sept-14.txt
EXH. 5 - H&H LEGAL OPINION
EXHIBIT 5
September 12, 2014
Strainwise, Inc.
1350 Independence St., Suite 300
Lakewood, CO 80125
This letter will constitute an opinion upon the legality of the sale by certain
selling shareholders of Strainwise, Inc., a Utah corporation (the "Company"), of
up to 4,130,500 shares of common stock, all as referred to in the Registration
Statement on Form S-1 filed by the Company with the Securities and Exchange
Commission.
We have examined the Articles of Incorporation, the Bylaws, and the minutes of
the Board of Directors of the Company, the applicable laws of the State of Utah,
and a copy of the Registration Statement. In our opinion,
o the Company was authorized to issue the shares of common stock held by
the selling shareholders and such shares were validly issued and
represent fully paid and non-assessable shares of the Company's common
stock, and
o the Company has authorized the shares of common stock issuable upon
the exercise of the warrants and, upon the exercise of the warrants,
such shares will, when sold, be legally issued, fully paid and
non-assessable.
Very truly yours,
HART & HART, LLC
/s/ William T. Hart
William T. Hart
EX-10
5
s1exh101sept-14.txt
EXH. 10.1 - EXCHANGE OPTION
EXHIBIT 10.1
EXCHANGE OPTION
This Agreement is made as of February 24, 2014 by and between Erin
Phillips, Shawn Phillips and Strainwise, Inc. (the "Company") to establish the
terms and conditions by which the Company will have the option to acquire
medical and recreational marijuana stores owned by Erin or Shawn Phillips.
1. Erin Phillips and Shawn Phillips (the "Phillips") do, by this Agreement,
grant the Company the option ("Exchange Option") to acquire medical or
recreational marijuana stores (the "Captive Stores") now owned, or that may
become owned, by the Phillips in the future. The Exchange Option may be
exercised by the Company anytime within six months from the date that laws or
regulations permit the Company to own all or a part of the Captive Stores.
2. Upon the exercise of the Exchange Option, the Phillips will be obligated
to exchange the Captive Stores (or such percentage interest in the Captive Store
that the Company can legally acquire) for shares of the Company's common stock
(the "Exchange Shares").
3. The number of the Exchange Shares to be issued to the Phillips will be
determined by the following formula:
5 x A x B
---------
C
Where:
A = the combined EBITDA of the Captive Stores for the immediately
preceding twelve (12) month period from the date the Exchange Option is
exercised.
B = The percentage in the Captive Stores that can be acquired by the
C ompany.
C = the average closing price on the Pink Sheets, OTC Bulletin Board,
NASDAQ Markets, or NYSE/MKT for the ninety (90) days preceding the date
the Exchange Option is exercised;
Combined EBITDA will be determined using generally accepted accounting
principles, consistently applied.
4. Notwithstanding the above, the number of Exchange Shares will be
reduced, if necessary, such that, following the issuance of the Exchange Shares,
the total number of shares of the Company's common stock owned by the Phillips,
together with any shares issuable upon the exercise of any option or warrants
held by the Phillips, or any shares issuable upon the conversion of any
securities owned by the Phillips, will not exceed 85% of the Company's
outstanding shares of common stock.
5. Any advances to the Phillips and/or accounts receivable from the
Phillips, or any distributions to them in excess of the capital account of any
Captive Store at the time of the completion of the exchange, will (i) be
personally guaranteed by both Shawn and Erin Phillips, (ii) will be payable 36
1
months from the date of the completion of the Mandatory Exchange, and (iii) will
bear interest, to be adjusted monthly, at the LIBOR rate plus 3%.
6. If the Exchange Option is exercised, the following is an example of the
number of Exchange Shares to be issued to the Phillips, assuming the Company can
legally acquire a 50% interest in the Captive Stores:
o Combined EBITDA for the immediately preceding twelve (12) month period
- $80,000,000;
o Fifty percent of the combined EBITDA - $80,000,000 X 50% =
$40,000,000;
o Combined EBITDA multiplied by 5 times - 40,000,000 X 5 = 200,000,000;
o Average market price for the preceding ninety (90) day period - $20;
and
o Number of Exchange Shares to be issues to Phillips - 10,000,000
7. The parties understand that the Captive Stores may not be owned equally
by Erin and Shawn Phillips. In such a case:
o the Exchange Shares to be issued to Erin Phillips will be based upon
the percentage of the combined EBITDA of the Captive Stores owed by
Erin Phillips; and
o the Exchange Shares to be issued to Shawn Phillips will be based upon
the percentage of the combined EBITDA of the Captive Stores owed by
Shawn Phillips
8. The Exchange Shares will be "restricted shares", as that term is defined
in Rule 144 of the Securities Exchange Commission. At the option of the holder
of the Exchange Shares, the Exchange Shares will be included in the first
registration statement filed by the Company with the Securities and Exchange
Commission following the exercise of the Exchange Option, excluding any
registration statement on Form S-4, S-8, or any other inapplicable form (the
"piggy-back" registration rights). Notwithstanding the above, the underwriter of
any public offering conducted by the Company may limit the Exchange Shares which
may be sold due to market conditions.
9. No shareholder of the Company will be granted piggyback registration
rights superior to those of the Exchange Shares. The Company will pay all
registration expenses (exclusive of underwriting discounts and commissions and
special counsel to the Phillips). The registration rights may be transferred
provided that the Company (i) is given prior written notice; (ii) the transfer
is in connection with a transfer of not less than 1,000,000 shares of the
Company's common stock; and (iii) the transfer is to no more than three persons.
2
10. Any disputes, claims or controversies concerning this Agreement will be
settled by binding arbitration in Denver, Colorado in accordance with the rules
of the American Arbitration Association.
11. All notices required or permitted to be given under this Agreement
shall be in writing and shall be delivered by hand or mailed by United States
mail, registered or certified, return receipt requested, postage prepaid,
addressed as follows:
In case of notice to the Company:
Strainwise, Inc.
1350 Independence St., Suite 300
Lakewood, CO 80125
In case of notice to the Phillips:
8468 Lewis Ct
Arvada, CO 80005
The address of either party hereto may be changed by written notice to the
other party hereto given in the manner hereinabove described. All such notices
shall be deemed to have been given when delivered or mailed as aforesaid.
12. This Agreement contains the entire Agreement and understanding between
the parties hereto, and supersedes all prior agreements or understandings
between the parties. No representations were made or relied upon by either
party, other than those that are expressly set forth. The section headings
throughout this Agreement are for convenience and reference only, and shall in
no way be deemed to define, limit, or add to the meaning of any provision of
this Agreement. This Agreement and any provision hereof, may not be waived,
changed, modified, or discharged orally, but only by an agreement in writing
signed by the party against whom enforcement of any waiver, change,
modification, or discharge is sought. Except as otherwise expressly provided
herein, no waiver of any covenant, condition, or provision of this Agreement
shall be deemed to have been made unless expressly in writing and signed by the
party against whom such waiver is charged; and (i) the failure of any party to
insist in any one or more cases upon the performance of any of the provisions,
covenants, or conditions of this Agreement or to exercise any option herein
contained shall not be construed as a waiver or relinquishment for the future of
any such provisions, convenants, or conditions, (ii) the acceptance of
performance of anything required by this Agreement to be performed with
knowledge of the breach or failure of a covenant, condition, or provision hereof
shall not be deemed a waiver of such breach or failure, and (iii) no waiver by
any party of one breach by another party shall be construed as a waiver with
respect to any other or subsequent breach. This Agreement shall inure to and be
binding upon the heirs, executors, personal representatives, successors and
assigns of each of the parties to this Agreement. The invalidity or
unenforceability of any provision of this Agreement shall not affect the
validity or enforceability of any other provisions of this Agreement which shall
continue in full force and effect except for any such invalid or unenforceable
3
provision. The agreement will be governed by the laws of Colorado, without
giving effect to conflict of law rules.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement the
day and year first above written.
STRAINWISE, INC.
By: /s/ Shawn Phillips
-----------------------------------
Shawn Phillips, Chief Executive
Officer
/s/ Shawn Phillips
------------------------------------
Shawn Phillips
/s/ Erin Phillips
------------------------------------
Erin Phillips
4
EX-10
6
s1exh107sept-14.txt
EXH. 10.7 - LOCK-UP/LEAK OUT AGREES & SCHEDULE
EXHIBIT 10.7
Shown below are the persons and shares that are subject to the
Lock-Up/Leak-Out Agreements:
Name Subject Shares
John Walsh 71,000 *
Jason Amos 32,500
Gary Ashurst 30,000
Matthew Cinquanta 90,000
William Emanuel 10,000
Mark McNeely 17,000
David Modica 11,500
* The Company has agreed to exempt 15,592 shares originally held by Mr.
Walsh from his Lock-up/Leak-out Agreement.
LOCK-UP/LEAK-OUT AGREEMENT
THIS LOCK-UP/LEAK-OUT AGREEMENT (the "Agreement") is between 4th GRADE
FILMS, INC., a Utah corporation (the "Company"), and the undersigned person or
entity listed on the Counterpart Signature Page hereof, sometimes referred to
herein as the "Shareholder." For all purposes of this Agreement, "Shareholder"
includes any "affiliate, controlling person of Shareholder, agent,
representative or other person with whom Shareholder is acting in concert.
WHEREAS, it is intended that the shares of common stock of the Company
covered by this Agreement shall only include the common stock currently owned by
the Shareholder and represented by the stock certificate (or any successor stock
certificate issued on the transfer of such stock certificate) described on the
Counterpart Signature Page hereof (the "Common Stock"); and
WHEREAS, the execution and delivery of this Agreement was a condition of
the purchase by the Shareholder of the Common Stock covered hereby; and
NOW, THEREFORE, in consideration of the foregoing premises and the mutual
covenants contained herein, the receipt and sufficiency of which are hereby
acknowledged, the parties hereto agree as follows:
1. Except as otherwise expressly provided herein, and except as the
Shareholder may be otherwise restricted from selling shares of Common Stock
under applicable federal or state securities laws, rules and regulations and
Securities and Exchange Commission (the "SEC") interpretations thereof, the
Shareholder may only sell the Common Stock subject to the following conditions,
commencing on the later of ninety (90) days from the date the Company completes
a "reverse" merger or acquisition with Strainwise, Inc., a Colorado corporation
("Strainwise"), and the date of the filing by the Company's current report with
the SEC under Item 5.01(8) on Form 8-K that contains the "Form 10 Information"
as required therein and in SEC Rule 144(i) (the "Lock-Up Period"). Following the
Lock-Up Period, the Shareholder may sell the Common Stock as follows (the
"Leak-Out Period"):
1.1 Subsequent to the Lock-Up Period, the Shareholder shall be
allowed to sell only 1/6th of such Shareholder's shares of Common Stock that are
covered hereby, per month, during each of the next successive six months
following the Lock-Up Period, on a non-cumulative basis, meaning that if no
Common Stock was sold during one month while Common Stock was qualified to be
sold, such shares of Common Stock cannot be sold in the next successive month
(the "Leak-Out Period").
1.2 Except as otherwise provided herein, all Common Stock shall be
sold by the Shareholder in "broker's transactions" and in compliance with the
"manner of sale" requirements as those terms are defined in Rule 144 of the SEC
during the Leak-Out Period.
1.3 The Shareholder shall not engage in an investment strategy based
upon selling the shares of the Company "short" while the shares of Common Stock
1
covered hereby remain unsold, and shall not "short" the Company's Common Stock
while such shares remain unsold
1.4 Each Shareholder agrees that all sales will be made at no less
than the best "asked" prices, and no sales will be made at the "bid" prices for
the Escrow Shares.
1.5 An appropriate legend describing this Agreement shall be
imprinted on each stock certificate representing Common Stock covered hereby,
and the transfer records of the Company's transfer agent shall reflect such
restrictions.
2. The delivery of a duly executed copy of the Shareholder Resale Agreement
that has been accepted and acknowledged by the Shareholder's broker (Exhibit A
hereto) shall be satisfactory evidence for all purposes of this Agreement that
the Shareholder and the broker will comply with the "brokers' transactions,"
"manner of sale" and "no shorting" requirements of this Agreement, and no
further evidence thereof will be required of the Shareholder; provided, however,
the Company may confirm such compliance with the Shareholder and the
Shareholder's broker, to the extent that it deems reasonably required or
necessary to assure compliance with this Agreement; and provided, however, that
the Shareholder can otherwise provide satisfactory evidence to the Company of
such compliance, subject to the Company's acceptance of any such alternative
compliance evidence.
3. Notwithstanding anything to the contrary set forth herein, the Company
may, in its sole discretion and in good faith, at any time and from time to
time, waive any of the conditions or restrictions contained herein to increase
the liquidity of the Common Stock or if such waiver would otherwise be in the
best interests of the development of the trading market for the Common Stock.
Unless otherwise agreed, all such waivers shall be pro rata, as to all
Shareholders of the Company who have executed a Lock-Up/Leak-Out Agreement as a
condition to the purchase of the Common Stock in any similar transaction
occurring prior to the acquisition of Strainwise. Notwithstanding, the Company
may allow any such Shareholder the right to sell or transfer Common Stock in a
private transaction, subject to receipt of an opinion of legal counsel for the
Company, and subject to any transferee's execution and delivery of a copy of
this Agreement.
4. In the event of: (a) a completed tender offer to purchase all or
substantially all of the Company's issued and outstanding securities; or (b) a
merger, consolidation or other reorganization of the Company with or into an
unaffiliated entity, then this Agreement shall terminate as of the closing of
such event, and the Common Stock restrictions on the resale of the Common Stock
pursuant hereto shall terminate, excluding, however, any merger, consolidation
or reorganization by which the Company becomes a publicly-held company by reason
of a "reverse" merger as mentioned above, which such event or such transaction
shall have no effect on the enforceability of this Agreement.
5. Except as otherwise provided in this Agreement or any other agreements
between the parties, the Shareholder shall be entitled to their respective
beneficial rights of ownership of the Common Stock, including the right to vote
the Common Stock for any and all purposes.
2
6. The number of shares of Common Stock included in any allotment that can
be sold by the Shareholder hereunder shall be appropriately adjusted should the
Company make a dividend or distribution, undergo a forward split or a reverse
split or otherwise reclassify its shares of Common Stock.
7. This Agreement may be executed in any number of counterparts with the
same force and effect as if all parties had executed the same document.
8. All notices, instructions or other communications required or permitted
to be given pursuant to this Agreement shall be given in writing and delivered
by certified mail, return receipt requested, overnight delivery or
hand-delivered to all parties to this Agreement, to the Company, at 1350
Independence St., Suite 300, Lakewood, CO 80215, and to the Shareholder, at the
address in the Counterpart Signature Page. All notices shall be deemed to be
given on the same day if delivered by hand or on the following business day if
sent by overnight delivery or the second business day following the date of
mailing.
9. The resale restrictions on the Common Stock set forth in this Agreement
shall be in addition to all other restrictions on transfer imposed by applicable
country-regionplaceUnited States and state securities laws, rules and
regulations.
10. The Company or the Shareholder who fails to fully adhere to the terms
and conditions of this Agreement shall be liable to every other party for any
damages suffered by any party by reason of any such breach of the terms and
conditions hereof. The Shareholder agrees that in the event of a breach of any
of the terms and conditions of this Agreement by the Shareholder, that in
addition to all other remedies that may be available in law or in equity to the
non-defaulting parties, a preliminary and permanent injunction, without bond or
surety, and an order of a court requiring such Shareholder to cease and desist
from violating the terms and conditions of this Agreement and specifically
requiring the Shareholder to perform his/her/its obligations hereunder is fair
and reasonable by reason of the inability of the parties to this Agreement to
presently determine the type, extent or amount of damages that the Company or
any non-defaulting Shareholder may suffer as a result of any breach or
continuation thereof.
11. This Agreement sets forth the entire understanding of the parties
hereto with respect to the subject matter hereof, and may not be amended except
by a written instrument executed by the parties hereto and approved by a
majority of the members of the Board of Directors of the Company.
12. This Agreement shall be governed by and construed in accordance with
the laws of the State of Utah applicable to contracts entered into and to be
performed wholly within said State; and the Company and the Shareholder agree
that any action based upon this Agreement may be brought in the United States
federal and state courts situated in Utah only, and that shall each submit to
the jurisdiction of such courts for all purposes hereunder.
13. In the event of default hereunder, the non-defaulting parties shall be
entitled to recover reasonable attorney's fees incurred in the enforcement of
this Agreement.
3
14. This Agreement shall be binding upon any successors or assigns of the
Common Stock, without qualification, and in the event of any exchange of the
Common Stock under a merger or reorganization or other transaction of the
Company by which the Common Stock is subject to exchange for other securities in
any manner, this Agreement shall remain if full force and effect and shall apply
to any securities received or receivable in exchange for such Common Stock,
without qualification.
IN WITNESS WHEREOF, the undersigned have duly executed and delivered this
Agreement as of the day and year first above written.
4th GRADE FILMS, INC.
Date: August 19, 2014. By: /s/ Erin Phillips
-----------------------------
Erin Phillips, President
4
LOCK-UP/LEAK-OUT AGREEMENT
COUNTERPART SIGNATURE PAGE
This Counterpart Signature Page for that certain Lock-Up/Leak-Out Agreement
(the "Agreement") effective as of the latest signature date hereof, among 4th
Grade Films, Inc., a Utah corporation (the "Company"); and the undersigned, by
which the undersigned, through execution and delivery of this Counterpart
Signature Page, intends to be legally bound by the terms of the Agreement, as a
Shareholder, of the number of shares of the Company set forth below and
represented by the stock certificate described below.
---------------------------------------------
(Name)
----------------------------------------------
(Street Address)
----------------------------------------------
(City and State)
----------------------------------------------
(Stock Certificate No. and Number of Shares)
----------------------------------------------
(Date)
----------------------------------------------
(Signature) (Representative Capacity, if Applicable)
5
EXHIBIT A
Form of
Shareholder's Resale Agreement
Company Name and Address
Transfer Agent Name and Address
Re: Resale of __________ shares of common stock of Strainwise,
Inc., formerly 4th Grade Films, Inc., a Utah corporation (the
"Company"), which are represented by Stock Certificate No. __,
representing ________ shares, in the name of and beneficially owned
by __________________ (the "Seller" and the "Customer"), under that
certain Lock-Up/Leak-Out Agreement dated ______, __, 2014, (the
"LULO Agreement")
Dear Ladies and Gentlemen:
In consideration of _____________________ (the "Broker") accepting the
deposit of the above referenced stock certificate and the shares of common stock
represented thereby into the account of the undersigned (the "Customer"), to
allow the Customer to sell the common stock through the Broker in customary
broker "agency" transactions" that are made in accordance with the strict
guidelines of the LULO Agreement, the Customer agrees:
(i) To effect all sales of the Customer's shares covered by the LULO
Agreement in accordance with the "brokers' transactions" and "manner
of sale" requirements of Rule 144, meaning, among other conditions,
that the Customer will pay only the usual and customary brokerage
commission or discount in connection with any such sale and will not
solicit or arrange for the solicitation of orders to buy any of the
Customer's shares;
(ii) Not to engage in an investment strategy based upon selling these or
any other shares of the Company, whether equity, debt or otherwise,
"short" while the Customer's shares covered hereby remain unsold, and
to not "short" the Company's shares while these shares remain unsold;
(iii) The Customer agrees to provide you with reasonable documentation, on
your request to verify compliance with the foregoing, and authorizes
the Broker to provide reasonable documentation to verify compliance
with the terms and provisions hereof.
(iv) The Customer is acting for the Customer's own account in the resale of
any of the Customer's shares, as outlined in the LULO Agreement, and
as represented by the above referenced stock certificate or
certificates or any stock certificate into which the Customer's shares
covered by the LULO Agreement are transferred and not in concert with
any other person whatsoever.
SHAREHOLDER
Date: _______________ --------------------------------------
Signature
ACCEPTED:
Broker
Date: _______________ By:
-----------------------------------
Signature
EX-10
7
s1exh108sept-14.txt
EXH. 10.8 - E. & S. PHILLIPS NON-DISCLOSURE/COMPETE AGREES
EXHIBIT 10.8
STRAINWISE, INC.
CONFIDENTIALITY AND NON-COMPETITION AGREEMENT
This CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (the "Agreement") is
made between STRAINWISE, INC., a Colorado corporation ("Strainwise" herein) and
the undersigned Shawn Phillips.
In consideration of my appointment as Chief Executive Officer of
Strainwise, my employment as an executive officer of Strainwise, the receipt of
confidential information while associated with Strainwise, and other good and
valuable consideration, I, Shawn Phillips, agree that:
1. Term of Agreement. This Agreement shall continue in full force and
effect for the duration of my relationship with Strainwise and shall continue
thereafter until terminated through a written instrument signed by both parties.
2. Confidentiality.
(a) Definitions. "Proprietary Information" is all information and
any idea of whatever form, tangible, pertaining in any manner to the business of
Strainwise and its eight (8) affiliated retail stores commonly known as "The
Retreat", "The Ridge", "The Shelter", "The Annies", The Haven", "The Sanctuary",
"The Grove", and "The Reserve", together with all associated cannabis
cultivation facilities (collectively Strainwise, such eight stores and the
cultivation facilities are called the "Company" herein), or any of its
employees, clients, consultants, or business associates, which was produced by
any employee or consultant of the Company in the course of his or her employment
or consulting relationship or otherwise produced or acquired by or on behalf of
the Company. Proprietary Information includes, but is not limited to, all
know-how and software, technology, formulae, product information, plans,
devices, compilations of information, technical data, distribution methods,
supplier and client lists, sales and marketing information, client account
records, training and operations materials, memoranda, personnel records, code
books, pricing information, and any financial information concerning or relating
to the business, accounts, customers, employees and affairs of the Company, or
others, obtained by or furnished, disclosed or disseminated to an employee, or
obtained, assembled, or composed by an employee or under his or her supervision,
during the course of his or her employment by the Company, including all trade
secrets, intellectual property, software programs, computer codes, internet
domain names, Internet and World Wide Web URLs or addresses, and any techniques,
systems, forms and methods which have been used and/or devised by the Company
with respect to the business of the Company, or which have been used and/or
devised by clients of the Company and disclosed to the Company, and all physical
embodiments (including copies) of the foregoing. All Proprietary Information not
generally known outside of the Company's organization, and all Proprietary
Information so known only through improper means, shall be deemed "Confidential
Information." By example and without limiting the foregoing definition,
Proprietary and Confidential Information shall include, but not be limited to:
1
(1) methods, processes and/or technologies for the growing,
cultivation and production of cannabis and marijuana plants and products;
(2) cannabis business processes, procedures and strategies;
(3) retail and medical cannabis store operations;
(4) cannabis branding and fulfillment services;
(5) forecasts, unpublished financial information, budgets, projections,
customer lists, and client identities, characteristics and agreements;
(6) software, processes, trade secrets, computer programs, electronic
codes, inventions, innovations, discoveries, improvements, data,
know-how, and formats;
(7) business, marketing, and strategic plans;
(8) information about costs, profits, markets, sales, contracts and
lists of clients and referral sources;
(9) employee personnel files and compensation information;
(10) customer lists and names of customer contact personnel;
and
(11) customer terms, information, payments and data.
Confidential Information is to be broadly defined, and includes all
information that has or could have commercial value or other utility in the
business in which the Company (or any part thereof) is engaged or contemplates
engaging, and all information of which the unauthorized disclosure could be
detrimental to the interests of Strainwise, whether or not such information is
identified as Confidential Information by Strainwise.
(b) Existence of Confidential Information. Strainwise, through and
in connection with the operations of the entities comprising the Company, owns
and has developed and compiled, and will develop and compile, certain trade
secrets, proprietary techniques and other Confidential Information which have
great value to its business. This Confidential Information includes not only
information disclosed by Strainwise to me, but also information learned by me
during the course of my relationship with the entities comprising the Company.
(c) Protection of Confidential Information. I will not, directly or
indirectly, use, make available, sell, disclose or otherwise communicate to any
third party, other than in my assigned duties and for the benefit of Strainwise,
any of the Strainwise's Confidential Information, either during or after my
relationship with Strainwise. I agree not to publish, disclose or otherwise
disseminate such information without prior written approval of an executive
officer (other than me) of Strainwise. I acknowledge that I am aware that the
unauthorized disclosure of Confidential Information of Strainwise may be highly
prejudicial to its interests, an invasion of privacy, and an improper disclosure
of trade secrets. Whenever the approval, designation, specification or other act
of an executive officer is required under this Agreement, an executive officer
2
may, by written designation, authorize an agent of the Company to perform such
act.
(d) Delivery of Confidential Information. Upon request or when my
relationship with the Company terminates, I will immediately deliver to
Strainwise all copies of any and all materials and writings received from,
created for, or belonging to the Company including, but not limited to, those
which relate to or contain Confidential Information.
(e) Prior Actions and Knowledge. I represent and warrant that from
the time of my first contact with Strainwise I held in strict confidence all
Confidential Information and have not disclosed any Confidential Information,
directly or indirectly, to anyone outside Strainwise, or used, copied,
published, or summarized any Confidential Information, except to the extent
otherwise permitted in this Agreement.
(f) Third Parties. I represent that my relationship with Strainwise
does not and will not breach any agreements with or duties to a former employer
or any other third party. I will not disclose to Strainwise or use on its behalf
any confidential information belonging to others and that I will not bring onto
the premises of Strainwise any confidential information belonging to any such
party unless consented to in writing by such party.
3. Proprietary Rights, Inventions and New Ideas.
(a) Definition. The term "Subject Ideas" includes any and all ideas,
processes, trademarks, service marks, inventions, designs, technologies,
computer software, original works of authorship, discoveries, copyrights,
copyrightable work products, marketing and business ideas, and all improvements,
know-how, data, rights, and claims related to the foregoing that, whether or not
patentable, which are conceived, developed or created which: (1) relate to the
Company's business; (2) result from any work performed by me for the Company;
(3) involve the use of the Company's information, equipment, supplies,
facilities or trade secrets; (4) relate to the Company's proposed or
contemplated business; (5) result from or are suggested by any work done by the
Company or at the Company's request, or any projects specifically assigned to
me; or (6) result from my access to any of the Company's memoranda, notes,
records, client lists, referral sources, research results, data, inventions,
processes, or other materials (collectively, "Strainwise Materials").
(b) Strainwise Ownership. All right, title and interest in and to
all Subject Ideas, shall be held and owned solely by Strainwise, and where
applicable, all Subject Ideas shall be considered works made for hire. In the
event that the Subject Ideas shall be deemed not to constitute works made for
hire, or in the event that I should otherwise, by operation of law, be deemed to
retain any rights (whether moral rights or otherwise) to any Subject Ideas, I
agree to assign to Strainwise, without further consideration, my entire right,
title and interest in and to each and every such Subject Idea and Invention.
(c) Determination of Subject Ideas. I further agree that all
information and records pertaining to any idea, process, trademark, service
mark, invention, technology, computer software, original work of authorship,
design, discovery, copyright, product, and all improvements, know-how, rights,
and claims related to the foregoing ("Intellectual Property"), that I do not
believe to be a Subject Idea, but that is conceived, developed, or reduced to
practice by the Company (alone by me or with others) during my relationship with
Strainwise and for five (5) years thereafter, shall be disclosed promptly by me
3
to Strainwise (such disclosure to be received in confidence). Strainwise shall
examine such information to determine if in fact the Intellectual Property is a
Subject Idea subject to this Agreement.
(d) Access. Because of the difficulty of establishing when any
Subject Ideas are first conceived by me, or whether it results from my access to
Confidential Information or Company Materials, I agree that any Subject Idea
shall, among other circumstances, be deemed to have resulted from my access
Strainwise Materials if: (1) it grew out of or resulted from my work with
Strainwise or is related to the business of the Company, and (2) it is made,
used, sold, exploited or reduced to practice within one (1) year of the
termination of my relationship with the Company.
(e) No Use of Name. I shall not at any time use any of the Company's
names or any Strainwise trade name(s) in any advertising or publicity without
the prior written consent of Strainwise.
4. Competitive Activity.
(a) Acknowledgment. I acknowledge that the pursuit of the activities
forbidden by Section 4(b) below would necessarily involve the use, disclosure or
misappropriation of Confidential Information.
(b) Prohibited Activity. To prevent the above-described disclosure,
misappropriation and breach, I agree that during my employment and for a period
of five (5) years after termination of my relationship with Strainwise, without
Strainwise's express written consent, I shall not, directly or indirectly (i)
employ, solicit for employment, or recommend for employment any person employed
by the Company; (ii) contact or solicit any person or business which was a
client of the Company at any time within twelve (12) months before the
termination of my employment with Strainwise in connection with any matters
similar in nature or related to any business conducted between or contemplated
by the Company and such client at any time during my employment with Strainwise;
(iii) engage in any present or contemplated business activity that is or may be
competitive with the Company (or any part thereof) in the State of Colorado or
any other state of the United States of America where the Company (or any part
thereof) conducts its business, unless I can prove that any action taken in
contravention of this subsection (b) was done without the use in any way of
Confidential Information. For purposes of this subsection, to "engage in a
business in competition with the business of the Company, or a "competitive
business" shall mean: To be employed by, own an interest in, be a consultant to,
be a partner in or otherwise participate in any business or venture which offers
or sells to businesses or persons, cannabis related products or services which
are the same as or similar to those which are, at the then applicable time,
being offered and sold by the Company (or any part thereof).
5. Representations and Warranties. I represent and warrant (i) that I have
no obligations, legal or otherwise, inconsistent with the terms of this
Agreement or with my undertaking a relationship with Strainwise; (ii) that the
4
performance of the services called for by this Agreement do not and will not
violate any applicable law, rule or regulation or any proprietary or other right
of any third party; (iii) that I will not use in the performance of my
responsibilities for Strainwise any materials or documents of a former employer;
and (iv) that I have not entered into or will enter into any agreement (whether
oral or written) in conflict with this Agreement.
6. Termination Obligations.
(a) Upon the termination of my relationship with the Company or
promptly upon Strainwise's request, I shall surrender to Strainwise all
equipment, tangible Proprietary Information, documents, books, notebooks,
records, reports, notes, memoranda, contracts, lists, computer disks (and other
computer-generated files and data), any other data and records of any kind, and
copies thereof (collectively, "Company Records"), created on any medium and
furnished to, obtained by, or prepared by myself in the course of or incident to
my employment, that are in my possession or under my control.
(b) My representations, warranties, and obligations contained in
this Agreement shall survive the termination of my relationship with Strainwise.
(c) Following any termination of the Period of Employment, I will
fully cooperate with the Company in all matters relating to my continuing
obligations under this Agreement.
(d) I hereby grant consent to notification by Strainwise to any of
my future employers or companies I consult with about my rights and obligations
under this Agreement.
(e) Upon termination of my relationship with Strainwise, I will
execute the Certificate contained in Exhibit A.
7. Injunctive Relief. I acknowledge that my failure to carry out any
obligation under this Agreement, or a breach by me of any provision herein, will
constitute immediate and irreparable damage to Strainwise, which cannot be fully
and adequately compensated in money damages and which will warrant preliminary
and other injunctive relief, an order for specific performance, and other
equitable relief. I further agree that no bond or other security shall be
required in obtaining such equitable relief and I hereby consent to the issuance
of such injunction and to the ordering or specific performance. I also
understand that other action may be taken and remedies enforced against me.
8. Modification. No modification of this Agreement shall be valid unless
made in writing and signed by both parties.
9. Binding Effect. This Agreement shall be binding upon me, my heirs,
executors, assigns and administrators and is for the benefit of Strainwise and
its successors and assigns.
10. Arbitration. Except as to any action to obtain injunctive relief and/or
specific performance as provided in Section 7 above, I agree that any dispute or
controversy arising out of or relating to any interpretation, construction,
5
performance or breach of this Agreement, shall be settled by arbitration to be
held in Denver, Colorado, in accordance with the rules then in effect of the
American Arbitration Association. The arbitrator may grant injunctions or other
relief in such dispute or controversy. The decision of the arbitrator shall be
final, conclusive and binding on the parties to the arbitration. Judgment may be
entered on the arbitrator's decision in any court having jurisdiction; provided,
however, that the arbitrator shall not have the power to alter or amend this
Agreement. As allowed by the provisions of Colorado law, depositions may be
taken and discovery obtained in any such arbitration proceedings and such
section shall be deemed to be made a part of this Agreement and applicable to
any such arbitration.
11. Governing Law. This Agreement shall be construed in accordance with,
and all actions arising under or in connection therewith shall be governed by,
the laws of the State ofColorado.
12. Integration. This Agreement, together with the Employment Agreement
between the Company and the undersigned set forth the parties mutual rights and
obligations with respect to proprietary information, prohibited competition, and
intellectual property. They are intended to be the cumulative final, complete,
and exclusive statements of the terms of the party's agreements regarding these
subjects. This Agreement, together with any Employment Agreement between
Strainwise and the undersigned supersede all other prior and contemporaneous
agreements and statements on these subjects, and they may not be contradicted by
evidence of any prior or contemporaneous statements or agreements. To the extent
that the practices, policies, or procedures of Strainwise, now or in the future,
apply to myself and are inconsistent with the terms of this Agreement, the
provisions of this Agreement shall control unless changed in writing by
Strainwise.
13. Employment At Will. This Agreement is not an employment agreement. I
understand that Strainwise may terminate my association or employment with it at
any time, with or without cause, subject to the terms of any separate written
employment agreement executed by a duly authorized officer of Strainwise.
14. Construction. This Agreement shall be construed as a whole, according
to its fair meaning, and not in favor of or against any party. By way of example
and not limitation, this Agreement shall not be construed against the party
responsible for any language in this Agreement. The headings of the paragraphs
hereof are inserted for convenience only, and do not constitute part of and
shall not be used to interpret this Agreement. The covenants and agreements
contained in Sections 4, 6, 7, and 10 of this Agreement, which are of the
essence of this Agreement, are reasonable and necessary to protect and preserve
the business interests and properties of the Company. Irreparable harm will be
suffered by Strainwise should I breach any of such covenants. Such covenants are
separate, distinct and severable not only from each other but also from all
other provisions of this Agreement. In the event that such covenants are held
invalid or unenforceable as written, any court of competent jurisdiction may
revise such covenants to make them enforceable under applicable law. The
unenforceability of any such covenant shall not affect the validity or
enforceability of any other such covenant, or any other provisions of this
Agreement. In addition to other remedies available to it, Strainwise shall be
entitled to petition an appropriate court for temporary restraining orders and
temporary and permanent injunctions without the necessity of proving actual
damages to prevent a breach or contemplated breach of any of such covenants
6
since Strainwise will have no adequate remedy at law.
15. Attorneys' Fees. Should either I or Strainwise, or my heir, personal
representative, successor or permitted assign of either party, resort to legal
proceedings to enforce this Agreement, the party prevailing in such legal
proceeding shall be entitled, in addition to such other relief as may be
granted, to recover its attorneys' fees and costs in such litigation from the
party against whom enforcement was sought.
16. Severability. If any term, provision, covenant or condition of this
Agreement, or the application thereof to any person, place or circumstance,
shall be held to be invalid, unenforceable or void, the remainder of this
Agreement and such term, provision, covenant or condition as applied to other
persons, places and circumstances shall remain in full force and effect.
17. Rights Cumulative. The rights and remedies provided by this Agreement
and any Employment Agreement to which Strainwise and I are parties are
cumulative, and the exercise of any right or remedy by either Strainwise or me
(or by that party's successor), whether pursuant hereto, to any other agreement,
or to law, shall not preclude or waive that party's right to exercise any or all
other rights and remedies. This Agreement will inure to the benefit of
Strainwise and its successors and assigns.
18. Nonwaiver. The failure of either Strainwise or me, whether purposeful
or otherwise, to exercise in any instance any right, power or privilege under
this Agreement or under law shall not constitute a waiver or any other right,
power or privilege, nor of the same right, power or privilege in any other
instance. Any waiver by Strainwise or by me must be in writing and signed by
either myself, if I am seeking to waive any of my rights under this Agreement,
or by an officer of Strainwise (other than me) or some other person duly
authorized by Strainwise.
19. Notices. Any notice, request, consent or approval required or permitted
to be given under this Agreement or pursuant to law shall be sufficient if it is
in writing, and if and when it is hand delivered or sent by regular mail, with
postage prepaid, to my residence (as noted in Strainwise's records), or to
Strainwise's principal office, as the case may be.
20. Date of Effectiveness. This Agreement shall be deemed effective as of
the commencement of my employment with Strainwise.
7
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the
date set forth below.
Dated: January 16, 2014 /s/ Shawn Phillips
--------------------------------
STRAINWISE, INC.
By:/s/ Erin E. Phillips
-------------------------------
Erin E. Phillips, President
8
Exhibit A to Confidentiality and Non-Competition Agreement
CERTIFICATE
This is to certify that I do not have in my possession, nor have I failed
to return, any devices, records, data, notes, reports, proposals, lists,
correspondence, specifications, software, computer programs, sketches,
materials, equipment, or other documents or property, or reproductions of any
aforementioned items belonging to Strainwise, Inc., its subsidiaries,
affiliates, successors or assigns (together, the "Company").
I further certify that I have complied with all the terms of the
Confidentiality and Non-Competition Agreement, signed by me, including the
reporting of any Subject Ideas and original works of authorship, conceived or
made by me (solely or jointly with others) covered by that Agreement.
I further agree that, in compliance with the Confidentiality and
Non-Competition Agreement, I will preserve as confidential all trade secrets,
confidential knowledge, data or other proprietary information relating to
products, processes, know-how, designs, formulae, developmental or experimental
work, computer programs, data bases, other original works of authorship,
customer lists, business plans, financial information or other subject matter
pertaining to any business of the Company of any of its clients, consultants or
licensees.
Dated: _______________, 2014
--------------------------------
Shawn Phillips
9
STRAINWISE, INC.
CONFIDENTIALITY AND NON-COMPETITION AGREEMENT
This CONFIDENTIALITY AND NON-COMPETITION AGREEMENT (the "Agreement") is
made between STRAINWISE, INC., a Colorado corporation ("Strainwise" herein) and
the undersigned Erin Phillips.
In consideration of my appointment as President of Strainwise, my
employment as an executive officer of Strainwise, the receipt of confidential
information while associated with Strainwise, and other good and valuable
consideration, I, Erin E. Phillips, agree that:
1. Term of Agreement. This Agreement shall continue in full force and
effect for the duration of my relationship with Strainwise and shall continue
thereafter until terminated through a written instrument signed by both parties.
2. Confidentiality.
(a) Definitions. "Proprietary Information" is all information and
any idea of whatever form, tangible, pertaining in any manner to the business of
Strainwise and its eight (8) affiliated retail stores commonly known as "The
Retreat", "The Ridge", "The Shelter", "The Annie", The Haven", "The Sanctuary",
"The Grove", "The Spring", and "The Reserve", together with all associated
cannabis cultivation facilities (collectively Strainwise, such eight stores and
the cultivation facilities are called the "Company" herein), or any of its
employees, clients, consultants, or business associates, which was produced by
any employee or consultant of the Company in the course of his or her employment
or consulting relationship or otherwise produced or acquired by or on behalf of
the Company. Proprietary Information includes, but is not limited to, all
know-how and software, technology, formulae, product information, plans,
devices, compilations of information, technical data, distribution methods,
supplier and client lists, sales and marketing information, client account
records, training and operations materials, memoranda, personnel records, code
books, pricing information, and any financial information concerning or relating
to the business, accounts, customers, employees and affairs of the Company, or
others, obtained by or furnished, disclosed or disseminated to an employee, or
obtained, assembled, or composed by an employee or under his or her supervision,
during the course of his or her employment by the Company, including all trade
secrets, intellectual property, software programs, computer codes, internet
domain names, Internet and World Wide Web URLs or addresses, and any techniques,
systems, forms and methods which have been used and/or devised by the Company
with respect to the business of the Company, or which have been used and/or
devised by clients of the Company and disclosed to the Company, and all physical
embodiments (including copies) of the foregoing. All Proprietary Information not
generally known outside of the Company's organization, and all Proprietary
Information so known only through improper means, shall be deemed "Confidential
Information." By example and without limiting the foregoing definition,
Proprietary and Confidential Information shall include, but not be limited to:
1
(1) methods, processes and/or technologies for the growing,
cultivation and production of cannabis and marijuana plants and products;
(2) cannabis business processes, procedures and strategies;
(3) retail and medical cannabis store operations;
(4) cannabis branding and fulfillment services;
(5) forecasts, unpublished financial information, budgets, projections,
customer lists, and client identities, characteristics and agreements;
(6) software, processes, trade secrets, computer programs, electronic
codes, inventions, innovations, discoveries, improvements, data,
know-how, and formats;
(7) business, marketing, and strategic plans;
(8) information about costs, profits, markets, sales, contracts and
lists of clients and referral sources;
(9) employee personnel files and compensation information;
(10) customer lists and names of customer contact personnel;
and
(11) customer terms, information, payments and data.
Confidential Information is to be broadly defined, and includes all
information that has or could have commercial value or other utility in the
business in which the Company (or any part thereof) is engaged or contemplates
engaging, and all information of which the unauthorized disclosure could be
detrimental to the interests of Strainwise, whether or not such information is
identified as Confidential Information by Strainwise.
(b) Existence of Confidential Information. Strainwise, through and
in connection with the operations of the entities comprising the Company, owns
and has developed and compiled, and will develop and compile, certain trade
secrets, proprietary techniques and other Confidential Information which have
great value to its business. This Confidential Information includes not only
information disclosed by Strainwise to me, but also information learned by me
during the course of my relationship with the entities comprising the Company.
(c) Protection of Confidential Information. I will not, directly or
indirectly, use, make available, sell, disclose or otherwise communicate to any
third party, other than in my assigned duties and for the benefit of Strainwise,
any of the Strainwise's Confidential Information, either during or after my
relationship with Strainwise. I agree not to publish, disclose or otherwise
disseminate such information without prior written approval of an executive
officer (other than me) of Strainwise. I acknowledge that I am aware that the
unauthorized disclosure of Confidential Information of Strainwise may be highly
prejudicial to its interests, an invasion of privacy, and an improper disclosure
of trade secrets. Whenever the approval, designation, specification or other act
of an executive officer is required under this Agreement, an executive officer
2
may, by written designation, authorize an agent of the Company to perform such
act.
(d) Delivery of Confidential Information. Upon request or when my
relationship with the Company terminates, I will immediately deliver to
Strainwise all copies of any and all materials and writings received from,
created for, or belonging to the Company including, but not limited to, those
which relate to or contain Confidential Information.
(e) Prior Actions and Knowledge. I represent and warrant that from
the time of my first contact with Strainwise I held in strict confidence all
Confidential Information and have not disclosed any Confidential Information,
directly or indirectly, to anyone outside Strainwise, or used, copied,
published, or summarized any Confidential Information, except to the extent
otherwise permitted in this Agreement.
(f) Third Parties. I represent that my relationship with Strainwise
does not and will not breach any agreements with or duties to a former employer
or any other third party. I will not disclose to Strainwise or use on its behalf
any confidential information belonging to others and that I will not bring onto
the premises of Strainwise any confidential information belonging to any such
party unless consented to in writing by such party.
3. Proprietary Rights, Inventions and New Ideas.
(a) Definition. The term "Subject Ideas" includes any and all ideas,
processes, trademarks, service marks, inventions, designs, technologies,
computer software, original works of authorship, discoveries, copyrights,
copyrightable work products, marketing and business ideas, and all improvements,
know-how, data, rights, and claims related to the foregoing that, whether or not
patentable, which are conceived, developed or created which: (1) relate to the
Company's business; (2) result from any work performed by me for the Company;
(3) involve the use of the Company's information, equipment, supplies,
facilities or trade secrets; (4) relate to the Company's proposed or
contemplated business; (5) result from or are suggested by any work done by the
Company or at the Company's request, or any projects specifically assigned to
me; or (6) result from my access to any of the Company's memoranda, notes,
records, client lists, referral sources, research results, data, inventions,
processes, or other materials (collectively, "Strainwise Materials").
(b) Strainwise Ownership. All right, title and interest in and to
all Subject Ideas, shall be held and owned solely by Strainwise, and where
applicable, all Subject Ideas shall be considered works made for hire. In the
event that the Subject Ideas shall be deemed not to constitute works made for
hire, or in the event that I should otherwise, by operation of law, be deemed to
retain any rights (whether moral rights or otherwise) to any Subject Ideas, I
agree to assign to Strainwise, without further consideration, my entire right,
title and interest in and to each and every such Subject Idea and Invention.
(c) Determination of Subject Ideas. I further agree that all
information and records pertaining to any idea, process, trademark, service
mark, invention, technology, computer software, original work of authorship,
design, discovery, copyright, product, and all improvements, know-how, rights,
and claims related to the foregoing ("Intellectual Property"), that I do not
believe to be a Subject Idea, but that is conceived, developed, or reduced to
3
practice by the Company (alone by me or with others) during my relationship with
Strainwise and for five (5) years thereafter, shall be disclosed promptly by me
to Strainwise (such disclosure to be received in confidence). Strainwise shall
examine such information to determine if in fact the Intellectual Property is a
Subject Idea subject to this Agreement.
(d) Access. Because of the difficulty of establishing when any
Subject Ideas are first conceived by me, or whether it results from my access to
Confidential Information or Company Materials, I agree that any Subject Idea
shall, among other circumstances, be deemed to have resulted from my access
Strainwise Materials if: (1) it grew out of or resulted from my work with
Strainwise or is related to the business of the Company, and (2) it is made,
used, sold, exploited or reduced to practice within one (1) year of the
termination of my relationship with the Company.
(e) No Use of Name. I shall not at any time use any of the Company's
names or any Strainwise trade name(s) in any advertising or publicity without
the prior written consent of Strainwise.
4. Competitive Activity.
(a) Acknowledgment. I acknowledge that the pursuit of the activities
forbidden by Section 4(b) below would necessarily involve the use, disclosure or
misappropriation of Confidential Information.
(b) Prohibited Activity. To prevent the above-described disclosure,
misappropriation and breach, I agree that during my employment and for a period
of five (5) years after termination of my relationship with Strainwise, without
Strainwise's express written consent, I shall not, directly or indirectly (i)
employ, solicit for employment, or recommend for employment any person employed
by the Company; (ii) contact or solicit any person or business which was a
client of the Company at any time within twelve (12) months before the
termination of my employment with Strainwise in connection with any matters
similar in nature or related to any business conducted between or contemplated
by the Company and such client at any time during my employment with Strainwise;
(iii) engage in any present or contemplated business activity that is or may be
competitive with the Company (or any part thereof) in the State of Colorado or
any other state of the United States of America where the Company (or any part
thereof) conducts its business, unless I can prove that any action taken in
contravention of this subsection (b) was done without the use in any way of
Confidential Information. For purposes of this subsection, to "engage in a
business in competition with the business of the Company, or a "competitive
business" shall mean: To be employed by, own an interest in, be a consultant to,
be a partner in or otherwise participate in any business or venture which offers
or sells to businesses or persons, cannabis related products or services which
are the same as or similar to those which are, at the then applicable time,
being offered and sold by the Company (or any part thereof).
5. Representations and Warranties. I represent and warrant (i) that I have
no obligations, legal or otherwise, inconsistent with the terms of this
Agreement or with my undertaking a relationship with Strainwise; (ii) that the
4
performance of the services called for by this Agreement do not and will not
violate any applicable law, rule or regulation or any proprietary or other right
of any third party; (iii) that I will not use in the performance of my
responsibilities for Strainwise any materials or documents of a former employer;
and (iv) that I have not entered into or will enter into any agreement (whether
oral or written) in conflict with this Agreement.
6. Termination Obligations.
(a) Upon the termination of my relationship with the Company or
promptly upon Strainwise's request, I shall surrender to Strainwise all
equipment, tangible Proprietary Information, documents, books, notebooks,
records, reports, notes, memoranda, contracts, lists, computer disks (and other
computer-generated files and data), any other data and records of any kind, and
copies thereof (collectively, "Company Records"), created on any medium and
furnished to, obtained by, or prepared by myself in the course of or incident to
my employment, that are in my possession or under my control.
(b) My representations, warranties, and obligations contained in
this Agreement shall survive the termination of my relationship with Strainwise.
(c) Following any termination of the Period of Employment, I will
fully cooperate with the Company in all matters relating to my continuing
obligations under this Agreement.
(d) I hereby grant consent to notification by Strainwise to any of
my future employers or companies I consult with about my rights and obligations
under this Agreement.
(e) Upon termination of my relationship with Strainwise, I will
execute the Certificate contained in Exhibit A.
7. Injunctive Relief. I acknowledge that my failure to carry out any
obligation under this Agreement, or a breach by me of any provision herein, will
constitute immediate and irreparable damage to Strainwise, which cannot be fully
and adequately compensated in money damages and which will warrant preliminary
and other injunctive relief, an order for specific performance, and other
equitable relief. I further agree that no bond or other security shall be
required in obtaining such equitable relief and I hereby consent to the issuance
of such injunction and to the ordering or specific performance. I also
understand that other action may be taken and remedies enforced against me.
8. Modification. No modification of this Agreement shall be valid unless
made in writing and signed by both parties.
9. Binding Effect. This Agreement shall be binding upon me, my heirs,
executors, assigns and administrators and is for the benefit of Strainwise and
its successors and assigns.
10. Arbitration. Except as to any action to obtain injunctive relief and/or
specific performance as provided in Section 7 above, I agree that any dispute or
controversy arising out of or relating to any interpretation, construction,
5
performance or breach of this Agreement, shall be settled by arbitration to be
held in Denver, Colorado, in accordance with the rules then in effect of the
American Arbitration Association. The arbitrator may grant injunctions or other
relief in such dispute or controversy. The decision of the arbitrator shall be
final, conclusive and binding on the parties to the arbitration. Judgment may be
entered on the arbitrator's decision in any court having jurisdiction; provided,
however, that the arbitrator shall not have the power to alter or amend this
Agreement. As allowed by the provisions of Colorado law, depositions may be
taken and discovery obtained in any such arbitration proceedings and such
section shall be deemed to be made a part of this Agreement and applicable to
any such arbitration.
11. Governing Law. This Agreement shall be construed in accordance with,
and all actions arising under or in connection therewith shall be governed by,
the laws of the State ofColorado.
12. Integration. This Agreement, together with the Employment Agreement
between the Company and the undersigned set forth the parties mutual rights and
obligations with respect to proprietary information, prohibited competition, and
intellectual property. They are intended to be the cumulative final, complete,
and exclusive statements of the terms of the party's agreements regarding these
subjects. This Agreement, together with any Employment Agreement between
Strainwise and the undersigned supersede all other prior and contemporaneous
agreements and statements on these subjects, and they may not be contradicted by
evidence of any prior or contemporaneous statements or agreements. To the extent
that the practices, policies, or procedures of Strainwise, now or in the future,
apply to myself and are inconsistent with the terms of this Agreement, the
provisions of this Agreement shall control unless changed in writing by
Strainwise.
13. Employment At Will. This Agreement is not an employment agreement. I
understand that Strainwise may terminate my association or employment with it at
any time, with or without cause, subject to the terms of any separate written
employment agreement executed by a duly authorized officer of Strainwise.
14. Construction. This Agreement shall be construed as a whole, according
to its fair meaning, and not in favor of or against any party. By way of example
and not limitation, this Agreement shall not be construed against the party
responsible for any language in this Agreement. The headings of the paragraphs
hereof are inserted for convenience only, and do not constitute part of and
shall not be used to interpret this Agreement. The covenants and agreements
contained in Sections 4, 6, 7, and 10 of this Agreement, which are of the
essence of this Agreement, are reasonable and necessary to protect and preserve
the business interests and properties of the Company. Irreparable harm will be
suffered by Strainwise should I breach any of such covenants. Such covenants are
separate, distinct and severable not only from each other but also from all
other provisions of this Agreement. In the event that such covenants are held
invalid or unenforceable as written, any court of competent jurisdiction may
revise such covenants to make them enforceable under applicable law. The
unenforceability of any such covenant shall not affect the validity or
enforceability of any other such covenant, or any other provisions of this
Agreement. In addition to other remedies available to it, Strainwise shall be
entitled to petition an appropriate court for temporary restraining orders and
temporary and permanent injunctions without the necessity of proving actual
6
damages to prevent a breach or contemplated breach of any of such covenants
since Strainwise will have no adequate remedy at law.
15. Attorneys' Fees. Should either I or Strainwise, or my heir, personal
representative, successor or permitted assign of either party, resort to legal
proceedings to enforce this Agreement, the party prevailing in such legal
proceeding shall be entitled, in addition to such other relief as may be
granted, to recover its attorneys' fees and costs in such litigation from the
party against whom enforcement was sought.
16. Severability. If any term, provision, covenant or condition of this
Agreement, or the application thereof to any person, place or circumstance,
shall be held to be invalid, unenforceable or void, the remainder of this
Agreement and such term, provision, covenant or condition as applied to other
persons, places and circumstances shall remain in full force and effect.
17. Rights Cumulative. The rights and remedies provided by this Agreement
and any Employment Agreement to which Strainwise and I are parties are
cumulative, and the exercise of any right or remedy by either Strainwise or me
(or by that party's successor), whether pursuant hereto, to any other agreement,
or to law, shall not preclude or waive that party's right to exercise any or all
other rights and remedies. This Agreement will inure to the benefit of
Strainwise and its successors and assigns.
18. Nonwaiver. The failure of either Strainwise or me, whether purposeful
or otherwise, to exercise in any instance any right, power or privilege under
this Agreement or under law shall not constitute a waiver or any other right,
power or privilege, nor of the same right, power or privilege in any other
instance. Any waiver by Strainwise or by me must be in writing and signed by
either myself, if I am seeking to waive any of my rights under this Agreement,
or by an officer of Strainwise (other than me) or some other person duly
authorized by Strainwise.
19. Notices. Any notice, request, consent or approval required or permitted
to be given under this Agreement or pursuant to law shall be sufficient if it is
in writing, and if and when it is hand delivered or sent by regular mail, with
postage prepaid, to my residence (as noted in Strainwise's records), or to
Strainwise's principal office, as the case may be.
20. Date of Effectiveness. This Agreement shall be deemed effective as of
the commencement of my employment with Strainwise.
7
IN WITNESS WHEREOF, the undersigned have executed this Agreement as of the
date set forth below.
Dated: January 16, 2014 /s/ Erin E. Phillips
---------------------------------
STRAINWISE, INC.
By:/s/ Shawn Phillips
-------------------------------------
Shawn Phillips, Chief Executive Officer
8
Exhibit A to Confidentiality and Non-Competition Agreement
CERTIFICATE
This is to certify that I do not have in my possession, nor have I failed
to return, any devices, records, data, notes, reports, proposals, lists,
correspondence, specifications, software, computer programs, sketches,
materials, equipment, or other documents or property, or reproductions of any
aforementioned items belonging to Strainwise, Inc., its subsidiaries,
affiliates, successors or assigns (together, the "Company").
I further certify that I have complied with all the terms of the
Confidentiality and Non-Competition Agreement, signed by me, including the
reporting of any Subject Ideas and original works of authorship, conceived or
made by me (solely or jointly with others) covered by that Agreement.
I further agree that, in compliance with the Confidentiality and
Non-Competition Agreement, I will preserve as confidential all trade secrets,
confidential knowledge, data or other proprietary information relating to
products, processes, know-how, designs, formulae, developmental or experimental
work, computer programs, data bases, other original works of authorship,
customer lists, business plans, financial information or other subject matter
pertaining to any business of the Company of any of its clients, consultants or
licensees.
Dated: _______________, 2014
--------------------------------
Erin Phillips
EX-21
8
s1exh21sept-14.txt
EXH. 21 - SUBSIDIARIES
EXHIBIT 21
The Company's only subsidiary is Strainwise, Inc., a Colorado corporation.
Strainwise, Inc. conducts business under its own name.
EX-23
9
s1exh231sept-14.txt
EXH. 23.1 - CONSENT OF ATTORNEYS H&H
EXHIBIT 23.1
CONSENT OF ATTORNEYS
Reference is made to the Registration Statement of Strainwise, Inc. on Form
S-1 whereby certain shareholders of the Company propose to sell up to 4,130,500
shares of the Company's common stock. Reference is also made to Exhibit 5
included in the Registration Statement relating to the validity of the
securities proposed to be sold.
We hereby consent to the use of our opinion concerning the validity of the
securities proposed to be sold.
Very truly yours,
HART & HART, LLC
/s/ William T. Hart
--------------------
William T. Hart
Denver, Colorado
September 12, 2014
EX-23
10
s1exh232sept-14.txt
EXH. 23.2 - CONSENT OF ACCOUNTANT BORGERS
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this Registration Statement on Form S-1 of
our report dated August 14, 2014 with respect to the audited financial
statements of Strainwise, Inc. for the year ended January 31, 2014 and the
period ended January 31, 2013.
/s/ B.F. Borgers CPA PC
BF Borgers CPA PC
Denver, Colorado
September 16, 2014